<SEC-DOCUMENT>0001104659-23-050580.txt : 20230427
<SEC-HEADER>0001104659-23-050580.hdr.sgml : 20230427
<ACCEPTANCE-DATETIME>20230427060407
ACCESSION NUMBER:		0001104659-23-050580
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20230427
FILED AS OF DATE:		20230427
DATE AS OF CHANGE:		20230427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BELLUS Health Inc.
		CENTRAL INDEX KEY:			0001259942
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39034
		FILM NUMBER:		23851589

	BUSINESS ADDRESS:	
		STREET 1:		275 ARMAND-FRAPPIER BLVD.
		CITY:			LAVAL
		STATE:			A8
		ZIP:			H7V 4A7
		BUSINESS PHONE:		450-680-4500

	MAIL ADDRESS:	
		STREET 1:		275 ARMAND-FRAPPIER BLVD.
		CITY:			LAVAL
		STATE:			A8
		ZIP:			H7V 4A7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEUROCHEM INC
		DATE OF NAME CHANGE:	20030814
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2313190d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">REPORT OF FOREIGN PRIVATE ISSUER<BR>
PURSUANT TO RULE&nbsp;13a-16 OR 15d-16<BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">For the month of April&nbsp;2023</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Commission File Number: 001-39034</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>BELLUS
HEALTH INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant<B>&rsquo;</B>s name
into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">275 Armand-Frappier Blvd.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Laval, Qu&eacute;bec</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">H7V 4A7</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Canada</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Address of principal executive office)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
files or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form&nbsp;20-F&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F&nbsp;<FONT STYLE="font-family: Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DOCUMENTS FURNISHED AS PART OF THIS FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Material Change Report dated April 26, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Arrangement Agreement dated April 17, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Form of D&amp;O Support and Voting Agreement
between BELLUS Health Inc. and its directors and executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="tm2313190d1_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1 &ndash; Material Change Report dated April 26, 2023.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><A HREF="tm2313190d1_ex99-2.htm" STYLE="-sec-extract: exhibit">99.2 &ndash; Arrangement Agreement dated April 17, 2023.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><A HREF="tm2313190d1_ex99-3.htm" STYLE="-sec-extract: exhibit">99.3
 &ndash; Form of D&amp;O Support and Voting Agreement between BELLUS Health Inc. and its directors and executive officers.</A></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BELLUS Health Inc.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 27, 2023</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Ramzi Benamar</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramzi Benamar</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tm2313190d1_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM 51-102F3</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">MATERIAL CHANGE REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 1</B></TD>
  <TD><B>Name and Address of Company</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">BELLUS Health Inc. (&#8220;<B>BELLUS
Health</B>&#8221;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">275 Blvd. Armand-Frappier</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Laval (Qu&eacute;bec)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">H7V 4A7</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 2</B></TD>
  <TD><B>Date of Material Change</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">April 17, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 3</B></TD>
  <TD><B>News Release</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A news release was issued on April 18,
2023, and disseminated by <FONT STYLE="font-family: Times New Roman, Times, Serif">Business Wire</FONT>, a copy of which has been filed
and is available on the SEC website at www.sec.gov and on the SEDAR website at www.sedar.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 4</B></TD>
  <TD><B>Summary of Material Change</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">GSK plc (&#8220;<B>GSK</B>&#8221;) and
BELLUS Health announced that they have entered into an agreement under which GSK will acquire BELLUS Health for US$14.75 per share of
common stock in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 5</B></TD>
  <TD><B>Full Description of Material Change</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Full
Description of Material Change</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">On April 18, 2023, GSK and BELLUS Health
announced that they have entered into an agreement under which GSK will acquire BELLUS Health for US$14.75 per share of common stock in
cash representing an approximate total equity value of US$2.0 billion (&pound;1.6 billion).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Under the terms of the agreement, the
acquisition will be effected through a Plan of Arrangement pursuant to the <I>Canada Business Corporations Act</I> in which the shares
of BELLUS Health outstanding will be acquired by GSK in consideration of US$14.75 per share in cash. Subject to customary conditions,
including court approval, the approval of the acquisition by at least 66.67% of the votes cast at a meeting of BELLUS Health&#8217;s shareholders
and a majority of the votes cast by non-interested shareholders at such meeting, and approval by the appropriate regulatory agencies,
the transaction is expected to close in the third quarter of 2023 or earlier.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The per-share price represents a premium of approximately 103% to BELLUS&rsquo; closing stock price on April 17th, 2023 and a premium
of approximately 101% to BELLUS&rsquo; volume-weighted average price (VWAP) over the last 30 trading days. BELLUS&rsquo; Board of Directors
has unanimously recommended that BELLUS&rsquo; shareholders vote in favour of the approval of the acquisition.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>5.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disclosure
for Restructuring Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">N/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 6</B></TD>
  <TD><B>Reliance on subsection 7.1(2) of National Instrument 51-102</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">This report is not being filed on a
confidential basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 7</B></TD>
  <TD><B>Omitted Information</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">N/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 8</B></TD>
  <TD><B>Executive Officer</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">For further information, please contact
Ramzi Benamar, Chief Financial Officer (450)&nbsp;680-4500.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Item 9</B></TD>
  <TD><B>Date of Report</B></TD></TR>
</TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">April 26, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Cautionary statement regarding forward-looking
statements relating to BELLUS Health</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This material change report may include
 &#8220;forward-looking statements&#8221; within the meaning of the applicable securities laws, including with respect to the timing
and completion of the arrangement, the proposed timing of filings, the impact of the proposed transaction on BELLUS Health, and the
operations of BELLUS Health post-transaction. Each forward-looking statement contained in this material change report is based on the
current expectations of management and is subject to known and unknown risks and uncertainties and other unknown factors that could
cause actual results to differ materially from historical results and those expressed or implied by such statement. In addition to
statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labelled with the terms
 &#8220;believes,&#8221; &#8220;belief,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;anticipates,&#8221;
 &#8220;will,&#8221; or &#8220;plans&#8221; to be uncertain and forward-looking. Such statements include, but are not limited to, the
potential of camlipixant to successfully treat RCC and other hypersensitization-related disorders, the success of BELLUS
Health&#8217;s preclinical studies and clinical trials, and the timing and outcome of anticipated regulatory approvals. Additional
risk factors include, but are not limited to, the impact of general economic conditions, general conditions in the pharmaceutical
industry, the impact of the COVID-19 pandemic, including impact to the initiation and completion of clinical trials in a timely
manner or at all, changes in the regulatory environment, supply chain impacts, fluctuations in costs, changes to the competitive
environment, reliance on third parties to conduct preclinical studies and clinical trials for camlipixant. Furthermore, the risks
and uncertainties include, among others, the risk that a condition to closing of the arrangement may not be satisfied, the risk that
any required shareholder, court or applicable regulatory approvals for the arrangement may not be obtained or be obtained subject to
conditions that are not anticipated, the failure to realize the anticipated benefits of the transaction, the occurrence of any event
that could give rise to termination of the transaction, and potential litigation in connection with the transaction or other
settlements or investigations that may affect the timing or occurrence of the transaction or result in significant costs of defence,
indemnification and liability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">BELLUS Health cautions investors not to rely on the
forward-looking statements contained in this material change report when making an investment decision in their securities. Investors
are encouraged to read BELLUS Health&#8217;s filings available on the SEC website at www.sec.gov and on the SEDAR website at www.sedar.com,
for a discussion of these and other risks and uncertainties. The forward-looking statements in this material change report speak only
as of the date of this material change report and BELLUS Health undertakes no obligation to update or revise any of these statements,
whether as a result of new information, future events or otherwise, except as required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>tm2313190d1_ex99-2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit 99.2</B></FONT></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><U>EXECUTION VERSION</U></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>GSK
PLC</B></FONT>,</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>14934792
CANADA INC.</B></FONT>,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BELLUS HEALTH INC.</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARRANGEMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>April&nbsp;17, 2023</B></P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;I INTERPRETATIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 15%"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Defined Terms</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain Rules&nbsp;of Interpretation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Disclosure Schedule</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;II THE ARRANGEMENT</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arrangement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Order</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company Meeting</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Circular</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Final Order</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Court Proceedings</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Articles of Arrangement and Effective Time</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposit of Consideration</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Withholding Taxes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incentive Plan Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further Assurances</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;III REPRESENTATIONS AND WARRANTIES</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations and Warranties of the Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations and Warranties of Parent and Purchaser</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;IV COVENANTS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Access to Information</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operation of the Company&rsquo;s Business</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filings, Consents, and Approvals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">401(k)&nbsp;Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification of Officers and Directors</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">37</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securityholder Litigation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">39</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional Agreements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice and Cure Provisions.</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock Exchange Delisting; Deregistration</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Regulatory Matters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.12</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;338 Elections; Entity Classification Elections.</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">42</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.13</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Actions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.15</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. Tax Treatment of Amalgamation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">43</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;V ADDITIONAL COVENANTS REGARDING
    NON-SOLICITATION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.1</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Solicitation</FONT></TD>
    <TD STYLE="text-align: right; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">44</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notification of Acquisition Proposals</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">45</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Responding to an Acquisition Proposal</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Right to Match</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;VI CONDITIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligation of Each Party to Consummate
    the Arrangement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligation of the Company to Consummate
    the Arrangement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Conditions to Obligations of Parent and Purchaser to
    Consummate the Arrangement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Frustration of Closing Conditions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deemed Satisfaction of Conditions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">51</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;VII TERMINATION</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination and Abandonment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">52</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effect of Termination/Survival</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination Fee and Expenses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">53</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE&nbsp;VIII GENERAL PROVISIONS</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.1</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.2</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.3</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Entire Agreement; Counterparts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.4</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable Laws; Jurisdiction; Specific Performance;
    Remedies</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">56</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.5</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assignability</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.6</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No Third-Party Beneficiary</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.7</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notices</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.8</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Severability</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.9</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Obligation of Parent</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.10</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Taxes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.11</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Waiver of Conflicts; Non-Assertion of Attorney-Client
    Privilege</FONT></TD>
    <TD STYLE="text-align: right">60</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
    A</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 85%; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan
    of Arrangement</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
    B</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arrangement
    Resolution</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
    C</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations
    and Warranties of the Company</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
    D</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representations
    and Warranties of Parent and Purchaser</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 2pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>SCHEDULE
    E</U></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D&amp;O
    Support and Voting Agreement</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARRANGEMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>THIS
AGREEMENT</B></FONT> is made as of April&nbsp;17, 2023,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">BY AND AMONG:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">GSK plc, a public limited company formed under
the laws of England and Wales</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(&ldquo;<B><I>Parent</I></B>&rdquo;),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">14934792 Canada Inc., a corporation existing under the Canada
Business Corporations Act and a wholly owned Subsidiary of Parent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(&ldquo;<B><I>Purchaser</I></B>&rdquo;),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">-and-</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">Bellus Health Inc.,
a corporation existing under the Canada Business Corporations Act (the &ldquo;<B><I>Company</I></B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">NOW THEREFORE,
in consideration of the covenants and agreements herein contained, the Parties agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;I<BR>
INTERPRETATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.1</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Defined
Terms</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As used in this Agreement, the following terms
have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>401(k)&nbsp;Plan</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;4.4</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Acquisition Proposal</I></B>&rdquo;
means, other than the transactions contemplated by this Agreement and any transaction solely between the Company, on the one hand, and
one or more of its wholly owned Subsidiaries, on the other hand, or solely between or among the Company&rsquo;s wholly owned Company
Subsidiaries, any indication of interest, inquiry, request for information, proposal or offer (including any thereto) from or made by
any Person or group of Persons &ldquo;acting jointly or in concert&rdquo; (within the meaning of National Instrument 62-104 &ndash; Take-Over
Bids and Issuer Bids) (other than Parent and Purchaser) made after the date of this Agreement relating to, in a single transaction or
series of related transactions (i)&nbsp;any direct or indirect sale, disposition, joint venture, transfer or license (or any lease, long-term
supply agreement or other arrangement having the same economic effect as a sale) of assets (including securities of Company Subsidiaries)
representing 20% or more of the Company and the Company Subsidiaries&rsquo; assets (taken as a whole) or to which 20% or more of the
Company and the Company Subsidiaries&rsquo; revenues or earnings (taken as a whole) are attributable (in each case based on the consolidated
financial statements of the Company most recently filed on SEDAR prior to such offer or proposal), (ii)&nbsp;any direct or indirect take-over
bid, recapitalization, tender offer, exchange offer, treasury issuance, acquisition, transfer, or other transaction that if consummated,
would result in any Person or group of Persons beneficially owning or exercising control or direction over, directly or indirectly, 20%
or more of any class of voting or equity securities (including securities convertible into or exercisable or exchangeable for voting
or equity securities) of the Company or any of its Company Subsidiaries whose assets represent 20% or more of the Company and the Company
Subsidiaries&rsquo; assets (taken as a whole) or to which 20% or more of the Company and the Company Subsidiaries&rsquo; revenues or
earnings (taken as a whole) are attributable (in each case based on the consolidated financial statements of the Company most recently
filed on SEDAR prior to such offer or proposal), (iii)&nbsp;any plan of arrangement, merger, amalgamation, consolidation, reorganization,
spin-off, amalgamation, share exchange, business combination, recapitalization, liquidation, dissolution, joint venture or similar transaction
involving the Company or any of its Subsidiaries pursuant to which any such Person or group of Persons would own, directly or indirectly,
assets representing 20% or more of the consolidated assets or contributing 20% or more of the consolidated revenue of the Company and
its Subsidiaries, taken as a whole, or (iv)&nbsp;any other similar transaction or series of related transactions involving the Company
or any of its Subsidiaries whose assets represent 20% or more of the Company and the Company Subsidiaries&rsquo; assets (taken as a whole)
or to which 20% or more of the Company and the Company Subsidiaries&rsquo; revenues or earnings (taken as a whole) are attributable (in
each case based on the consolidated financial statements of the Company most recently filed on SEDAR prior to such offer or proposal).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Affected Securityholders</I></B>&rdquo;
means, collectively, the Shareholders and the holders of any Company Equity Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Affiliate</I></B>&rdquo; means, as
to any Person, any other Person that, directly or indirectly, controls, or is controlled by, or is under common control with, such Person.
For this purpose, &ldquo;control&rdquo; (including, with its correlative meanings, &ldquo;controlled by&rdquo; and &ldquo;under common
control with&rdquo;) means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies
of a Person, whether through the ownership of securities or partnership or other ownership interests, by Contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Aggregate Arrangement Consideration</I></B>&rdquo;
means the aggregate Arrangement Consideration to be received by Shareholders under this Agreement and the Plan of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Agreement</I></B>&rdquo; means this
arrangement agreement, including all schedules annexed hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&ldquo;<I>AMF</I></B></FONT>&rdquo;
means the <I>Autorit&eacute; des march&eacute;s financiers </I>(Qu&eacute;bec).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Anti-Corruption Laws</I></B>&rdquo;
means applicable Laws related to corruption and bribery, including the U.S. Foreign Corrupt Practices Act of 1977, the Anti-Kickback
Act of 1986, the U.K. Bribery Act 2010, the Anti-Bribery Laws of the People&rsquo;s Republic of China, legislation adopted in furtherance
of the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, the <I>Corruption of
Foreign Public Officials Act </I>(Canada), the <I>Proceeds of Crime (Money Laundering) and Terrorist Financing Act </I>(Canada), the
<I>Criminal Code </I>(Canada), and any other applicable Law of similar effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Antitrust Laws</I></B>&rdquo; means
the Sherman Act, the Clayton Act, the HSR Act, the Federal Trade Commission Act, the Competition Act, state antitrust Laws, and all other
applicable Laws and regulations (including non-U.S. Laws and regulations) issued by a Governmental Body that are designed or intended
to preserve or protect competition, prohibit and restrict agreements in restraint of trade or monopolization, attempted monopolization,
restraints of trade and abuse of a dominant position, or to prevent acquisitions, mergers or other business combinations and similar
transactions, the effect of which may be to lessen or impede competition or to tend to create or strengthen a dominant position or to
create a monopoly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement</I></B>&rdquo; means
an arrangement of the Company under section 192 of the CBCA on the terms and subject to the conditions set out in the Plan of Arrangement,
subject to any amendments or variations to the Plan of Arrangement made in accordance with the terms of this Agreement and the Plan of
Arrangement or made at the direction of the Court in the Final Order with the prior written consent of the Company and Parent, each acting
reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement Consideration</I></B>&rdquo;
means $14.75 per Share in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement Resolution</I></B>&rdquo;
means the special resolution approving the Plan of Arrangement to be considered at the Company Meeting, substantially in the form of
Schedule B.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Articles of Arrangement</I></B>&rdquo;
means the articles of arrangement of the Company in respect of the Arrangement, required by the CBCA to be sent to the CBCA Director
after the Final Order is made, which shall include the Plan of Arrangement and otherwise be in a form and content satisfactory to the
Company and Parent, each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Balance Sheet</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;16</U> of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Bloom Burton Engagement Letter</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;32</U> of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Breaching Party</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;4.9(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><I>Business
Day</I></B>&rdquo; means a day except (i)&nbsp;a Saturday, a Sunday, or any other day on which (a)&nbsp;commercial banks in Montreal,
</FONT>Qu&eacute;bec are authorized or required by Laws to be closed or (b)&nbsp;banks are required or authorized by Law to be closed
in the City of London, United Kingdom, and (ii)&nbsp;the period from December&nbsp;24 to January&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Canadian Plan</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;27(g)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>CBCA</I></B>&rdquo; means the Canada
Business Corporations Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>CBCA Director</I></B>&rdquo; means
the director appointed pursuant to section 260 of the CBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Certificate of Arrangement</I></B>&rdquo;
means the certificate of arrangement to be issued by the CBCA Director pursuant to subsection 192(7)&nbsp;of the CBCA in respect of the
Articles of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Change in Recommendation</I></B>&rdquo;
means (i)&nbsp;the Company Board or any committee thereof fails to unanimously recommend or withdraws, amends, modifies or qualifies
the Company Board Recommendation or publicly proposes or states its intention to do any of the foregoing; (ii)&nbsp;the Company Board
or any committee thereof accepts, approves, endorses or recommends, or publicly proposes to accept, approve, endorse or recommend an
Acquisition Proposal, (iii)&nbsp;the Company Board or any committee thereof takes no position or remains neutral with respect to any
publicly announced Acquisition Proposal (it being understood that publicly taking no position or a neutral position with respect to a
publicly announced Acquisition Proposal for a period of no more than five (5)&nbsp;Business Days following the public announcement of
such Acquisition Proposal will not constitute a Change in Recommendation <I>provided</I> the Company Board has rejected such Acquisition
Proposal and affirmed the Company Board Recommendation by press release by the end of such five (5)&nbsp;Business Day period (or in the
event that the Company Meeting is scheduled to occur within such five (5)&nbsp;Business Day period, by the end of the third (3<SUP>rd</SUP>)
Business Day prior to the date of the Company Meeting)), (iv)&nbsp;the Company Board or any committee thereof fails to publicly reaffirm
by press release (without qualification) the Company Board Recommendation within five (5)&nbsp;Business Days after having been requested
in writing by Parent to do so (or in the event that the Company Meeting is scheduled to occur within such five (5)&nbsp;Business Day
period, prior to the third (3<SUP>rd</SUP>) Business Day prior to the date of the Company Meeting), or (v)&nbsp;the Company, Company
Board or any committee thereof publicly announces or publicly discloses any intention to do any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Chosen Courts</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;8.4(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Circular</I></B>&rdquo; means the
notice of the Company Meeting and accompanying management information circular, including all schedules, appendices and exhibits to,
and information incorporated by reference in, such management information circular, to be sent to the Shareholders in connection with
the Company Meeting, as amended, supplemented or otherwise modified from time to time in accordance with the terms of the Arrangement
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Closing</I></B>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.7(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Closing Date</I></B>&rdquo; means
the date on which the Closing actually occurs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Code</I></B>&rdquo; means the Internal
Revenue Code of 1986.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Collective Bargaining Agreement</I></B>&rdquo;
means any collective bargaining agreement, works council, labor, voluntary recognition, or similar agreement with respect to any current
or former Company Associate or other Contract with a union or employee association, including a neutrality or accretion clause or agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Commissioner of Competition</I></B>&rdquo;
means the Commissioner of Competition appointed pursuant to subsection 7(1)&nbsp;of the Competition Act or his or her designee, and,
when the context so requires, includes persons authorized to exercise the powers and perform the duties of the Commissioner of Competition
in accordance with section 8 of the Competition Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company</I></B>&rdquo; has the meaning
set forth in the preamble hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Advisor Engagement Letter</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;32</U> of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Associate</I></B>&rdquo;
means each current or former officer or other employee, or individual who is a current or former independent contractor, consultant,
or director, of or to the Company or any Company Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Board</I></B>&rdquo; means
the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Board Recommendation</I></B>
has the meaning set forth in <U>Section&nbsp;2.4(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Contract</I></B>&rdquo; means
any (i)&nbsp;Contract between the Company or any Company Subsidiary, on the one hand, and any party other than the Company or any Company
Subsidiary, on the other hand or (ii)&nbsp;Contract pursuant to which the Company or any Company Subsidiary is otherwise bound (other
than a Contract solely by and among the Company and the Company Subsidiaries).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Deferred Share Unit</I></B>&rdquo;
means a deferred share unit granted by the Company pursuant to the Company Equity Plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Disclosure Schedule</I></B>&rdquo;
means the disclosure schedule that has been prepared by the Company in accordance with the requirements of this Agreement and that has
been delivered by the Company to Parent on the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Equity Awards</I></B>&rdquo;
means the Company Options and the Company Deferred Share Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Equity Plans</I></B>&rdquo;
means the Company&rsquo;s Amended and Restated Stock Option Plan and the Company&rsquo;s Deferred Share Unit Plan for Designated Members
of the Boards, and Designated Employees, of the Company and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company IP</I></B>&rdquo; means all
Owned IP and all Exclusively Licensed IP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Lease</I></B>&rdquo; means
any Company Contract pursuant to which real property is licensed, leased, or subleased by the Company or a Company Subsidiary, as applicable,
from another Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Meeting</I></B>&rdquo; means
the special meeting of the Shareholders, including any adjournment or postponement thereof in accordance with the terms of the Arrangement
Agreement, to be called and held in accordance with the Interim Order to consider the Arrangement Resolution and for any other purpose
as may be set out in the Circular and agreed to in writing by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Option</I></B>&rdquo; means
an option to purchase Shares granted by the Company pursuant to a Company Equity Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Parties</I></B>&rdquo; means
the Company, any Company Subsidiary, and any of their respective current or former shareholders, optionholders, unitholders, members,
Affiliates, or Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Products</I></B>&rdquo; means
all compounds and other chemical entities, including camlipixant, and all products that are being researched, tested or developed by
or on behalf of the Company or any Company Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Publicly Filed Documents</I></B>&rdquo;
means all reports, schedules, forms, statements, and other documents (including exhibits and all other information incorporated therein,
amendments and supplements thereto) required to be filed or furnished by the Company (i)&nbsp;with or to the SEC or (ii)&nbsp;on SEDAR,
as the case may be, on or after January&nbsp;1, 2022 and prior to the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Registered IP</I></B>&rdquo;
means any Patent, trademark, copyright, or domain name included in the Company IP that is registered or issued under the authority of
any Governmental Body or internet domain name registrar, and any application for the registration of any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Representative</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;24 </U>of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company U.S. Subsidiary</I></B>&rdquo;
means Bellus Health Corp., a Delaware corporation that is a Company Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Competition Act</I></B>&rdquo; means
the Competition Act (Canada) as now in effect and as it may be amended from time to time to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Competition Act Approval</I></B>&rdquo;
means, with respect to the Transactions: (i)&nbsp;receipt by Parent of an advance ruling certificate from the Commissioner of Competition
under subsection 102(1)&nbsp;of the Competition Act to the effect that the Commissioner of Competition is satisfied that he or she would
not have sufficient grounds upon which to apply to the Competition Tribunal for an order under section 92 of the Competition Act, or
(ii)&nbsp;both of the (A)&nbsp;expiry or termination of the waiting period, including any extension of such waiting period, under section
123 of the Competition Act or the waiver of the obligation to provide a pre-merger notification in accordance with paragraph 113(c)&nbsp;of
the Competition Act, and (B)&nbsp;receipt by Parent of a No Action Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Confidentiality Agreement</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Consent</I></B>&rdquo; means any
approval, consent, ratification, permission, waiver, or authorization (including any Governmental Authorization).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Constating Documents</I></B>&rdquo;
means articles of incorporation, amalgamation, arrangement or continuation, as applicable, by-laws or other constating documents and
all amendments to such articles or by-laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Contract</I></B>&rdquo; means any
legally binding agreement, contract, subcontract, lease, understanding, instrument, bond, debenture, note, option, warrant, warranty,
purchase order, license, sublicense, insurance policy, benefit plan, or other legally binding commitment or undertaking of any nature
inclusive of all amendments, supplements or modifications thereto (except, in each case, ordinary course of business purchase orders).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Court</I></B>&rdquo; means the Qu&eacute;bec
Superior Court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>COVID-19</I></B>&rdquo; means SARS-CoV-2
or COVID-19, and any evolution or variant thereof or any related or associated epidemic, pandemic, or disease outbreak.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>D&amp;O Support and Voting Agreement</I></B>&rdquo;
means each support and voting agreement entered into between Parent and a director or officer of the Company, substantially in the form
of Schedule E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Depositary</I></B>&rdquo; means Computershare
Investor Services Inc. or such other Person as the Company and Parent may mutually agree to engage and appoint to act as depositary in
relation to the Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Designated Person</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Dissent Rights</I></B>&rdquo; has
the meaning set forth in the Plan of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Dissenting Holder</I></B>&rdquo;
has the meaning set forth in the Plan of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>DOJ</I></B>&rdquo; means the U.S.
Department of Justice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Effective Time</I></B>&rdquo; means
the Effective Time of the Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Employee Plan</I></B>&rdquo; means
each employment, consulting, executive compensation, incentive compensation, deferred compensation, bonus, stock purchase, stock options,
phantom share, deferred unit or other equity-based compensation, salary continuation, change-in-control, retention, severance, termination,
garden leave, pay in lieu, gross-up, pension, profit-sharing, savings, retirement, vacation, sick leave, disability, death benefit, group
insurance, hospitalization, medical, dental, life (including all individual life insurance policies as to which the Company or any of
its Subsidiaries is the owner, the beneficiary or both), Code Section&nbsp;125 &ldquo;cafeteria&rdquo; or &ldquo;flexible&rdquo; benefit,
employee loan, relocation, repatriation, clawback, educational assistance or fringe benefit plan, program, policy, practice, agreement
or arrangement, whether written or oral, formal or informal, funded or unfunded, insured or self-insured, registered or unregistered,
including, without limitation, each &ldquo;employee benefit plan&rdquo; within the meaning of Section&nbsp;3(3)&nbsp;of ERISA, each multiemployer
plan and any other employee benefit plan, program, policy, practice, agreement or arrangement, whether or not subject to ERISA (including
any funding instrument therefor now in effect or required in the future as a result of the Transactions or otherwise), in each case,
(i)&nbsp;under which any Company Associate (or any dependent or beneficiary thereof) has any present or future right to compensation
or benefits and (ii)&nbsp;that is maintained, sponsored or contributed to by the Company or any of its Subsidiaries, or with respect
to which the Company or any of its Subsidiaries has any obligation to maintain, sponsor or contribute, or (iii)&nbsp;with respect to
which the Company or any of its Subsidiaries has any direct or indirect liability, whether contingent or otherwise, other than any statutory
plans administered by a Governmental Body, including the Canada Pension Plan and Qu&eacute;bec Pension Plan and plans administered pursuant
to applicable federal or provincial health, worker&rsquo;s compensation or employment insurance legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Encumbrance</I></B>&rdquo; means
any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, encroachment, claim, infringement, interference, option,
right of first refusal, right of first offer, lease, covenant, condition, restriction, preemptive right, community property interest,
or other similar restriction (including any restriction on the voting of any security, any restriction on the transfer of any security
or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset, and any
restriction on the possession, exercise, or transfer of any other attribute of ownership of any asset) and any conditional sales agreement,
title retention agreement or lease in the nature thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>End Date</I></B>&rdquo; has the meaning
set forth in <U>Section&nbsp;7.1(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Enforceability Exceptions</I></B>&rdquo;
means legal limitations on enforceability: (i)&nbsp;arising from applicable bankruptcy and other similar Laws affecting the rights of
creditors generally; (ii)&nbsp;arising from Laws governing specific performance, injunctive relief, and other equitable remedies; and
(iii)&nbsp;based on any indemnity against liabilities under Securities Laws in connection with the offering, sale, or issuance of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Entity</I></B>&rdquo; means any corporation
(including any nonprofit corporation), general partnership, limited partnership, limited liability partnership, joint venture, estate,
trust, company (including any company limited by shares, limited liability company, or joint stock company), firm, society, or other
enterprise, association, organization, or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Environmental Law</I></B>&rdquo;
means any federal, state, local, or foreign Law relating to pollution or protection of human health, worker health, or the environment
(including ambient air, surface water, ground water, land surface, or subsurface strata), including any Law or regulation relating to
emissions, discharges, Releases, or threatened Releases of Hazardous Materials, or otherwise relating to the manufacture, processing,
distribution, use, treatment, storage, disposal, transport, or handling of Hazardous Materials.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>ERISA</I></B>&rdquo; means the Employee
Retirement Income Security Act of 1974, as amended, and the regulations issued thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>ERISA Affiliate</I></B>&rdquo; means
with respect to the Company or any of its Subsidiaries, any trade or business, whether or not incorporated, that together with the Company
or any of its Subsidiaries would be deemed a &ldquo;single employer&rdquo; within the meaning of Section&nbsp;414 of the Code or Section&nbsp;4001(b)(1)&nbsp;of
ERIA or that is a member of the same &ldquo;controlled group&rdquo; as the Company or any of its Subsidiaries pursuant to Section&nbsp;4001(a)(14)
of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>ETA</I></B>&rdquo; means the Excise
Tax Act (Canada).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Exchange Act</I></B>&rdquo; means
the Securities Exchange Act of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Exclusively Licensed IP</I></B>&rdquo;
means all Intellectual Property Rights that are exclusively (or co-exclusively) licensed to the Company or any Company Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Exclusivity Agreement</I></B>&rdquo;
means that certain letter agreement, dated as of April&nbsp;7, 2023, by and between Parent and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Existing Representation</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Fairness Opinions</I></B>&rdquo;
means the opinions of each of the Company Financial Advisor and Bloom Burton Securities Inc. to the effect that, as of the date of each
such opinion and based upon and subject to the various assumptions, limitations, and qualifications set forth therein, the Arrangement
Consideration to be received by the Shareholders is fair, from a financial point of view, to such holders (other than Parent, Purchaser
and their Affiliates).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>FDA</I></B>&rdquo; has the meaning
set forth in <U>Section&nbsp;23(a)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>FDCA</I></B>&rdquo; means the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. &sect; 301 <I>et seq.</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Final Order</I></B>&rdquo; means
the final order of the Court in a form acceptable to the Company and Parent, each acting reasonably, approving the Arrangement, as such
order may be amended by the Court (with the consent of both the Company and Parent, each acting reasonably) at any time prior to the
Effective Time or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed or as amended (<I>provided </I>that any
such amendment is acceptable to both the Company and Parent, each acting reasonably) on appeal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Foreign Direct Investment Laws</I></B>&rdquo;
means any Law that provides for review of the cross-border acquisition of any interest in or assets of a business or entity (including
for national security or defense reasons) under the jurisdiction of an applicable Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>FTC</I></B>&rdquo; means the U.S.
Federal Trade Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Good Manufacturing Practices</I></B>&rdquo;
means the applicable Laws for current Good Manufacturing Practices promulgated by the FDA under the FDCA (including 21 C.F.R. Parts 210
and 211), Health Canada, the European Medicines Agency or under the European Union guide to Good Manufacturing Practice for medical products
and any other applicable Regulatory Authority in each jurisdiction where the Company or a third party acting on its behalf is undertaking
a clinical trial or any manufacturing activities as of or prior to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Good Clinical Practices</I></B>&rdquo;
means standards for clinical trials for pharmaceuticals (including all applicable requirements relating to protection of human subjects),
as set forth in the FDCA and applicable regulations promulgated thereunder (including, for example, 21 C.F.R. Parts 50, 54, and 56),
as amended from time to time, and such standards of good clinical practice (including all applicable requirements relating to protection
of human subjects) as are required by any Governmental Body in any other countries, including applicable regulations or guidelines from
the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, in which the
Company Products are distributed, sold or intended to be sold, to the extent such standards are not less stringent than in the United
States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Good Laboratory Practices</I></B>&rdquo;
means the FDA&rsquo;s regulations for conducting non-clinical laboratory studies codified at 21 C.F.R. Part&nbsp;58, and comparable foreign
Laws to the extent applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Governmental Authorization</I></B>&rdquo;
means any (i)&nbsp;permit, license, certificate, franchise, permission, variance, clearance, registration, qualification, or authorization
issued, granted, given, or otherwise made available by or under the authority of any Governmental Body or pursuant to any Law or (ii)&nbsp;right
under any Contract with any Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Governmental Body</I></B>&rdquo;
means any (i)&nbsp;nation, state, supra-national body, commonwealth, province, territory, county, municipality, district, or other jurisdiction
of any nature, (ii)&nbsp;federal, state, provincial, local, municipal, foreign, or other government, (iii)&nbsp;governmental or quasi-governmental
authority of any nature, including any governmental division, department, agency, bureau, commission, commissioner, instrumentality,
official, ministry, fund, foundation, center, organization, unit, body, or Entity, (iv)&nbsp;any court, arbitrator, or other tribunal,
or (v)&nbsp;any stock exchange, including Nasdaq, NYSE, LSE and TSX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Hazardous Materials</I></B>&rdquo;
means any (i)&nbsp;medical, biological or biohazardous material (including any infectious material, biological product, bodily fluid,
stock, culture, diagnostic specimen, regulated animal, or medical waste) that is regulated as &ldquo;hazardous&rdquo; or &ldquo;toxic&rdquo;
under any Environmental Law, (ii)&nbsp;petroleum product, derivative or by-product, asbestos-containing material, radon, urea formaldehyde
foam insulation, polychlorinated biphenyls, radioactive materials, toxic mold or fungi, or (iii)&nbsp;other chemical, substance, material
or waste that in relevant form, quantity or concentration is regulated as &ldquo;hazardous&rdquo; or &ldquo;toxic&rdquo; under any Environmental
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Healthcare Laws</I></B>&rdquo; means,
as applicable: (i)&nbsp;the U.S. Anti-Kickback Statute (42 U.S.C. &sect; 1320a-7b(b)), the Stark Physician Self-Referral Law (42 U.S.C.
 &sect; 1395nn), the U.S. Civil False Claims Act (31 U.S.C. &sect; 3729 <I>et seq.</I>), 42 U.S.C. &sect;&sect; 1320a-7, 1320a-7a, and
1320a-7b and the regulations promulgated pursuant to such statutes, and any comparable self-referral or fraud and abuse laws promulgated
by any Governmental Body; (ii)&nbsp;the U.S. Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. &sect; 1320d <I>et
seq.</I>), as amended by the Health Information Technology for Economic and Clinical Health Act (42 U.S.C. &sect; 17921 <I>et seq.</I>),
and the regulations promulgated thereunder and any Law or regulation the purpose of which is to protect the privacy of individually-identifiable
patient information; (iii)&nbsp;Medicare (Title XVIII of the Social Security Act); (iv)&nbsp;Medicaid (Title XIX of the Social Security
Act); (v)&nbsp;Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Affordability Reconciliation
Act of 2010; (vi)&nbsp;the Sunshine/Open Payments Law (42 U.S.C. &sect; 1320a-7h); (vii)&nbsp;the FDCA, the Veterans Health Care Act
of 1992, the Public Health Service Act, FDA regulations promulgated thereunder, or any similar Laws of foreign jurisdictions in which
the Company or any Company Subsidiary currently conducts business or provide services; (viii)&nbsp;the Prescription Drug Marketing Act
of 1987; (ix)&nbsp;quality, safety and accreditation standards and requirements of all applicable Governmental Bodies, (x)&nbsp;all Laws
pursuant to which permits relating to human subjects research, clinical trials, pre-clinical trials, or health care are issued, (xi)&nbsp;all
Laws related to the conduct of human subjects research, clinical trials, and pre-clinical trials, including without limitation the United
States Federal Common Rule&nbsp;(45 CFR Part&nbsp;46), the Food&nbsp;&amp; Drug Administration Common Rule&nbsp;(21 CFR Parts 50 and
56),&nbsp;International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), Good Clinical
Practices, World Health Organization (WHO) clinical research standards, United Nations Educational, Scientific and Cultural Organization
(UNESCO) Universal Declaration on Bioethics and Human Research, (xii)&nbsp;Good Manufacturing Practices, (xiii)&nbsp;any and all other
applicable comparable Laws of other Regulatory Authorities and (xiv)&nbsp;any other requirements of Law that relates to the design, development,
testing, studying, manufacturing, processing, storing, holding, shipping, transporting, distributing, importing or exporting, licensing,
labeling, packaging, advertising, promotion, selling, pricing, or marketing of pharmaceutical products, or that is related to remuneration
(including ownership) to or by physicians or other health care providers (including kickbacks) or the disclosure or reporting of the
same, patient or program charges, record-keeping, claims processing, documentation requirements, medical necessity, referrals, the hiring
of employees or acquisition of services or supplies from those who have been excluded from government health care programs, quality,
safety, privacy, security, licensure, accreditation or any other aspect of providing health care products or services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>HSR Act</I></B>&rdquo; means the
Hart-Scott-Rodino Antitrust Improvements Act of 1976.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>IFRS</I></B>&rdquo; means International
Financial Reporting Standards, as issued by the International Accounting Standards Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Indebtedness</I></B>&rdquo; means
(i)&nbsp;any indebtedness for borrowed money (including the issuance of any debt security) to any Person (other than the Company or any
Company Subsidiary), (ii)&nbsp;any obligation evidenced by notes, bonds, debentures, or similar Contracts to any Person, (iii)&nbsp;any
obligation in respect of letters of credit and bankers&rsquo; acceptances (other than letters of credit used as security for leases),
(iv)&nbsp;any obligation to any Person (other than the Company or any Company Subsidiary) that grants a right to revenue and royalty
payments from Company Products to such Person, or (v)&nbsp;any guaranty of any such obligation described in clauses&nbsp;(i)&nbsp;through
(iv)&nbsp;of any Person (other than, in any case, accounts payable to trade creditors and accrued expenses, in each case, arising in
the ordinary course of business).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Indemnified Persons</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.5(a).</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Indemnifying Parties</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.5(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Intellectual Property Rights</I></B>&rdquo;
means all rights in or to the following, anywhere in the world, whether registered or unregistered: (i)&nbsp;patents, patent applications
and registrations, design patents, community designs and all other supra-national or national design rights, whether registered or unregistered,
and other patent rights, including all divisions, continuations, continuations-in-part, renewals, reissues, extensions, certificates
of reexamination, utility models and supplementary protection certificates (collectively, &ldquo;<B><I>Patents</I></B>&rdquo;), (ii)&nbsp;trademarks,
service marks, brand names, certification marks, collective marks, logos, symbols, trade dress, assumed names, company names, fictitious
names, trade names, and other indicia of origin, together with all goodwill associated therewith and symbolized thereby (collectively,
 &ldquo;<B><I>Trademarks</I></B>&rdquo;), (iii)&nbsp;trade secrets, proprietary or confidential information and know-how, including unpatented
inventions, processes, procedures, techniques, schematics, algorithms, methods, formulae, drawings, blueprints, data, databases, data
sets, compilations, prototypes, models (including data models), and designs (collectively, &ldquo;<B><I>Trade Secrets</I></B>&rdquo;),
(iv)&nbsp;copyrights and published and unpublished works of authorship, (v)&nbsp;rights in software, data, and databases, (vi)&nbsp;domain
names, and (vii)&nbsp;any other intellectual property, intangible property or proprietary rights of any kind, nature or description,
together with all registrations, issuances, applications, renewals, extensions, restorations, and reversions thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Interim Order</I></B>&rdquo; means
the interim order of the Court made pursuant to section 192 of the CBCA in a form acceptable to Company and Parent, each acting reasonably,
providing for, among other things, the calling and holding of the Company Meeting, as such order may be amended by the Court with the
consent of Company and Parent, each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>IRS</I></B>&rdquo; means the United
States Internal Revenue Service, or any successor agency thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>IT Systems</I></B>&rdquo; has the
meaning set forth in <U>Section&nbsp;19(a)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>ITCs</I></B>&rdquo; has the meaning
set forth in <U>Section&nbsp;26(m)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>knowledge</I></B>,&rdquo; with respect
to an Entity, means with respect to the matter in question the actual knowledge of the Persons listed on <U>Schedule 1.1</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Law</I></B>&rdquo; means any federal,
state, provincial, local, municipal, foreign, multinational, or other law, statute, constitution, principle of common law, resolution,
ordinance, code, edict, decree, rule, regulation, ruling, or other legal requirement issued, enacted, adopted, promulgated, implemented,
or otherwise put into effect by or under the authority of any Governmental Body or under the authority of TSX, LSE, NYSE or Nasdaq (including
the NASDAQ Marketplace Rules&nbsp;as promulgated by Nasdaq, as amended).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Leased Real Property</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;17(b)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Legal Proceeding</I></B>&rdquo; means
any action, suit, charge, demand, complaint, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative,
or appellate proceeding), hearing, inquiry, audit, examination, investigation or other proceeding commenced, brought, conducted, or heard
by or before, or otherwise involving, any court or other Governmental Body, or any arbitrator or arbitration panel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Legal Restraint</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;6.1(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>LSE</I></B>&rdquo; means the London
Stock Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Major Supplier</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;34</U> of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Matching Period</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;5.4(a)v</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Material Adverse Effect</I></B>&rdquo;
means an event, effect, change, occurrence, condition, circumstance, state of facts or development or combination of the foregoing (an
 &ldquo;<B><I>Effect</I></B>&rdquo;) that, individually or taken together, has had or would reasonably be expected to have a material
adverse effect on the Product or the business, assets, liabilities, properties, operations, condition (financial or otherwise), or results
of operations of the Company and the Company Subsidiaries, taken as a whole; <I>provided </I>that no Effect arising out of or resulting
from any of the following shall be deemed either alone or in combination to constitute a Material Adverse Effect, and none of the following
shall be taken into account in determining whether there is, or would reasonably likely to be, a Material Adverse Effect: (i)&nbsp;any
change in the market price or trading volume of the Shares; (ii)&nbsp;any event, effect, change, occurrence or development resulting
from the execution or announcement of this Agreement (including the identity of Parent) (other than (A)&nbsp;for purposes of any representation
or warranty in <U>Section&nbsp;5</U> of Schedule C but subject to disclosures in Section&nbsp;5 of the Company Disclosure Schedule or
(B)&nbsp;any other representation or warranty that addresses the consequences resulting from the execution or announcement of this Agreement);
(iii)&nbsp;general changes or developments in the clinical-stage biopharmaceutical industry or changes in the economy generally or changes
in other general business, financial, or market conditions (including interest rates, exchange rates, tariffs, trade wars, and credit
markets); (iv)&nbsp;fluctuations in the value of any currency; (v)&nbsp;(A)&nbsp;changes to any domestic, foreign or global political
condition, (B)&nbsp;any act of terrorism, war (whether or not declared), civil unrest, civil disobedience, protests, public demonstrations,
insurrection, national or international calamity, sabotage or terrorism, (C)&nbsp;any pandemic or epidemic (including COVID-19) or other
outbreak of contagious diseases (or the escalation or worsening of any of the foregoing) or (D)&nbsp;any volcano, tsunami, earthquake,
hurricane, tornado, other natural or man-made disaster, or act of God, or any similar force majeure event; (vi)&nbsp;the failure of the
Company to meet internal or analyst&rsquo;s expectation, forecast, estimate, or prediction in respect of revenues, earnings, or other
financial or operating metrics for any period; (vii)&nbsp;any action taken (or failure to act) by the Company at the written direction
of Parent and any action specifically required to be taken by the Company under this Agreement (excluding the requirement that the Company
use reasonable best efforts to conduct its business in all material respects in the ordinary course); or (viii)&nbsp;any change in, or
any compliance with or action taken for the purpose of complying with, any applicable Law or IFRS (or authoritative interpretations of
any applicable Law or IFRS), after the date hereof; <I>it being understood</I> that the exceptions in clauses&nbsp;(i)&nbsp;and (vi)&nbsp;shall
not prevent or otherwise affect a determination that the underlying cause of any such change, decline or failure referred to therein
(if not otherwise falling within any of the exceptions provided by clauses (ii)&nbsp;through (v)&nbsp;or (vii)&nbsp;through (viii)&nbsp;hereof)
is or would be reasonably likely to be a Material Adverse Effect or has otherwise resulted in or contributed to a Material Adverse Effect;
<I>provided</I>, <I>further</I>, that with respect to subclauses (iii), (iv), (v)&nbsp;and (viii), if such Effect disproportionately
affects the Product or the Company and its Subsidiaries, taken as a whole, compared to other similar biopharmaceutical companies or biopharmaceutical
companies generally, then such Effect shall be taken into account in determining whether there has been, or would reasonably expected
to be, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Material Contract</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;20(a)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>MI 61-101</I></B>&rdquo; means Multilateral
Instrument 61-101 &ndash; Protection of Minority Security Holders in Special Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Misrepresentation</I></B>&rdquo;
means (a)&nbsp;a misrepresentations for purpose of Canadian Securities Laws; and (b)&nbsp;for purposes of U.S. Securities Laws, an untrue
statement of a material fact or an omission to state a material fact required to be stated or necessary in order to make the statements
contained therein not misleading in light of the circumstances in which they were made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Nasdaq</I></B>&rdquo; means Nasdaq
Global Select Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>NI 52-109</I></B>&rdquo; means National
Instrument 52-109 &ndash; Certification of Disclosure in Issuers&rsquo; Annual and Interim Filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>No Action Letter</I></B>&rdquo; means
written confirmation from the Commissioner of Competition that they do not, at that time, intend to make an application under Section&nbsp;92
of the Competition Act in respect of the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>NYSE</I></B>&rdquo; means the New
York Stock Exchange, any successor stock exchange operated by the NYSE Euronext, or any successor thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>OHSA</I></B>&rdquo; has the meaning
set forth in <U>Section&nbsp;27(f)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>ordinary course of business</I></B>&rdquo;
means the ordinary course of business consistent with past practice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Owned IP</I></B>&rdquo; means all
Intellectual Property Rights owned or purported to be owned by the Company or any Company Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent</I></B>&rdquo; has the meaning
set forth in the preamble hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent Counsel</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;8.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent Disclosure Schedule</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;3.2(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent Information</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.4(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent Material Adverse Effect</I></B>&rdquo;
means an event, change, occurrence, or development that would prevent, materially delay, or materially impair the ability of Parent or
Purchaser to perform its obligations under this Agreement or to consummate the Transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent Parties</I></B>&rdquo; means
Parent, Purchaser, or any of their respective current, former, or future shareholders, optionholders, members, Representatives, or Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parties</I></B>&rdquo; means Parent,
Purchaser, and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>PBA</I></B>&rdquo; means the Pension
Benefits Act (Ontario).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Permitted Encumbrance</I></B>&rdquo;
means (i)&nbsp;any Encumbrance for Taxes that is either (A)&nbsp;not yet due and payable or (B)&nbsp;being contested in good faith by
appropriate proceedings and for which adequate reserves have been established in the consolidated financial statements of the Company
to the extent required by IFRS, (ii)&nbsp;any Encumbrance representing the right of any customer, supplier, or subcontractor in the ordinary
course of business under the terms of any Contract to which the relevant party is a party or under general principles of commercial or
government contract Law (including mechanic&rsquo;s, materialmen&rsquo;s, carriers&rsquo;, workmen&rsquo;s, warehouseman&rsquo;s, repairmen&rsquo;s,
landlords&rsquo;, and similar liens granted or which arise in the ordinary course of business), (iii)&nbsp;in the case of any Contract,
any Encumbrance that is a restriction against the transfer or assignment thereof and is included in the terms of such Contract, (iv)&nbsp;any
Encumbrance for which appropriate reserves have been established in the consolidated financial statements of the Company, (v)&nbsp;any&nbsp;non-exclusive
license of or with respect to Intellectual Property Rights granted by the Company or any Company Subsidiary, (vi)&nbsp;any defect, imperfection
of title (other than with respect to any material Company IP), or other Encumbrance not, individually or in the aggregate, materially
impairing the value of the assets subject thereto or otherwise materially interfering with the conduct of the business of the Company
and the Company Subsidiaries in the ordinary course, and (vii)&nbsp;in the case of real property, any Encumbrance that is an easement,&nbsp;right-of-way,&nbsp;encroachment,
restriction, condition, or other similar Encumbrance incurred or suffered in the ordinary course of business and that, individually or
in the aggregate, does not and would not materially impair the use (or contemplated use), utility, or value of the applicable real property
or otherwise materially impair the present or contemplated business operations at such location, or zoning, entitlement, building, and
other land use regulations imposed by Governmental Bodies having jurisdiction over such real property or that are otherwise set forth
on a title report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Person</I></B>&rdquo; means any individual,
Entity, or Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Personal Information</I></B>&rdquo;
means any information concerning an identified or identifiable individual, and any information defined as &ldquo;personal information,&rdquo;
 &ldquo;personally identifiable information,&rdquo; &ldquo;personal health information,&rdquo; &ldquo;protected health information,&rdquo;
or any similar term by an applicable Privacy Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Plan of Arrangement</I></B>&rdquo;
means the plan of arrangement, substantially in the form set out in Schedule A, subject to any amendments or variations to such plan
made in accordance with this Agreement and the Plan of Arrangement or made at the direction of the Court in the Final Order with the
prior written consent of the Company and Parent, each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Post-Closing Matter</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Post-Closing Representation</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.11(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Pre-Closing Designated Persons</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.11(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Pre-Closing Period</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.1(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Pre-Closing Privileges</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;8.11(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Privacy Laws</I></B>&rdquo; means
all applicable Laws and binding standards relating to the processing, privacy or security of Personal Information and all legally binding
guidance issued thereunder, including, to the extent applicable, the Canada Personal Information Protection and Electronics Document
Act, Qu&eacute;bec Law 25, Qu&eacute;bec Bill 64, the European Union General Data Protection Regulation (EU) 2016/679 and all Laws implementing
it, the UK GDPR as defined in the Data Protection, Privacy and Electronic Communications (Amendments etc) (EU Exit) Regulations 2019,
the UK Data Protection Act 2018, the PCI-DSS Standards,, and any Law concerning requirements for website and mobile application privacy
policies and practices, or any outbound communications (including e-mail marketing, telemarketing and text messaging), tracking, and
marketing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Product</I></B>&rdquo; means camlipixant,
also known as BLU-5937.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Provincial Securities Act</I></B>&rdquo;
means the <I>Securities Act</I> (Qu&eacute;bec).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Purchaser</I></B>&rdquo; has the
meaning set forth in the preamble hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Reference Date</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;3(a)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Regulatory Authority</I></B>&rdquo;
means any Governmental Body (including the European Medicines Agency (&ldquo;<B><I>EMA</I></B>&rdquo;) and Health Canada) that performs
functions similar to those performed by the FDA or otherwise has jurisdiction over the safety, efficacy, approval, development, testing,
labeling, manufacturing, storage, marketing, promotion, sale, commercialization, shipment, import, export, sale or distribution of pharmaceutical
products, biological products, or any product that the Company or any Company Subsidiary manufactures or is developing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Regulatory Authorizations</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;23(a)</U>&nbsp;of Schedule C.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Release</I></B>&rdquo; means any
emission, spill, seepage, leak, escape, leaching, discharge, injection, pumping, pouring, emptying, dumping, disposal, migration, or
release of Hazardous Materials from any source into or upon the environment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Representatives</I></B>&rdquo; means
officers, directors, partners, members, employees, managers, attorneys, accountants, investment bankers, consultants, agents, financial
advisors, other advisors, and other representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Required Shareholder Approval</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;2.2(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Requisite Regulatory Approvals</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;6.1(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Research Programs</I></B>&rdquo;
means all research and development programs, pre-clinical and clinical trials, pre-clinical and clinical studies and the results therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Sanctioned Country</I></B>&rdquo;
means any country or region that is, or has been in the five (5)&nbsp;years prior to the date of this Agreement, the subject or target
of a comprehensive embargo under Sanctions (including Cuba,&nbsp;Iran, North Korea, Russia, Syria, and the Crimea region of Ukraine)
in effect at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Sanctioned Person</I></B>&rdquo;
means any Person that is: (i)&nbsp;listed on any applicable U.S. or non-U.S. sanctions-related restricted party list, including any list
maintained by the U.S. Department of the Treasury Office of Foreign Assets Control (&ldquo;<B><I>OFAC</I></B>&rdquo;), the U.S. Department
of Commerce, the U.S. Department of State, the United Nations Security Council, the European Union or its member states, His Majesty&rsquo;s
Treasury or Global Affairs Canada, or His Majesty&rsquo;s Treasury of the United Kingdom, (ii)&nbsp;in the aggregate, 50% or greater
owned, directly or indirectly, or otherwise controlled by a Person or Persons described in (i), or (iii)&nbsp;organized, resident or
located in a Sanctioned Country.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Sanctions</I></B>&rdquo; means all
Laws and orders relating to economic or trade sanctions administered or enforced by the United States (including by OFAC, the U.S. Department
of State and the U.S. Department of Commerce), Global Affairs Canada and the Royal Canadian Mounted Police or other relevant sanctions
authority in Canada), the European Union, His Majesty&rsquo;s Treasury, the United Nations Security Council, or any other relevant Governmental
Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Sarbanes-Oxley Act</I></B>&rdquo;
means the Sarbanes-Oxley Act of 2002.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>SEC</I></B>&rdquo; means the United
States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Securities Authorities</I></B>&rdquo;
means the AMF, the SEC, and any other applicable securities commissions or securities regulatory authority in Canada or the United States,
including, Nasdaq and TSX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Securities Laws</I></B>&rdquo; means
the Provincial Securities Act, the United States Securities Act of 1933, the Exchange Act, and all other applicable securities Laws,
in each case together with all rules&nbsp;and regulations and published policies thereunder and the rules&nbsp;and published policies
of the Nasdaq and TSX Exchanges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>SEDAR</I></B>&rdquo; means the System
for Electronic Document Analysis and Retrieval maintained on behalf of the AMF.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Shareholders</I></B>&rdquo; means
the registered or beneficial holders of the Shares, as the context requires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Shares</I></B>&rdquo; means the common
shares in the capital of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Subsidiary</I></B>&rdquo; means,
with respect to a Person, any other Person, whether incorporated or unincorporated, of which (i)&nbsp;at least 50% of the securities
or ownership interests having by their terms ordinary voting power to elect a majority of the board of directors or other Persons performing
similar functions, (ii)&nbsp;a general partner interest, or (iii)&nbsp;a managing member interest, in each case, is directly or indirectly
owned or controlled by such Person or by one (1)&nbsp;or more of its respective Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Superior Proposal</I></B>&rdquo;
means a <I>bona fide</I> written Acquisition Proposal made by a Person or group of Persons &ldquo;acting jointly or in concert&rdquo;
(within the meaning of National Instrument 62-104 &ndash; Take-Over Bids and Issuer Bids) to acquire not less than all of the outstanding
Shares or all or substantially all of the assets of the Company and its Company Subsidiaries on a consolidated basis that (i)&nbsp;did
not result from a breach of <U>ARTICLE&nbsp;V</U> or any other provision of this Agreement, (ii)&nbsp;complies with applicable Securities
Laws and (iii)&nbsp;the Board determines, in its good faith judgment, after receiving the advice of its outside legal counsel and financial
advisors, is reasonably likely to be consummated in accordance with its terms and conditions, and, taking into account all legal, regulatory,
and financing aspects (including certainty of closing) of the Acquisition Proposal and the identity of the Person or group of Persons
making the proposal and other aspects of the Acquisition Proposal that the Company Board deems relevant, if consummated in accordance
with its terms, would result in a transaction which is more favorable, from a financial point of view, to Shareholders than the Arrangement
(including any amendments to the terms and conditions of the Arrangement proposed by Parent pursuant to <U>Section&nbsp;5.4(b)</U>&nbsp;of
this Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Superior Proposal Notice</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;5.4(a)iii</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Tax</I></B>&rdquo; means any tax
or similar charge of any kind whatsoever (including any income tax, franchise tax, capital gains tax, gross receipts tax, value-added
tax, goods and services tax, harmonized sales tax, retail sales tax, surtax, estimated tax, employment tax, unemployment tax, social
security, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, withholding tax, escheat
tax, alternative tax, alternative minimum tax, real or personal property tax or payroll tax, and including any health insurance, parental
insurance or government pension plan premiums or contributions and including any liability relating to any deemed overpayment of Taxes
under Section&nbsp;125.7 of the Tax Act or other amount received in respect of any COVID-19 measure), including any installment of Taxes,
interest, fine, penalty, or addition thereto, in each case, imposed, assessed, or collected by or under the authority of any Governmental
Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Tax Act</I></B>&rdquo; means the
<I>Income Tax Act</I> (Canada) and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Tax Return</I></B>&rdquo; means any
return (including any information return), report, statement, declaration, estimate, schedule, notice, notification, form, election,
designation, certificate, or other document or information filed with or submitted to, or required to be filed with or submitted to,
any Governmental Body in connection with the determination, assessment, collection, or payment of any Tax (including any documents filed,
or required to be kept in file, under Section&nbsp;125.7 of the Tax Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Taxing Authority</I></B>&rdquo; means
any Governmental Body exercising Tax regulatory authority or otherwise imposing or administrating any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Terminating Party</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.9(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Termination Fee</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;7.3(a)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Termination Notice</I></B>&rdquo;
has the meaning set forth in <U>Section&nbsp;4.9(c)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B>Transaction Committee</B>&rdquo; means
the transaction committee of the Board formed in connection with the Arrangement and the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Transactions&rdquo;</I></B> means
the Arrangement and the other transactions contemplated by this Agreement, the Plan of Arrangement and the Articles of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>TSX</I></B>&rdquo; means the Toronto
Stock Exchange.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>U.S. Securities Act</I></B>&rdquo;
means the Securities Act of 1933.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Willful Breach</I></B>&rdquo; means
any material breach of any covenant or agreement set forth in this Agreement prior to the date of its termination that is a consequence
of any act, or failure to act, undertaken by the breaching Party with the knowledge that the taking of such act, or failure to act, would,
or would reasonably be likely to, result in such breach. Notwithstanding anything in the foregoing definition to the contrary, such term
shall include the failure to consummate the Closing when required to do so by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.2</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Rules&nbsp;of Interpretation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this Agreement, unless otherwise specified:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
purposes of this Agreement, whenever the context requires: the singular number shall include the plural, and vice versa; and one gender
shall include all other genders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Parties agree that any rule&nbsp;of construction to the effect that ambiguities are to be resolved against the drafting Party shall not
be applied in the construction or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
used in this Agreement, the words &ldquo;include&rdquo; and &ldquo;including,&rdquo; and variations thereof, shall not be deemed to be
terms of limitation, but rather shall be deemed to be followed by the words &ldquo;without limitation.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as otherwise indicated, all references in this Agreement to &ldquo;Sections,&rdquo; &ldquo;Exhibits,&rdquo; &ldquo;Annexes,&rdquo; and
 &ldquo;Schedules&rdquo; are intended to refer to sections of this Agreement and Exhibits, Annexes, and Schedules&nbsp;to this Agreement,
as applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
phrase &ldquo;made available,&rdquo; when used in reference to anything made available to Parent, Purchaser, or any of their respective
Representatives, in each case, shall be deemed to include anything uploaded to the electronic data room maintained by or on behalf of
the Company or its Representatives for purposes of the Transaction no later than twenty-four (24) hours prior to the execution and delivery
of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
bold-faced headings in this Agreement are for convenience of reference only, shall not be deemed to be a part of this Agreement, and
shall not be referred to in connection with the construction or interpretation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
reference to (i)&nbsp;any Contract (including this Agreement) are to the Contract as amended, modified, supplemented, restated, or replaced
from time to time (in the case of any Contract, to the extent permitted by the terms thereof and, if applicable, the terms of this Agreement);
(ii)&nbsp;any Governmental Body includes any successor to that Governmental Body; and (iii)&nbsp;any applicable Law refers to such applicable
Law as amended, modified, supplemented, or replaced from time to time (and, in the case of statutes, include any rule&nbsp;and regulation
promulgated under such statute) and references to any section of any applicable Law includes any successor to such section (<I>provided
</I>that, for purposes of any representation and warranty in this Agreement that is made as of a specific date, references to any Law
or Contract shall be deemed to refer to such Law or Contract, as amended, and to any rule&nbsp;or regulation promulgated thereunder,
in each case, as of such date).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
terms &ldquo;Dollars&rdquo; and &ldquo;$&rdquo; mean U.S. dollars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
reference herein to &ldquo;as of the date hereof,&rdquo; &ldquo;as of the date of this Agreement,&rdquo; or words of similar import shall
be deemed to mean April&nbsp;17, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">When
 &ldquo;since&rdquo; is used in connection with a date, the period covered thereby shall be inclusive of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
reference in this Agreement to a date or time shall be deemed to be such date or time in the City of Montreal, Qu&eacute;bec, Canada,
unless otherwise specified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;1.3</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Company
Disclosure Schedule</U>. The disclosures set forth in any particular part or subpart of the Company Disclosure Schedule shall be deemed
to be an exception to (or, as applicable, a disclosure for purposes of): (a)&nbsp;the representations and warranties or covenants of
the Company that are set forth in the corresponding section or subsection of this Agreement and (b)&nbsp;any other representation and
warranty or covenant of the Company that is set forth in this Agreement to the extent, in the case of this clause&nbsp;(b), the relevance
of that disclosure as an exception to (or a disclosure for purposes of) such other representation and warranty or covenant is reasonably
apparent on the face of such disclosure. No Party may deem the mere inclusion of an item in the Company Disclosure Schedule&nbsp;as an
exception to a representation and warranty or covenant as an admission that such item represents a material exception or material fact,
event, or circumstance or that such item is material or constitutes a Material Adverse Effect (and no Party concedes such materiality
or effect by its inclusion), and no reference to, or disclosure of, any item or other matter in the Company Disclosure Schedule shall
necessarily imply that any other undisclosed matter or item having a greater value or significance is material.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;II<BR>
THE ARRANGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.1</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Arrangement</U>.
The Parties agree that the Arrangement will be implemented in accordance with and subject to the terms and conditions of this Agreement
and the Plan of Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.2</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Interim
Order</U>. As soon as reasonably practicable after the date of this Agreement, but in any event in sufficient time to permit the Company
Meeting to be convened in accordance with <U>Section&nbsp;2.3</U>, the Company shall apply for, in a manner reasonably acceptable to
Parent pursuant to section 192 of the CBCA and, in cooperation with Parent, prepare, file and diligently pursue, an application for the
Interim Order, which must provide, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">for
the classes of Persons to whom notice is to be provided in respect of the Arrangement and the Company Meeting and for the manner in which
such notice is to be provided;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">that
the required level of approval for the Arrangement Resolution (the &ldquo;<B><I>Required Shareholder Approval</I></B>&rdquo;) for the
Arrangement Resolution shall be (a)&nbsp;at least 66 2/3% of the votes cast on the Arrangement Resolution by the Shareholders present
in person or represented by proxy at the Company Meeting voting together as a single class, and (b)&nbsp;if, and to the extent, required,
a majority of the votes cast on the Arrangement Resolution by the Shareholders present in person or represented by proxy at the Company
Meeting voting together as a single class, excluding for this purpose votes attached to Shares held by Persons described in items (a)&nbsp;through
(d)&nbsp;of section 8.1(2)&nbsp;of MI 61-101;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">that,
in all other respects, the terms, restrictions and conditions of the Company&rsquo;s Constating Documents, including quorum requirements
and all other matters, shall apply in respect of the Company Meeting;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">for
the grant of Dissent Rights to registered Shareholders as contemplated in the Plan of Arrangement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">for
the notice requirements with respect to the presentation of the application to the Court for the Final Order;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">that
the Company Meeting may be adjourned or postponed from time to time by the Company in accordance with the terms of this Agreement or
as otherwise agreed in writing by the Parties without the need for additional approval of the Court;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">confirmation
of the record date for Shareholders entitled to receive notice of and to vote at the Company Meeting;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">that
the record date will not change in respect or as a consequence of any adjournment(s)&nbsp;or postponement(s)&nbsp;of the Company Meeting,
unless required by Securities Law or the Court;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">that
the Parties may amend, modify and/or supplement the Plan of Arrangement in accordance with the terms thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">for
such other matters as Parent or the Company may reasonably require, subject to obtaining the prior consent of the other, such consent
not to be unreasonably withheld, conditioned or delayed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.3</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>The
Company Meeting</U>. The Company shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">convene
and conduct the Company Meeting in accordance with the Interim Order, the Company&rsquo;s Constating Documents and applicable Law as
soon as reasonably practicable, (and in any event on or before June&nbsp;16, 2023), for the purpose of considering the Arrangement Resolution
and for any other proper purpose as may be set out in the Circular and agreed to by Parent and not adjourn, postpone or cancel (or propose
the adjournment, postponement or cancellation of) the Company Meeting without the prior written consent of Parent: (i)&nbsp;except as
required or permitted under <U>Section&nbsp;2.3(m), Section&nbsp;4.9(d)</U>&nbsp;and <U>Section&nbsp;5.4(e)</U>; or (ii)&nbsp;in the
case of an adjournment, except as required for quorum purposes;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">solicit
proxies in favor of the approval of the Arrangement Resolution and against any resolution submitted by any Person that is inconsistent
with the Arrangement Resolution and the completion of any Transaction, including, at the Company&rsquo;s discretion or if so requested
by Parent, and at the expense of the Company, using proxy solicitation services firms and cooperating with any Persons engaged by Parent
to solicit proxies in favor of the approval of the Arrangement Resolution and against any resolution submitted by any Person that is
inconsistent with the Arrangement Resolution;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">permit
Parent to, at Parent&rsquo;s expense, directly or through a proxy solicitation services firm of its choice, actively solicit proxies
in favor of the Arrangement and against any resolution submitted by any Person that is inconsistent with the Arrangement Resolution in
compliance with applicable Law and the Company shall disclose in the Circular that Parent may make such solicitations;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">provide
Parent with copies of, or access to, information regarding the Company Meeting generated by the Company&rsquo;s registrar and transfer
agent or any dealer or proxy solicitation services firm retained by the Company, as requested from time to time by Parent and instruct
any dealer or proxy solicitation services firm retained by the Company to report to Parent and its Representatives and legal counsel
concurrently with their reports to the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">consult
with Parent in fixing the date of the Company Meeting and the record date for the Company Meeting, give notice to Parent of the Company
Meeting and allow Parent&rsquo;s Representatives and legal counsel to attend the Company Meeting;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">advise
Parent, at such times as Parent may reasonably request and at least on a daily basis on each of the last five (5)&nbsp;Business Days
prior to the date of the Company Meeting, as to the aggregate tally of the proxies (for greater certainty, specifying votes &ldquo;for&rdquo;
and votes &ldquo;against&rdquo; the Arrangement Resolution) received by the Company in respect of the Arrangement Resolution;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">promptly
advise Parent of any communication (written or oral) from, or claims brought by (or threatened to be brought by), any Person in opposition
to the Arrangement and any purported exercise or withdrawal of Dissent Rights by the Shareholders; and cooperate and provide Parent with
(i)&nbsp;an opportunity to review and comment upon in advance any written communications to be sent by or on behalf of the Company to
any such Person, (ii)&nbsp;a copy of any such written communication and (iii)&nbsp;the opportunity to participate in any discussions,
negotiations or proceedings with or including any such Persons;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">not
waive any failure by any Shareholder to timely deliver a notice of exercise of Dissent Rights, not settle, compromise or make any payment
with respect to, or agree to settle, compromise or make any payment with respect to, any exercise or purported exercise of Dissent Rights
without the prior written consent of Parent (which may be granted or withheld in Parent&rsquo;s sole and absolute discretion);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">not
change the record date for the Shareholders entitled to vote at the Company Meeting in connection with any adjournment or postponement
of the Company Meeting unless required by applicable Law or the Court;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">ensure
that the Arrangement Resolution is the first substantive matter on the agenda for the Company Meeting, unless otherwise previously agreed
to in writing by Parent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">not
propose or submit for consideration at the Company Meeting any business other than the Arrangement without Parent&rsquo;s written consent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">at
the reasonable request of Parent from time to time, (i)&nbsp;provide Parent with a list (in both written and electronic form) of (A)&nbsp;the
registered Shareholders, together with their addresses and respective holdings of Shares, (B)&nbsp;the names, addresses and holdings
of all Persons having rights issued by the Company to acquire Shares (including holders of Company Equity Awards), and (C)&nbsp;participants
and book-based nominee registrants such as CDS&nbsp;&amp; Co., CEDE&nbsp;&amp; Co. and DTC, and non-objecting beneficial owners of Shares,
together with their addresses and respective holdings of Shares, and (ii)&nbsp;require that its registrar and transfer agent furnish
Parent with such additional information, including updated or additional lists of Shareholders, and lists of securities positions and
other assistance as Parent may reasonably request; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">at
the request of the Purchaser, adjourn or postpone the Company Meeting to a date specified by the Purchaser that is not later than 15
Business Days after the date on which the Company Meeting was originally scheduled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.4</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>The
Circular</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall prepare as promptly as practicable and complete, in consultation with Parent and its legal counsel, the Circular together
with any other documents required by Law in connection with the Company Meeting and the Arrangement, and the Company shall, as promptly
as reasonably practicable after obtaining the Interim Order, cause the Circular and such other documents to be filed and sent to each
of the Shareholders and other Persons as required by the Interim Order and applicable Law, in each case so as to permit the Company Meeting
to be held in accordance with the timeline specified in <U>Section&nbsp;2.3(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall ensure that the Circular complies in all material respects with Law, does not contain any Misrepresentation (<I>provided
</I>that the Company shall not be responsible for the accuracy of any information furnished by Parent in writing specifically for purposes
of inclusion in the Circular pursuant to <U>Section&nbsp;2.4(d)</U>) and provides the Shareholders with sufficient information to permit
them to form a reasoned judgement concerning the Arrangement Resolution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Without
limiting the generality of the foregoing, the Circular must include: (i)&nbsp;a copy of the Fairness Opinions; (ii)&nbsp;a statement
that the Company Board has received the Fairness Opinions and has, after receiving legal and financial advice, unanimously determined
that the Arrangement is in the best interests of the Company and is fair to the Shareholders and that the Company Board unanimously recommends
that the Shareholders vote in favor of the Arrangement Resolution (the &ldquo;<B><I>Company Board Recommendation</I></B>&rdquo;); and
(iii)&nbsp;a statement that each Director and executive officer of the Company has entered into a D&amp;O Support and Voting Agreement
pursuant to which such Director or executive officer has agreed to vote all of such individual&rsquo;s Shares in favor of the Arrangement
Resolution and against any resolution that is inconsistent with the Arrangement Resolution, subject to the terms of the D&amp;O Support
and Voting Agreement. The Company shall give Parent and its legal counsel a reasonable opportunity to review and comment on drafts of
the Circular and other related documents, and shall give reasonable consideration to any comments made by Parent and its legal counsel
and accept the reasonable comments of Parent and its legal counsel, and agrees that all information relating solely to Parent included
in the Circular must be in a form and content satisfactory to Parent, acting reasonably.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Parent
shall provide the Company, on a timely basis, all necessary information concerning Parent, its Affiliates and the Arrangement Consideration
that is required by applicable Law to be included in the Circular to the Company in writing (such information provided in writing pursuant
to this <U>Section&nbsp;2.4(d)</U>, the &ldquo;<B><I>Parent Information</I></B>&rdquo;), and shall ensure that the Parent Information
does not contain any Misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
Party shall promptly notify the other Parties if it becomes aware that the Circular contains any (or any alleged) Misrepresentation or
otherwise requires an amendment or supplement. The Parties shall co-operate in the preparation of any such amendment or supplement as
required or appropriate, and the Company shall promptly mail, file or otherwise publicly disseminate any such amendment or supplement
to the Shareholders and, if required by the Court or by applicable Law, file the same with the Securities Authorities or any other Governmental
Body.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.5</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Final
Order</U>. If the Interim Order is obtained and the Arrangement Resolution is passed at the Company Meeting as provided for in the Interim
Order, the Company shall take all steps necessary or desirable to submit the Arrangement to the Court and diligently pursue an application
for the Final Order pursuant to section 192 of the CBCA, as soon as reasonably practicable, but in any event not later than three (3)&nbsp;Business
Days after the Arrangement Resolution is passed at the Company Meeting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.6</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Court
Proceedings</U>. In connection with all Court proceedings relating to obtaining the Interim Order and the Final Order, the Company shall:
(a)&nbsp;diligently pursue, and cooperate with Parent in diligently pursuing, the Interim Order and the Final Order; (b)&nbsp;provide
Parent and its legal counsel with reasonable opportunity to review and comment upon drafts of all materials to be filed with, or submitted
to, the Court, the CBCA Director or the AMF in connection with the Arrangement (including drafts of the motion for Interim Order and
Final Order, affidavits,&nbsp;Interim Order and Final Order), prior to the service and filing of such materials, and give reasonable
and due consideration to all such comments of Parent and its legal counsel, <I>provided</I> all Parent Information shall be in a form
and substance satisfactory to Parent; (c)&nbsp;not file any material with the Court in connection with the Arrangement or serve any such
material, or agree to modify or amend any material so filed or served, except as contemplated by this Agreement or with Parent&rsquo;s
prior written consent, such consent not to be unreasonably withheld, conditioned or delayed, <I>provided</I> that Parent shall not be
required to agree or consent to any increase in or variation in the form of the Arrangement Consideration or other modification or amendment
to such filed or served materials that expands or increases Parent&rsquo;s obligations, or diminishes or limits Parent&rsquo;s rights,
set forth in any such filed or served materials or under this Agreement or the Arrangement and the D&amp;O Support and Voting Agreements;
(d)&nbsp;oppose any proposal from any Person that the Final Order contain any provision inconsistent with this Agreement and consult
with Parent with respect to the defense or settlement of any Company shareholder or derivative proceeding and shall not settle in respect
of any such proceeding without Parent&rsquo;s prior written consent, such consent not to be unreasonably withheld, conditioned or delayed;
(e)&nbsp;ensure that all material filed with the Court in connection with the Arrangement is consistent in all material respects with
the terms of this Agreement and the Plan of Arrangement; (f)&nbsp;not object to legal counsel to Parent making such submissions on the
application for the Interim Order and the application for the Final Order as such counsel considers appropriate, acting reasonably, <I>provided
</I>Parent advises the Company of the nature of any such submissions prior to the hearing and such submissions are consistent with this
Agreement and the Plan of Arrangement; and (g)&nbsp;provide Parent on a timely basis with copies of any notice and evidence served on
the Company or its legal counsel in respect of the application for the Interim Order or the Final Order or any appeal therefrom, and
any notice, written or oral, indicating the intention of any Person to appeal, or oppose the granting of, the Interim Order or Final
Order. If, at any time after the issuance of the Final Order and prior to the Effective Time, the Company is required by the terms of
the Final Order or by Law to return to the Court with respect to the Final Order, it shall do so only after notice to, and in good faith
consultation and cooperation with, Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.7</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Articles
of Arrangement and Effective Time. </U>(a)</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt">The Articles of Arrangement
shall implement the Plan of Arrangement. The Articles of Arrangement shall include the Plan of Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Unless
another time or date is agreed to in writing by the Parties, the completion of the Arrangement (the &ldquo;<B><I>Closing</I></B>&rdquo;)
will take place remotely by exchange of documents and signatures (or their electronic counterparts), unless another place is agreed to
in writing by the Parties hereto, at 9:00 a.m.&nbsp;(Montreal time) on the third (3<SUP>rd</SUP>) Business Day after the satisfaction,
or where not prohibited, the waiver by the applicable Party or Parties in whose favor the condition is, of the conditions set out in
<U>ARTICLE&nbsp;VI</U> (excluding conditions that, by their terms, are to be satisfied at the Effective Time, but subject to the satisfaction,
or where not prohibited, the waiver by the applicable Party or Parties in whose favor the condition is, of those conditions as of the
Effective Time). The Company shall send the Articles of Arrangement to the CBCA Director on the day of Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.8</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Deposit
of Consideration</U>. Purchaser shall, following receipt of the Final Order and immediately prior to the sending by the Company of the
Articles of Arrangement to the CBCA Director in accordance with <U>Section&nbsp;2.7(b)</U>, provide, or cause to be provided, the Depositary
with sufficient funds to satisfy the Aggregate Arrangement Consideration payable to Shareholders pursuant to the Plan of Arrangement
(other than with respect to the Shareholders exercising Dissent Rights as provided in the Plan of Arrangement) in each case into escrow
(the terms and conditions of such escrow to be satisfactory to the Company and Parent, each acting reasonably).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.9</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Withholding
Taxes</U>. Any Person shall be entitled to deduct and withhold from any amount otherwise payable or deliverable under the Plan of Arrangement
or this Agreement such amounts as such Person is required to deduct and withhold, or reasonably believes to be required to deduct and
withhold, from such amount otherwise payable or deliverable under any provision of any applicable Laws in respect of Taxes. Any such
amounts will be deducted, withheld and remitted from the amount otherwise payable or deliverable pursuant to the Plan of Arrangement
or this Agreement and shall be treated for all purposes under the Plan of Arrangement or this Agreement as having been paid to the Person
in respect of which such deduction, withholding and remittance was made; <I>provided</I> that such deducted and withheld amounts are
actually remitted to the appropriate Governmental Body. Notwithstanding anything herein to the contrary, to the extent a payment pursuant
to the Plan of Arrangement would trigger a Tax or penalty under Section&nbsp;409A of the Code or any corresponding provision in the Tax
Act, Parent may adjust the time and/or manner of such payment, and such payment shall instead be made on the earliest date that payment
would not trigger such Tax or penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.10</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Incentive
Plan Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Parties acknowledge that the outstanding Company Equity Awards shall be treated in accordance with the provisions of the Plan of Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Parties acknowledge and agree that the Company and the Company Subsidiaries shall, and that the Parent and the Purchaser shall cause
the Company and the Company Subsidiaries to, make an election under subsection 110(1.1) of the Tax Act (or any equivalent provision under
provincial Law) in prescribed form and in a timely manner and that the Parties shall comply more generally with the provisions of subsection
110(1.1) of the Tax Act (and any equivalent provision under provincial Law), in respect of any payment made under the Plan of Arrangement
by or on behalf of the Company or a Company Subsidiary to any holder of any Company Option who is otherwise entitled to claim a deduction
under paragraph 110(1)(d)&nbsp;of the Tax Act (or any equivalent provision under provincial Law) in respect of such payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;2.11</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Further
Assurances</U>. Prior to the Effective Time, the Company Board (or, if appropriate, any appropriate committee thereof) shall adopt such
resolutions or take such other necessary actions to effect the treatment described in Section&nbsp;2.3 of the Plan of Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;III<BR>
REPRESENTATIONS AND WARRANTIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.1</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of the Company</U><SUP>.</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in (i)&nbsp;the correspondingly numbered section of the Company Disclosure Schedule or (ii)&nbsp;the Company Publicly Filed
Documents that were filed after December&nbsp;31, 2021, and prior to the date of this Agreement, (excluding from the Company Publicly
Filed Documents all risk factor disclosures, disclosures about market risk, or other cautionary, predictive or forward-looking disclosures
contained therein that do not relate to specific historical events or circumstances affecting the Company), the Company represents and
warrants to Parent as set forth in Schedule C.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for the express written representations and warranties made by the Company in Schedule C as qualified by the Company Disclosure Schedule
and in any instrument or other document delivered pursuant to this Agreement, no Company Party makes any (express or implied) representation
or warranty with respect to the Company or any Company Associate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, the Company hereby acknowledges and agrees (on its own behalf and on behalf of the Company
Parties) that: except for the express written representations and warranties made by Parent and Purchaser in Schedule D (as qualified
by the Parent Disclosure Schedule) and in any instrument or other document delivered pursuant to this Agreement (i)&nbsp;none of the
Parent Parties makes, or has made, any representation or warranty relating to Parent or Purchaser, their Subsidiaries or any of their
businesses, operations or otherwise in connection with this Agreement or the Transactions, (ii)&nbsp;no Person has been authorized by
Parent or Purchaser, any of their Subsidiaries or any of their respective Affiliates or Representatives to make any representation or
warranty relating to Parent or Purchaser, their respective Subsidiaries or any of their businesses or operations or otherwise in connection
with this Agreement or the Transactions and if made, such representation or warranty must not be relied upon by the Company or any of
its Subsidiaries, Affiliates or Representatives as having been authorized by Parent or Purchaser, any of their respective Subsidiaries
or any of their Affiliates or Representatives (or any other Person); and (iii)&nbsp;and representations and warranties made by Parent
or Purchaser in this Agreement are in lieu of and are exclusive of all other representations and warranties, including any express or
implied or as to merchantability or fitness for a particular purpose, and each of Parent and Purchaser disclaims any other or implied
representations or warranties, notwithstanding the delivery or disclosure to the Company or any of its Affiliates or Representatives
of any documentation or other information (including any financial information, supplemental data or financial projections or other forward-looking
statements). The Company on its behalf and on behalf the Company Parties, expressly waives any such claim related to the foregoing matters
to the extent stated therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;3.2</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Representations
and Warranties of Parent and Purchaser</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in the correspondingly numbered section of the disclosure letter delivered by Parent to the Company concurrently with the
execution of this Agreement (the &ldquo;<B><I>Parent Disclosure Schedule</I></B>&rdquo;) (it being expressly understood and agreed to
that the exceptions and disclosures contained in any section of the Parent Disclosure Schedule shall be deemed to be disclosed only with
respect to any other section or subsection to the extent that it is reasonably apparent from the face of such disclosure that such exception
or disclosure is applicable thereto), Parent and Purchaser represent and warrant to the Company as set forth in Schedule D.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
for the express written representations and warranties made by Parent and Purchaser in Schedule D as qualified by the Parent Disclosure
Schedule and in any instrument or other document delivered pursuant to this Agreement, no Parent Party makes any express or implied representation
or warranty with respect to Parent, Purchaser, or any of their respective Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in this Agreement, Parent and Purchaser each hereby acknowledge and agree (on its own behalf and on behalf of
Parent Parties) that: except for the express written representations and warranties made by the Company in Schedule C (as qualified by
the Company Disclosure Schedule) and in any instrument or other document delivered pursuant to this Agreement (i)&nbsp;none of the Company
Parties makes, or has made, any representation or warranty relating to any Company Party or any of their businesses, operations or otherwise
in connection with this Agreement or the Transactions, (ii)&nbsp;no Person has been authorized by the Company, any of its Subsidiaries
or any of their respective Affiliates or Representatives to make any representation or warranty relating to any Company Party or any
of their businesses or operations or otherwise in connection with this Agreement or the Transactions and if made, such representation
or warranty must not be relied upon by Parent, Purchaser or any of their respective Subsidiaries, Affiliates or Representatives as having
been authorized by any Company Party or any of their respective Affiliates or Representatives (or any other Person), and (iii)&nbsp;representations
and warranties made by the Company in this Agreement are in lieu of and are exclusive of all other representations and warranties, including
any express or implied or as to merchantability or fitness for a particular purpose, and the Company disclaims any other or implied representations
or warranties, notwithstanding the delivery or disclosure to Parent, Purchaser or any of their Affiliates or Representatives of any documentation
or other information (including any financial information, supplemental data or financial projections or other forward-looking statements).
Each of Parent and Purchaser on its behalf and on behalf of its respective Affiliates, expressly waives any such claim related to the
foregoing matters to the extent stated therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;IV<BR>
COVENANTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.1</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Access
to Information</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to applicable Law, during the period from the date of this Agreement until the earlier of the Effective Time and the termination of this
Agreement in accordance with <U>Section&nbsp;7.1</U> (the &ldquo;<B><I>Pre-Closing&nbsp;Period</I></B>&rdquo;) on reasonable advance
notice to the Company, the Company shall, and shall cause its Subsidiaries to, promptly provide Parent and Parent&rsquo;s Representatives
with reasonable access during the Company&rsquo;s normal business hours to the Company and its Subsidiaries and its personnel, and books
and records reasonably in connection with strategic and integration planning, confirmatory due diligence or for other purposes reasonably
related to the transactions contemplated hereby; <I>provided </I>that any such access shall be conducted at a reasonable time and in
such a manner as not to unreasonably interfere with the normal operation of the business of the Company or any Company Subsidiary. Any
such access shall be subject to the Company&rsquo;s reasonable security measures and insurance requirements. Nothing in this Agreement
shall require the Company to disclose or provide access to any information to the extent that the Company determines in its reasonable
discretion (after consultation with its outside legal counsel) that such disclosure would (i)&nbsp;jeopardize any attorney-client or
other legal privilege (so long as the Company has reasonably cooperated with Parent to permit such inspection of or to disclose such
information on a basis that does not waive such privilege with respect thereto) or (ii)&nbsp;contravene any applicable Law, fiduciary
duty, or binding agreement entered into prior to the date of this Agreement (including any confidentiality agreement to which the Company
or any of its Affiliates is a party); <I>provided</I>, <I>however</I>, the Company shall inform Parent and Parent&rsquo;s Representatives
as to the general nature of what is being withheld and the Company shall reasonably cooperate to make appropriate substitute arrangements
to permit reasonable disclosure that does not suffer from any of the foregoing impediments, including through the use of reasonable best
efforts to (A)&nbsp;if reasonably requested by the Party requesting the relevant information, obtain the required Consent or waiver of
any third party required to provide such information and (B)&nbsp;implement appropriate and mutually agreeable measures to permit the
disclosure of such information in a manner to remove the basis for the objection, including by arrangement of appropriate clean room
procedures, redaction or entry into a customary joint defense agreement with respect to any information to be so provided, if the Parties
determine that doing so would reasonably permit the disclosure of such information without violating applicable Law or jeopardizing such
privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">With
respect to the information disclosed pursuant to this <U>Section&nbsp;4.1</U>, Parent shall comply with, and shall instruct Parent&rsquo;s
Representatives to comply with, all of its obligations under the Confidential Disclosure Agreement, dated March&nbsp;2, 2023, between
the Company and GlaxoSmithKline Services Unlimited (the &ldquo;<B><I>Confidentiality Agreement</I></B>&rdquo;). All requests for information
made pursuant to this <U>Section&nbsp;4.1</U> shall be directed to the Persons listed on Section&nbsp;4.1 of the Company Disclosure Schedule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
information provided or obtained pursuant to this <U>Section&nbsp;4.1</U> shall affect any representation or warranty in this Agreement
of any Party or any condition to the obligations of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.2</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Operation
of the Company&rsquo;s Business</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the Pre-Closing&nbsp;Period, except (i)&nbsp;as expressly required or otherwise contemplated under this Agreement or as required by applicable
Laws, (ii)&nbsp;with the prior written consent of Parent, which consent shall not be unreasonably withheld, conditioned, or delayed,
or (iii)&nbsp;as set forth in Section&nbsp;4.2(a)&nbsp;of the Company Disclosure Schedule, the Company shall, and shall cause the Company
Subsidiaries to (x)&nbsp;conduct its business in the ordinary course in a manner consistent with the past practice of the Company prior
to the date of this Agreement and (y)&nbsp;use reasonable best efforts to preserve intact the value of the Company&rsquo;s business,
its business organizations and relationships with employees, customers, suppliers, licensors, licensees, Governmental Body and other
Persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the&nbsp;Pre-Closing&nbsp;Period, except (A)&nbsp;as expressly required by this Agreement or by applicable Laws, (B)&nbsp;with the prior
written consent of Parent, which consent shall not be unreasonably withheld, conditioned, or delayed or (C)&nbsp;as set forth in Section&nbsp;4.2(b)&nbsp;of
the Company Disclosure Schedule, neither Company nor any Company Subsidiary shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">i.</TD><TD>(A)&nbsp;establish a record date for, declare, accrue, set aside,
                                            or pay any dividend or make any other distribution in respect of any securities (including
                                            the Shares) (other than with respect to any dividend or distribution by a direct or indirect
                                            wholly owned Company Subsidiary to its direct or indirect parent consistent with past practice)
                                            or (B)&nbsp;other than with respect to transactions among the Company and its wholly owned
                                            Subsidiaries or among the Company&rsquo;s wholly owned Subsidiaries, repurchase, redeem,
                                            or otherwise reacquire any securities (including any Share), or any right, warrant, or option
                                            to acquire any securities, other than in connection with the forfeiture, vesting, exercise,
                                            or settlement of Company Options or in connection with withholding to satisfy the exercise
                                            price and/or Tax obligations with respect to Company Options;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD>split, combine, subdivide, or reclassify any of its securities (including
                                            the Shares) or other equity interests;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD>sell, issue, grant, deliver, pledge, transfer, encumber, or authorize
                                            the issuance, sale, delivery, pledge, transfer, Encumbrance, or grant by the Company of (A)&nbsp;any
                                            Share, equity interest, or other security of the Company, (B)&nbsp;any option, call, warrant,
                                            restricted securities, or right to acquire any Share, equity interest, or other security
                                            of the Company, or (C)&nbsp;any instrument convertible into, exchangeable for or with respect
                                            to any Share, equity interest, or other security of the Company (except on the exercise of
                                            Company Options in accordance with their present terms);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD>adopt a plan or agreement of complete or partial liquidation or
                                            dissolution, merger, consolidation, restructuring, recapitalization, or other reorganization
                                            of the Company or any Company Subsidiary;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">v.</TD><TD>except as required by the express terms of this Agreement or as may
                                            be required under applicable Law or the terms of any Employee Plan as in effect on the date
                                            hereof: (A)&nbsp;establish, adopt, terminate, amend, renew, announce or waive any rights
                                            with respect to (or commit to do any of the preceding in respect of) any Employee Plan or
                                            other compensation or benefit, plan, program, policy, practice, agreement or arrangement
                                            that would constitute an Employee Plan if in effect on the date of this Agreement; (B)&nbsp;take
                                            any action to accelerate the vesting or payment, or fund or in any other way secure the payment,
                                            of any compensation or benefits under any Employee Plan; (C)&nbsp;increase the compensation
                                            or benefits payable to any Company Associate; (D)&nbsp;grant, provide or amend the terms
                                            of any change-of-control, retention, severance or termination compensation or benefits to
                                            any Company Associate; or (E)&nbsp;hire (other than as set forth in Section&nbsp;4.2(b)(v)&nbsp;of
                                            the Company Disclosure Schedule), terminate (other than for cause), or lay off (or give notice
                                            of any such action to) any Company Associate;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD>amend or permit the adoption of any amendment to any of its Constating
                                            Documents;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">vii.</TD><TD>form any Subsidiary, acquire any equity interest or equity-linked
                                            interest in any other Entity (other than securities in a publicly traded company held for
                                            investment by the Company and consisting of less than 1% of the outstanding capital stock
                                            of such Entity) or enter into any joint venture, partnership, limited liability corporation,
                                            or similar arrangement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">viii.</TD><TD>make or authorize aggregate capital expenditures other than as
                                            set forth in the Company&rsquo;s capital expense budget made available to Parent or Parent&rsquo;s
                                            Representatives;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ix.</TD><TD>acquire, lease, license, sublicense, pledge, sell, or otherwise
                                            dispose of, abandon, waive, relinquish or fail to renew, permit to lapse (other than in the
                                            Company&rsquo;s reasonable judgment), transfer, assign, encumber, or subject to any material
                                            Encumbrance (other than Permitted Encumbrances) any material right or other material asset
                                            or property, excluding any Intellectual Property Right or other right in or to any Company
                                            Product (except, in the case of any of the foregoing, (A)&nbsp;in the ordinary course of
                                            business, (B)&nbsp;pursuant to dispositions of obsolete, surplus, or worn-out assets that
                                            are no longer useful for the conduct of the business of the Company or any Company Subsidiary
                                            and (C)&nbsp;as permitted by <U>Section&nbsp;4.2(b)(viii)</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">x.</TD><TD>(A)&nbsp;acquire, lease, license, sublicense, pledge, sell, or otherwise
                                            dispose of, abandon, waive, relinquish or fail to renew, permit to lapse, transfer, assign,
                                            encumber, or subject to any material Encumbrance (other than Permitted Encumbrances), fail
                                            to diligently prosecute, renew or maintain, waive, allow to lapse, grant a third party any
                                            right to receive payments with respect to, or grant a covenant-not-to-assert to a third party
                                            with respect to (x)&nbsp;any Company Product or any Intellectual Property Rights relating
                                            to any Company Product or (y)&nbsp;any other material Company IP (in the case of clause (x)&nbsp;or&nbsp;(y),
                                            except for non-exclusive licenses or sublicenses in the ordinary course of business to contract
                                            manufacturers, contract research organizations or distributors, in each case, subject to
                                            written confidentiality obligations with respect to any Trade Secrets); or (B)&nbsp;enter
                                            into, terminate, or exercise or waive any option under any collaboration, development, research,
                                            commercialization or royalty agreement or any other similar agreement in connection with
                                            or relating to any Company Product, any Company IP relating to any Company Product or any
                                            other material Company IP;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xi.</TD><TD>disclose any Trade Secrets relating to any Company Product or that
                                            are otherwise material to the Company or any Company Subsidiary to any third party, other
                                            than in the ordinary course of business pursuant to written confidentiality obligations binding
                                            on such third party;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xii.</TD><TD>(A)&nbsp;acquire, or agree to acquire, fee ownership (or its jurisdictional
                                            equivalent) of any real property or (B)&nbsp;enter into, amend, renew (or fail to exercise
                                            a renewal option under), or modify a Company Lease if such Company Lease, amendment, renewal,
                                            or modification would increase the aggregate amount of payments under such Company Lease
                                            (as amended, renewed, or modified, as the case may be) by in excess of $250,000 or terminate
                                            any Company Lease (except any termination that shall occur at the end of the maximum term
                                            of such Company Lease, other than by extending such term through the payment of any extension
                                            fee in excess of $250,000);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xiii.</TD><TD>make any material capital contribution or advance to, or material
                                            investment in, any Person (other than between the Company and any of its wholly owned Subsidiaries),
                                            or incur, assume, prepay, repurchase, redeem, modify in any material respect or guarantee
                                            any indebtedness for borrowed money (except for (A)&nbsp;advances to employees and consultants
                                            for travel and other business-related expenses in the ordinary course of business and (B)&nbsp;any
                                            drawdown of any existing credit facility of the Company or any Company Subsidiary as of the
                                            date of this Agreement);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xiv.</TD><TD>amend or modify, accelerate or waive any material right under,
                                            terminate, replace, or release, settle, or compromise any material claim, liability, or obligation
                                            under any Material Contract or enter into any Contract that, if entered into prior to the
                                            date of this Agreement, would have been a Material Contract (except for any non-exclusive
                                            licenses or sublicenses in the ordinary course of business to contract manufacturers, contract
                                            research organizations or distributors, in each case, subject to written confidentiality
                                            obligations with respect to any Trade Secrets and <I>provided</I> no such Contract purports,
                                            after the Effective Time, to grant any third party any license, covenant not-to-assert or
                                            other right with respect to any Intellectual Property Rights owned by or licensed to Parent
                                            or its Subsidiaries or to otherwise subject Parent or its Subsidiaries to any non-compete
                                            or other restrictions on the operation or scope of its business);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xv.</TD><TD>amend or modify in any material respect any privacy policies, or
                                            any administrative, technical, or physical safeguards related to privacy or cybersecurity
                                            except to remediate any security issue, to enhance data security or integrity, to comply
                                            with or improve compliance with applicable Law, as otherwise directed or required by a Governmental
                                            Body, or in relation to any new or updated software, products or technologies of the Company
                                            and the Company&rsquo;s Subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xvi.</TD><TD>commence any Legal Proceeding, except: (A)&nbsp;with respect to
                                            routine matters in the ordinary course of business; (B)&nbsp;in such cases where the Company
                                            reasonably determines in good faith that the failure to commence suit would result in a material
                                            impairment of a valuable aspect of its business (<I>provided</I> that the Company consults
                                            with Parent and considers in good faith the views and comments of Parent with respect to
                                            any such Legal Proceeding prior to commencement thereof); or (C)&nbsp;in connection with
                                            a breach of this Agreement or any other agreement contemplated hereby;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xvii.</TD><TD>settle, release, waive, or compromise any Legal Proceeding or other claim (or threatened Legal Proceeding or other claim), other
                                                                   than (A)&nbsp;any actual or threatened non-material Legal Proceeding or other non-material claim in respect of Taxes, (B)&nbsp;any
                                                                   actual or threatened Legal Proceeding or other claim arising out of or relating to a breach of this Agreement or any other agreement
                                                                   contemplated hereby, or (C)&nbsp;pursuant to a settlement that does not relate to any of the Transactions and, in the case of this
                                                                   clause&nbsp;(C), (1)&nbsp;that results solely in a monetary obligation involving only the payment of monies by the Company of not
                                                                   more than [Redacted &ndash; commercially sensitive information] in the aggregate; (2)&nbsp;that results solely in a monetary
                                                                   obligation that is funded by an indemnity obligation to, or an insurance policy of, the Company and the payment of monies by the
                                                                   Company that together with any settlement made under clause&nbsp;(1)&nbsp;are not more than [Redacted &ndash; commercially sensitive
                                                                   information] in the aggregate (not funded by an indemnity obligation or through insurance policies); (3)&nbsp;that results solely in
                                                                   a monetary obligation involving payment by the Company of an amount not greater than the amount specifically reserved in accordance
                                                                   with IFRS with respect to such Legal Proceeding or claim on the Balance Sheet; or (4)&nbsp;that does not result in any monetary
                                                                   obligation of the Company or a Company Subsidiary; <I>provided</I> that this <U>Section&nbsp;4.2(b)(xvii)</U>&nbsp;shall not apply
                                                                   to any Legal Proceeding arising out of or relating to any matter set forth in the Plan of Arrangement, <U>Section&nbsp;4.3</U>, or <U>Section&nbsp;4.7</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xviii.</TD><TD>negotiate, adopt, enter into, amend, or terminate any Collective
                                            Bargaining Agreement or other similar arrangement relating to unions, work council, similar
                                            entities or other organized employees, or voluntarily recognize any new union, works council
                                            or similar entities or other organized employees;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xix.</TD><TD>enter into any Contract that materially limits the freedom or right
                                            of the Company or any Company Subsidiary (or following the Closing, Parent, Purchaser, or
                                            the Company or their respective Affiliates or investors or Affiliates of such investors)
                                            to sell, distribute or manufacture any product or service either (A)&nbsp;by materially limiting
                                            any freedom or right to engage in any line of business or to compete with any other Person
                                            in any location or line of business or (B)&nbsp;by providing &ldquo;most favored nation&rdquo;
                                            rights (including with respect to pricing) or exclusivity obligations or restrictions, in
                                            each case, in favor of a party other than the Company or a Company Subsidiary;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xx.</TD><TD>change in any material respect their material financial accounting
                                            principles, practices or methods, except as required by IFRS or applicable Law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxi.</TD><TD>in each case, except in the ordinary course of business: (A)&nbsp;make,
                                            change, or rescind any material Tax election; (B)&nbsp;settle or compromise any material
                                            Tax claim; (C)&nbsp;change (or request to change) any material method of accounting for Tax
                                            purposes; (D)&nbsp;file any material amended Tax Return or file any Tax Return in a manner
                                            materially inconsistent with past practice; (E)&nbsp;waive or extend any statute of limitations
                                            or consent to any waiver or extension in respect of a period within which an assessment or
                                            reassessment of material Taxes may be issued; (F)&nbsp;request any extension in respect of
                                            a period within which material Taxes must be paid; (G)&nbsp;apply for any material Tax ruling;
                                            (H)&nbsp;enter into any Tax sharing, allocation or similar agreement (other than such agreements
                                            or arrangements that form part of a commercial agreement or arrangement, the primary subject
                                            of which is not Tax, and agreements or arrangements wholly between the Company and/or its
                                            Subsidiaries) or (I)&nbsp;enter into any material &ldquo;closing agreement&rdquo; as described
                                            in Section&nbsp;7121 of the Code (or any corresponding or similar provision of state, local,
                                            or non-U.S. Tax Laws) or material voluntary disclosure agreement or material Tax amnesty
                                            filing with any Governmental Body;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxii.</TD><TD>abandon or fail to maintain or perform any material obligations
                                            with respect to, any material Regulatory Authorizations;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxiii.</TD><TD>with regard to any Company Product in development, (A)&nbsp;initiate
                                            or commence any new clinical trials, (B)&nbsp;materially amend or modify any existing clinical
                                            trial protocols, study recruitment efforts, study enrollment activities or clinical trial
                                            timelines, or (C)&nbsp;terminate any ongoing clinical trials or activities for planned clinical
                                            trials, unless in the case of any of (A)&nbsp;through (C), mandated or required by a Governmental
                                            Body;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxiv.</TD><TD>with regard to any Company Product in development or in commercial
                                            distribution, modify any specification for such Company Product unless such modification
                                            is mandated or required by a Governmental Body;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxv.</TD><TD>enter into any new material line of business;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxvi.</TD><TD>terminate cancel or make any material changes to the structure,
                                            limits or terms and conditions of any material insurance policies, including allowing such
                                            insurance policies to expire without renewal or comparable replacement coverage or otherwise
                                            maintain insurance at less than current levels or otherwise in a manner inconsistent with
                                            past practice; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">xxvii.</TD><TD>enter into or authorize, agree, or commit to take any action
                                            described in clauses (i)&nbsp;through (xxvi)&nbsp;of this <U>Section&nbsp;4.2(b)</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nothing in this Agreement shall give to Parent or Purchaser, directly
or indirectly, any right to control or direct the operations of the Company prior to the Effective Time. Prior to the Effective Time,
each of Parent and the Company shall exercise, consistent with the terms and conditions hereof, complete control and supervision of its
respective operations and those of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.3</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Filings,
Consents, and Approvals</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the terms and conditions set forth in this Agreement, each of the Parties shall, and shall cause their respective Affiliates to, use
their respective reasonable best efforts to take, or cause to be taken, all actions, to file, or cause to be filed, all documents, and
to do, or cause to be done, and to assist and cooperate with the other Parties in doing, all things necessary, proper, or advisable under
applicable Antitrust Laws or Foreign Direct Investment Laws to consummate and make effective the Transactions as soon as reasonably practicable,
including, (i)&nbsp;the obtaining of all necessary actions or nonactions, waivers, consents, clearances, decisions, declarations, approvals
and, expirations, or terminations of waiting periods from Governmental Bodies and the making of all necessary registrations and filings
and the taking of all steps as may be reasonably necessary to obtain any such consent, decision, declaration, approval, clearance, or
waiver, or expiration or termination of a waiting period by or from, or to avoid a Legal Proceeding by, any Governmental Body in connection
with any Antitrust Law or Foreign Direct Investment Law, (ii)&nbsp;the giving of all notices and the obtaining of all necessary consents,
authorizations, approvals, or waivers from third parties, and (iii)&nbsp;the execution and delivery of any additional instrument reasonably
necessary to consummate the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the terms and conditions of this Agreement, each Party shall (and shall cause their respective Affiliates, if applicable, to) (i)&nbsp;as
promptly as reasonably practicable, but in no event later than ten (10)&nbsp;Business Days after the date of this Agreement (unless Parent
and the Company agree to a later date), both (x)&nbsp;make an appropriate filing of all Notification and Report forms as required by
the HSR Act with respect to the Transactions, and (y)&nbsp;make an appropriate filing pursuant to Section&nbsp;114(1)&nbsp;of the Competition
Act and, with respect to the Parent, file a request for an advance ruling certificate or, in the alternative, a no-action letter pursuant
to the Competition Act with respect to the Transactions, (ii)&nbsp;as promptly as reasonably practicable, make all other filings, notifications
or other consents as may be required to be made or obtained by such Party under Antitrust Laws or Foreign Direct Investment Laws in those
jurisdictions identified in Section&nbsp;4.3(b)&nbsp;of the Company Disclosure Schedule, which contains the list of the only jurisdictions
where filing, notification, expiration of a waiting period, or consent or approval is a condition to Closing, and (iii)&nbsp;cooperate
with each other in determining whether, and promptly preparing and making, any other filing or notification or other consent required
to be made with, or obtained from, any other Governmental Body in connection with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Without
limiting the generality of anything in this <U>Section&nbsp;4.3</U>, each Party shall use its reasonable best efforts to (i)&nbsp;cooperate
in all respects and consult with each other in connection with any filing or submission in connection with any investigation or other
inquiry, including allowing the other Parties to have a reasonable opportunity to review in advance and comment on drafts of filings
and submissions, (ii)&nbsp;give the other Parties prompt notice of the making or commencement of any request, inquiry, investigation,
action, or Legal Proceeding brought by a Governmental Body or brought by a third party before any Governmental Body, in each case, with
respect to the Transactions, (iii)&nbsp;keep the other Parties informed as to the status of any such request, inquiry, investigation,
action, or Legal Proceeding, (iv)&nbsp;promptly inform the other Parties of any material communication to or from the Commissioner of
Competition, the FTC, the DOJ, or any other Governmental Body in connection with any such request, inquiry, investigation, action, or
Legal Proceeding, (v)&nbsp;on request, promptly furnish to the other Party a copy of such communications, subject to a confidentiality
agreement limiting disclosure to outside counsel and consultants retained by such counsel, and subject to redaction of documents (A)&nbsp;as
necessary to comply with contractual arrangements and (B)&nbsp;to remove references to valuation of the Company or its Subsidiaries,
(vi)&nbsp;to the extent reasonably practicable, consult in advance and cooperate with the other Parties and consider in good faith the
views of the other Parties in connection with any substantive communication, analysis, appearance, presentation, memorandum, brief, argument,
opinion, or proposal to be made or submitted in connection with any such request, inquiry, investigation, action, or Legal Proceeding,
and (vii)&nbsp;except as may be prohibited by any Governmental Body, permit authorized Representatives of the other Parties to be present
at each meeting and telephone or video conference arising out of or relating to such request, inquiry, investigation, action, or Legal
Proceeding. Each Party shall supply as promptly as practicable following written request therefor such information, documentation, other
material, or testimony that may be reasonably requested by any Governmental Body, including by using reasonable best efforts to respond
promptly to any reasonable written request for additional information, documents or other materials, including any &ldquo;second request&rdquo;
under the HSR Act, received by any Party or any of their respective Subsidiaries from any Governmental Body in connection with such applications
or filings for the Transactions. Any Party may, as it deems advisable and necessary, reasonably designate any competitively sensitive
material provided to the other Parties under this <U>Section&nbsp;4.3</U> as &ldquo;outside counsel only.&rdquo; Such materials and the
information contained therein shall be given only to the outside legal counsel of the recipient and shall not be disclosed by such outside
counsel to employees, officers, or directors of the recipient, unless express written permission is obtained in advance from the source
of the materials. Each Party shall use reasonable best efforts to share information protected from disclosure under the attorney-client
privilege, work product doctrine, joint defense privilege, or any other privilege pursuant to this <U>Section&nbsp;4.3</U> so as to preserve
any applicable privilege. All filing fees under the HSR Act, the Competition Act and for any filing required under other Antitrust Laws
or Foreign Direct Investment Laws (if any) shall be paid by the Party incurring such expense. Parent, after prior consultation with the
Company, shall have the principal responsibility for devising and implementing the strategy for obtaining any necessary clearances under
the Antitrust Laws and Foreign Direct Investment Laws and shall take the lead in all meetings and communications with any Governmental
Body in connection therewith.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary in the foregoing, neither the Company nor any of the Company&rsquo;s Representatives or Affiliates shall commit
to or agree with any Governmental Body to not consummate the Arrangement for any period of time, or to stay, toll, or extend, directly
or indirectly, any applicable waiting period under the HSR Act or other applicable Antitrust Law, and shall not pull and refile any filing
made under the HSR Act or the Competition Act, in each case, without the prior written consent of Parent (such consent may be withheld,
conditioned or delayed in Parent&rsquo;s sole discretion).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall consult in advance with Parent, obtain Parent&rsquo;s prior written consent (such consent may be withheld, conditioned
or delayed in Parent&rsquo;s sole discretion) and shall address all of Parent&rsquo;s views and comments prior to taking any substantive
position with respect to (A)&nbsp;the filings under the HSR Act and Competition Act or required by any other Governmental Body under
any applicable Antitrust Laws or Foreign Direct Investment Laws and (B)&nbsp;any written submission or, to the extent practicable, any
discussion with any Governmental Body in connection with obtaining any necessary clearance under the HSR Act or Competition Act or any
other Antitrust Law or any Foreign Direct Investment Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notwithstanding
anything to the contrary set forth in this Agreement, including this <U>Section&nbsp;4.3</U>, in no event shall Parent, Purchaser or
any of their respective Affiliates or Subsidiaries (i)&nbsp;be obligated to undertake or commit or agree to undertake (and the Company
may not request or propose that Parent, Purchaser or any of their respective Affiliates or Subsidiaries take) any of the following actions:
(A)&nbsp;negotiating, committing to, and effecting, by consent decree, hold separate order, or otherwise, the sale, lease, license, divestiture,
or disposition of any asset, right, product line, or business of the Company, Parent, or any of their respective Affiliates, (B)&nbsp;terminating
any existing relationship, contractual right, or obligation of the Company, Parent, or any of their respective Affiliates, (C)&nbsp;terminating
any venture or other arrangement, (D)&nbsp;creating any relationship, contractual right, or obligation of the Company, Parent, or any
of their respective Affiliates, (E)&nbsp;effectuating any other change or restructuring of the Company, Parent, or any of their respective
Affiliates, (F)&nbsp;undertaking or agreeing to (or requesting or authorizing the Company or any Company Subsidiary to undertake, effective
upon the Closing) any requirement or obligation to provide prior notice to, or obtain prior approval from, any Governmental Body with
respect to any transaction, (G)&nbsp;otherwise taking or committing to take any action with respect to the businesses, product lines,
or assets of the Company, Parent, or any of their respective Affiliates, and (H)&nbsp;any sale, divestiture, disposition or other remedial
measure pursuant to this <U>Section&nbsp;4.3</U> or (ii)&nbsp;if any Legal Proceeding, including any Legal Proceeding by a Governmental
Body, Regulatory Authority or private party, is instituted (or threatened to be instituted) challenging this Agreement, the Arrangement
or any other Transaction (whether as violative of any Antitrust Law, Foreign Direct Investment Law, or otherwise), be obligated to contest
or resist any such action or Legal Proceeding or make efforts to have vacated, lifted, reversed or overturned any decree, judgment, injunction
or other order, whether temporary, preliminary or permanent, that is in effect and that prohibits, prevents or restricts consummation
of the Arrangement or the other Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.4</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>401(k)&nbsp;Plan</U>.
Effective as of no later than the day immediately preceding the Closing Date, if requested by Parent in writing at least ten (10)&nbsp;Business
Days prior to the Closing Date, the Company shall cause the BELLUS Health 401(k)&nbsp;Retirement Savings Plan (the &ldquo;<B><I>401(k)&nbsp;Plan</I></B>&rdquo;)
to be terminated. If Parent provides such written notice to the Company, the Company shall provide Parent with evidence that the 401(k)&nbsp;Plan
has been terminated (effective as of no later than the day immediately preceding the Closing Date), and the Company shall have taken
all steps necessary to terminate the 401(k)&nbsp;Plan as Parent may reasonably require.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.5</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Indemnification
of Officers and Directors</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
rights to indemnification, advancement of expenses, and exculpation by the Company existing in favor of those Persons who are directors
or officers of the Company as of the date of this Agreement or have been directors or officers of the Company in the past (collectively,
the &ldquo;<B><I>Indemnified Persons</I></B>&rdquo;) for their acts and omissions occurring prior to the Effective Time, as provided
in the Constating Documents of the Company (as in effect as of the date of this Agreement and made available to Parent) shall survive
the Arrangement and continue in full force and effect and shall not be amended, repealed, or otherwise modified in any manner that would
adversely affect the rights thereunder of any Indemnified Persons, and shall be observed and maintained by the Company and its Subsidiaries
to the fullest extent available under the CBCA or other applicable Law for a period of six (6)&nbsp;years from the Effective Time, and
any claim made pursuant to such rights within such six (6)-year period shall continue to be subject to this <U>Section&nbsp;4.5(a)</U>&nbsp;and
the rights provided under this <U>Section&nbsp;4.5(a)</U>&nbsp;until disposition of such claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">From
the Effective Time until the six (6)-year anniversary of the Closing Date, Parent and the Company (together with their successors and
assigns, the &ldquo;<B><I>Indemnifying Parties</I></B>&rdquo;) shall, to the fullest extent permitted under applicable Law and the Company&rsquo;s
Constating Documents in effect as of the date of this Agreement, indemnify and hold harmless each Indemnified Person in his or her capacity
as an officer or director of the Company against all losses, claims, damages, liabilities, fees, expenses, judgments, or fines incurred
by such Indemnified Person due to such Indemnified Person&rsquo;s capacity as an officer or director of the Company in connection with
any pending or threatened Legal Proceeding based on, arising out of, or relating to, in whole or in part, the fact that such Indemnified
Person is or was a director or officer of the Company at or prior to the Effective Time and pertaining to any and all matters pending,
existing, or occurring at or prior to the Effective Time, whether asserted or claimed prior to, at or after the Effective Time, including
any such matter arising under any claim with respect to the Transactions. Without limiting the foregoing, from the Effective Time until
the six (6)-year anniversary of Closing Date, the Indemnifying Parties shall also, to the fullest extent permitted under applicable Law,
advance reasonable and documented out-of-pocket costs and expenses (including reasonable and documented attorneys&rsquo; fees) incurred
by the Indemnified Persons in connection with matters for which such Indemnified Persons are eligible to be indemnified pursuant to this
<U>Section&nbsp;4.5(b)</U>&nbsp;within fifteen (15) days after receipt by Parent of a written request for such advance, subject to the
execution by such Indemnified Persons of appropriate undertakings in favor of the Indemnifying Parties to repay such advanced costs and
expenses if it is ultimately determined in a final and&nbsp;nonappealable&nbsp;judgment of a court of competent jurisdiction that such
Indemnified Person is not entitled to be indemnified under this <U>Section&nbsp;4.5(b)</U>&nbsp;or under applicable Law or the Company&rsquo;s
Constating Documents at the time of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
Indemnified Person wishing to claim indemnification under this <U>Section&nbsp;4.5</U> upon learning of any such Legal Proceeding, shall
promptly notify Parent thereof in writing, but the failure to so notify shall not relieve Parent or the Company of any liability it may
have to such Indemnified Person except to the extent such failure prejudices the Indemnifying Party. In the event of any Legal Proceeding:
(i)&nbsp;Parent or the Company shall have the right to assume the defense thereof (it being understood that by electing to assume the
defense thereof, neither Parent nor the Company will be deemed to have waived any right to object to the Indemnified Person&rsquo;s entitlement
to indemnification hereunder with respect thereto or assumed any liability with respect thereto), except that if Parent or the Company
elects not to assume such defense or legal counsel for the Indemnified Person advises that there are issues which raise conflicts of
interest between Parent or the Company and the Indemnified Person, the Indemnified Person may retain legal counsel satisfactory to them,
and Parent or the Company shall pay all reasonable and documented fees and expenses of such legal counsel for the Indemnified Person
promptly as statements therefor are received; <I>provided however</I>, that Parent and the Company shall be obligated pursuant to this
<U>Section&nbsp;4.5</U> to pay for only one (1)&nbsp;firm of legal counsel for all Indemnified Persons in any jurisdiction unless the
use of one (1)&nbsp;legal counsel for such Indemnified Persons would present such legal counsel with a conflict of interest (provided,
that the fewest number of legal counsels necessary to avoid conflicts of interest shall be used); (ii)&nbsp;the Indemnified Persons shall
cooperate in the defense of any such matter if Parent or the Company elects to assume such defense, and Parent and the Company shall
cooperate in the defense of any such matter if Parent or the Company elects not to assume such defense; (iii)&nbsp;the Indemnified Persons
shall not be liable for any settlement effected without their prior written consent (which consent shall not be unreasonably withheld,
conditioned or delayed) if Parent or the Company elects to assume such defense and Parent and the Company shall not be liable for any
settlement effected without their prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed) if
Parent or the Company elects not to assume such defense; (iv)&nbsp;Parent and the Company shall not have any obligation hereunder to
any Indemnified Person if and when a court of competent jurisdiction shall ultimately determine, and such determination shall have become
final, that the indemnified action of such Indemnified Person in the manner contemplated hereby is prohibited by applicable Law; and
(v)&nbsp;all rights to indemnification in respect of any such Legal Proceedings shall continue until final disposition of all such Legal
Proceedings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
a &ldquo;tail policy&rdquo; is not obtained prior to the Effective Time, from the Effective Time until the six-anniversary of the Closing
Date, the Company shall, and Parent shall cause the Company to, maintain, in effect, the existing directors&rsquo; and officers&rsquo;,
employment practices and fiduciary liability insurance policies maintained by the Company as of the date of this Agreement for the benefit
of the Company, the Company Subsidiaries and the Indemnified Persons who are currently covered by such existing policies with respect
to their acts and omissions occurring prior to the Effective Time in their capacities as directors and officers of the Company (as applicable),
on terms with respect to coverage, deductibles and amounts no less favorable than the existing policy; <I>provided</I> that, at or prior
to the Effective Time, the Company shall, unless otherwise directed by Parent in writing, through a nationally recognized insurance broker
approved by Parent (such approval not to be unreasonably withheld, delayed, or conditioned) purchase six (6)-year &ldquo;tail&rdquo;
policies for the existing policies effective as of the Effective Time and if an applicable &ldquo;tail policy&rdquo; has been obtained,
it shall be deemed to satisfy all obligations to obtain and/or maintain insurance pursuant to this <U>Section&nbsp;4.5</U> in respect
of the applicable policy; <I>provided </I>that in no event shall the Company be required to expend in any one (1)&nbsp;year an amount
in excess of 300% of the annual premiums currently payable by the Company with respect to such current policies, it being understood
that if the annual premiums payable for such insurance coverage exceeds such amount, Parent shall be obligated to cause the Company to
obtain policies with the greatest coverage available for a cost equal to such amount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
Parent or the Company or any of their respective legal successors or permitted assigns (i)&nbsp;consolidates with or merges into any
other Person and shall not be the continuing or surviving Person of such consolidation or merger or (ii)&nbsp;transfers all or substantially
all of its properties and assets to any Person or consummates any division transaction, then, and in each such case, proper provisions
shall be made so that the legal successors and permitted assigns of Parent or the Company shall assume all of the obligations set forth
in this <U>Section&nbsp;4.5</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
provisions of this <U>Section&nbsp;4.5</U> shall survive the consummation of the Transactions and are (i)&nbsp;intended to be for the
benefit of, and shall be enforceable by, each of the Indemnified Persons and their successors, assigns, and heirs and (ii)&nbsp;in addition
to, and not in substitution for, any other right to indemnification, advancement, or contribution that any such Person may have by contract
or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Nothing
in this Agreement is intended to, shall be construed to, or shall release, waive, or impair any right to any directors&rsquo; and officers&rsquo;,
employment practices and fiduciary liability insurance claims under any policy that is or has been in existence with respect to the Company
or any Company Subsidiary for any of their respective directors, officers or other employees, it being understood and agreed that the
indemnification provided for in this <U>Section&nbsp;4.5</U> is not prior to or in substitution for any such claim under such policies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.6</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Securityholder
Litigation</U>. During the Pre-Closing Period, the Company shall, as promptly as possible after obtaining knowledge thereof, notify Parent
of any Legal Proceeding brought by security holders of the Company (including Shareholders) against the Company or its directors arising
out of or relating to the Transactions. The Company shall control any such Legal Proceeding brought by securityholders of the Company
(including Shareholders) against the Company or its directors arising out of or relating to the Transactions;&nbsp;<I>provided&nbsp;</I>that
the Company shall give Parent the right to participate in and timely consult with Parent with respect to such Legal Proceeding and any
settlement, release waiver or compromise of such litigation and the Company shall in good faith take any comments into account; <I>provided
</I>that the disclosure of information in connection therewith shall be subject to the provisions of <U>Section&nbsp;4.1</U>, including
with respect to attorney-client privilege or any other applicable legal privilege. No such settlement shall be agreed without Parent&rsquo;s
prior written consent (such consent not to be unreasonably withheld, conditioned, or delayed) (a)&nbsp;with respect to the exercise of
any Dissent Rights and (b)&nbsp;except to the extent the settlement is fully covered by the Company&rsquo;s insurance policies (other
than any applicable deductible), but only if such settlement would not result in the imposition of any restriction on the business or
operations of the Company, with respect to any other matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.7</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Additional
Agreements</U>. Without limitation or contravention of the provisions of <U>Section&nbsp;4.3</U>, and subject to the terms and conditions
of this Agreement, Parent and the Company shall use reasonable best efforts to take, or cause to be taken, all actions necessary to consummate
the Transactions. Without limiting the generality of the foregoing, subject to the terms and conditions of this Agreement, each Party
to this Agreement shall (a)&nbsp;make all filings (if any), obtain all consents (if any) and give all notices (if any) required to be
made and given by such Party in connection with the Transactions pursuant to any applicable Law or Material Contract set forth in Section&nbsp;4.7
of the Company Disclosure Schedule, (b)&nbsp;use reasonable best efforts to lift any restraint, injunction or other legal bar (other
than with respect to Antitrust Laws and Foreign Direct Investment Laws) to this Agreement or the Arrangement brought by any third Person
against such Party, (c)&nbsp;use reasonable best efforts to satisfy all conditions precedent in this Agreement and take all steps set
forth in the Interim Order and Final Order applicable to it and comply promptly with all requirements imposed by applicable Law on it
or its Subsidiaries with respect to this Agreement or the Arrangement, and (d)&nbsp;not take any action, or refrain from taking any commercially
reasonable action, or permitting any action to be taken or not taken, in each case, which is inconsistent with this Agreement or would
reasonably be expected to prevent, materially delay or otherwise impede the consummation of the Arrangement or the transactions contemplated
by this Agreement. This <U>Section&nbsp;4.7</U> shall not apply to approval under Antitrust Laws or Foreign Direct Investment Laws, which
are the subject of <U>Section&nbsp;4.3</U>. The Company shall give notice to Parent as promptly as reasonably practicable after (and
shall subsequently keep Parent informed on a reasonably current basis of any developments related to such notice) it becomes aware of
(i)&nbsp;the receipt of any notice from any Person alleging that the Consent of such Person is or may be required in connection with
any of the Transactions or (ii)&nbsp;that any Legal Proceeding has been commenced or threatened in writing relating to or involving the
Company or any Company Subsidiary that relates to the consummation of the Transactions. For the avoidance of doubt, the Company shall
not be required to pay for any such consent, nor shall obtaining any such filing, notice or consent be a condition precedent to the Closing.
During the Pre-Closing Period, the Company and its Subsidiaries shall keep Parent promptly informed in writing of any material communication
(written or oral) with or from the FDA, Health Canada, or any other Governmental Body or Regulatory Authority performing functions similar
to those performed by the FDA related to a Company Product. The Company and the Company Subsidiaries shall consult with, and consider
any comment from, Parent in good faith prior to making any material submissions to or having material discussions with the FDA, Health
Canada, or any other Governmental Body or Regulatory Authority performing functions similar to those performed by the FDA. The Company
shall ensure that it has available (on hand or through capacity under a credit facility) funds to pay the Termination Fee, if payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.8</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Disclosure</U>.
Parent and the Company agree to issue a joint initial press release as the first public disclosure of this Agreement and with respect
to the Transactions. The Parties shall consult with and provide each other the opportunity to review and comment upon the initial press
release prior to the issuance of such initial press release relating to this Agreement and the Transactions. Thereafter, none of the
Parties or any of their Representatives acting on their behalf, shall, without the prior written consent of the other Parties (which
consent shall not be unreasonably withheld, conditioned, or delayed) issue or cause the publication of any press release or otherwise
make any public statement, disclosure, or communication with respect to the Transactions except (i)&nbsp;as may be required by any applicable
Law or by obligations pursuant to any listed agreement with any national securities exchange or as may be requested by a Governmental
Body or (ii)&nbsp;expressly permitted under <U>ARTICLE&nbsp;V</U>; <I>provided</I> that the foregoing shall not apply to any public statement,
disclosure, or communication so long as such statement, disclosure, or communication is substantially similar in tone and substance with
previous public statements, disclosures, or communications jointly made by the Company and Parent or to the extent that they have been
reviewed and previously approved by both the Company and Parent and would not otherwise require the other Party to make additional public
disclosure. The Parties acknowledge that the Company will file this Agreement and a material change report relating thereto on SEDAR.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.9</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notice
and Cure Provisions.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the period commencing on the date of this Agreement and continuing until the earlier of the Effective Time and the termination of this
Agreement in accordance with its terms, each Party shall promptly notify the other Party of the occurrence, or failure to occur, of any
event or state of facts which occurrence or failure would, or would be reasonably likely to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">i.</TD><TD>cause any of the representations or warranties of such Party contained
                                            in this Agreement to be untrue or inaccurate in any material respect at any time from the
                                            date of this Agreement to the Effective Time; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD>result in the failure to comply with or satisfy any covenant, condition
                                            or agreement to be complied with or satisfied by such Party under this Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Notification
provided under this <U>Section&nbsp;4.9</U> will not affect the representations, warranties, covenants, agreements or obligations of
the Parties (or remedies with respect thereto) or the conditions to the obligations of the Parties under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company may not elect to exercise its right to terminate this Agreement pursuant to <U>Section&nbsp;7.1(e)</U>&nbsp;and the Purchaser
may not elect to exercise its right to terminate this Agreement pursuant to <U>Section&nbsp;7.1(f)</U>, unless the Party seeking to terminate
the Agreement (the &ldquo;<B><I>Terminating Party</I></B>&rdquo;) has delivered a written notice (&ldquo;<B><I>Termination Notice</I></B>&rdquo;)
to the other Party (the &ldquo;<B><I>Breaching Party</I></B>&rdquo;) specifying in reasonable detail all breaches of covenants, representations
and warranties or other matters which the Terminating Party asserts as the basis for termination. After delivering a Termination Notice,
provided the Breaching Party is proceeding diligently to cure such matter and such matter is capable of being cured prior to the End
Date, the Terminating Party may not exercise such termination right until the earlier of (i)&nbsp;the End Date, and (ii)&nbsp;the date
that is fifteen (15) Business Days following receipt of such Termination Notice by the Breaching Party, if such matter has not been cured
by such date, provided that, for greater certainty, if any matter is not capable of being cured by the End Date, the Terminating Party
may immediately exercise the applicable termination right, and provided further that a breach caused by fraud or Willful Breach shall
be deemed to be incapable of being cured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Terminating Party delivers a Termination Notice prior to the date of the Company Meeting, unless the Parties agree otherwise, the
Company shall postpone or adjourn the Company Meeting to the earlier of (i)&nbsp;five (5)&nbsp;Business Days prior to the End Date and
(ii)&nbsp;the date that is fifteen (15) Business Days following receipt of such Termination Notice by the Breaching Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.10</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Stock
Exchange Delisting; Deregistration</U>. Prior to the Closing Date, the Company shall cooperate with Parent and use its reasonable best
efforts to take or cause to be taken all actions, and do or cause to be done all things, reasonably necessary, proper, or advisable on
its part under applicable Law to cause the delisting by the Company of the Shares from the Nasdaq and TSX, the deregistration of the
Shares under the Exchange Act and under any applicable Securities Laws as promptly as practicable after the Effective Time and to cause
the Company to cease being a reporting issuer under any applicable Securities Law as promptly as practicable after the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.11</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Regulatory
Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the Closing Date, the Company shall, to the extent permissible under applicable Law, inform Parent of, and provide Parent with a reasonable
opportunity to review and comment on, in advance, any material filing proposed to be made by or on behalf of the Company or any of its
Subsidiaries with respect to any Company Product, and any material correspondence or other material communication proposed to be submitted
or otherwise transmitted to the FDA, Health Canada, or any other Regulatory Authority by or on behalf of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Prior
to the Closing Date, the Company shall, to the extent permissible under applicable Law, reasonably promptly (and in any event within
three (3)&nbsp;Business Days upon discovery by the Company) notify Parent in writing of (i)&nbsp;any material FDA Form&nbsp;483, warning
letter, untitled letter, or other similar material correspondence or notice from the FDA, Health Canada, or any other applicable Regulatory
Authority alleging or asserting material noncompliance with any applicable Laws or Regulatory Authorizations received by the Company,
its Subsidiaries, or to the knowledge of the Company, any of their respective contract manufacturers with respect to the Company Products
(ii)&nbsp;any written notices, correspondence, or other communication from any institutional review board, the FDA, Health Canada, or
any applicable Regulatory Authority, recommending or requiring the termination, suspension, or material modification of any ongoing or
planned clinical trials conducted by, or on behalf of, the Company or any of its Subsidiaries, (iii)&nbsp;any Legal Proceedings (whether
complete or pending) or request from a Regulatory Authority seeking the recall, withdrawal, suspension or seizure of any Company Product
or (iv)&nbsp;any written notice or other communication from any applicable Regulatory Authority (A)&nbsp;withdrawing or placing any of
the Company Products on &ldquo;clinical hold&rdquo; or requiring the termination or suspension of any pre-clinical studies or clinical
trials of the Company Products or (B)&nbsp;alleging any material violation of any applicable Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.12</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Section&nbsp;338
Elections; Entity Classification Elections.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Parent
and Purchaser shall not make (and shall cause each of their respective Affiliates to not make) any election under Section&nbsp;338 of
the Code or any similar provision of any U.S. state or local or foreign Law with respect to the Company or any Company Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Parent
and Purchaser shall not make (and shall cause each of their respective Affiliates to not make) any entity classification election pursuant
to U.S. Treasury Regulations Section&nbsp;301.7701-3 with respect to the Company or any Company Subsidiary, which election would be effective
on or prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.13</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Other
Actions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall and shall cause the Company Subsidiaries to take the actions set forth on Section&nbsp;4.13(a)&nbsp;of the Company Disclosure
Schedule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">At
least 2 Business Days prior to the Effective Time, the Company shall incorporate a new wholly-owned Subsidiary of Bellus Health Cough
Inc. that will be a disregarded entity for U.S. tax purposes and incorporated in a jurisdiction designated by Purchaser (&ldquo;<B>Canada
IP Transfer Co</B>&rdquo;), the Constating Documents of which shall be reviewed and agreed upon by the Purchaser, acting reasonably.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Immediately
following the amalgamation contemplated in Section&nbsp;2.3(1)&nbsp;of the Plan of Arrangement and prior to the occurrence of the transactions
contemplated in Section&nbsp;2.3(2)&nbsp;of the Plan of Arrangement, AmalCo (as defined in the Plan of Arrangement) shall, to the extent
legally permissible, effectively transfer and assign, in writing, to Canadian IP Transfer Co all right, title and ownership in and to
all Selected IP (as defined in Section&nbsp;4.13(c)&nbsp;of the Company Disclosure Schedule) (including, without limitation, all rights
to sue for past, current or future infringement thereof, all rights to register, prosecute, maintain and defend such Selected IP, and
all income, royalties, profits and damages related thereto).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;4.14</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>U.S.
Tax Treatment of Amalgamation</U>. The Parties intend that, for United States federal income tax purposes, the Amalgamation (as defined
in the Plan of Arrangement) will qualify as a &ldquo;reorganization&rdquo; within the meaning of Section&nbsp;368(a)&nbsp;of the Code
and the Treasury Regulations thereunder, to which each of Subco (as defined in the Plan of Arrangement) and the Company are to be parties
under Section&nbsp;368(b)&nbsp;of the Code and the Treasury Regulations thereunder. The Plan of Arrangement, taken together with this
Arrangement Agreement, is intended to be, and is adopted as, a plan of reorganization for purposes of Sections 354, 361 and the 368 of
the Code and within the meaning of Treasury Regulations Section&nbsp;1.368-2(g). None of the Parties knows of any fact or circumstance
(without conducting independent inquiry or diligence of the other relevant Parties), or has taken or will take any action, if such fact,
circumstance or action would be reasonably expected to cause the Amalgamation to fail to qualify as a reorganization within the meaning
of Section&nbsp;368(a)&nbsp;of the Code and the Treasury Regulations thereunder. The Amalgamation shall be reported by the Parties for
all Tax purposes in accordance with the foregoing, unless otherwise required by a Governmental Body as a result of a &ldquo;determination&rdquo;
within the meaning of Section&nbsp;1313(a)&nbsp;of the Code. The Parties shall cooperate with each other and their respective counsel
to document and support the Tax treatment of the Amalgamation as a &ldquo;reorganization&rdquo; within the meaning of Section&nbsp;368(a)&nbsp;of
the Code, including providing factual support letters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;V<BR>
ADDITIONAL COVENANTS REGARDING NON-SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.1</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>No
Solicitation</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as expressly provided in this <U>ARTICLE&nbsp;V</U>, the Company shall not, and shall cause the Company Subsidiaries not to, directly
or indirectly, through any of its or their Representatives or otherwise, and shall not permit or authorize any such Person to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">i.</TD><TD>solicit, assist, initiate, knowingly encourage, or otherwise knowingly
                                            facilitate (including by way of furnishing or providing copies of, access to, or disclosure
                                            of, any confidential or non-public information, properties, facilities, books or records
                                            of the Company or any Company Subsidiary or entering into any form of agreement, arrangement
                                            or understanding) any inquiry, proposal, discussion, negotiation, or offer that constitutes
                                            or may reasonably be expected to constitute or lead to, an Acquisition Proposal;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD>enter into, continue, or otherwise initiate, solicit, knowingly
                                            encourage, engage, assist, or participate in or knowingly facilitate (including by the furnishing
                                            any confidential or nonpublic information regarding the Company or any Company Subsidiary)
                                            any discussions or negotiations with any Person (other than with Parent, Purchaser, Parent&rsquo;s
                                            Representatives or any Person acting jointly or in concert with Parent or Purchaser) regarding
                                            any inquiry, proposal or offer that constitutes or may reasonably be expected to constitute
                                            or lead to, an Acquisition Proposal, provided that the Company may (A)&nbsp;communicate with
                                            any Person who submits an Acquisition Proposal for the purpose of clarifying the terms and
                                            conditions of any Acquisition Proposal and (B)&nbsp;advise any Person of the restrictions
                                            of this Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD>make a Change in Recommendation;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD>enter into, or publicly propose to enter into, any agreement, letter
                                            of intent, agreement in principle understanding or arrangement in respect of an Acquisition
                                            Proposal other than a confidentiality and standstill agreement permitted by and in accordance
                                            with <U>Section&nbsp;5.3</U>; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">v.</TD><TD>approve, authorize or publicly announce any intention to do any of
                                            the foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall, and shall cause the Company Subsidiaries and its and their respective Affiliates and Representatives to, immediately cease
and terminate, any solicitation, encouragement, discussion, activity or negotiation commenced prior to the date of this Agreement with
any Person and such Person&rsquo;s Representatives (other than with Parent, Purchaser or Parent&rsquo;s Representatives) with respect
to any inquiry, proposal, discussion, negotiation, or offer that constitutes, or may reasonably be expected to constitute or lead to,
an Acquisition Proposal, and in connection therewith, the Company will:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">i.</TD><TD>immediately discontinue access to and disclosure of all information,
                                            including (A)&nbsp;any physical or electronic data room access for such Persons and their
                                            Representatives to diligence or other information regarding the Company or any Company Subsidiary
                                            or any of their businesses or assets and (B)&nbsp;any access to the properties, facilities,
                                            books and records of the Company or of any Company Subsidiaries; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD>within two (2)&nbsp;Business Days of the date hereof, request (A)&nbsp;the
                                            immediate return or destruction of all copies of any confidential information regarding the
                                            Company or any Company Subsidiary provided to any Person (other than Parent, Purchaser, and
                                            Parent&rsquo;s Representatives) since January&nbsp;1, 2021 in respect of a possible acquisition
                                            business combination, joint venture or other similar transaction, and (B)&nbsp;the immediate
                                            destruction of all material including or incorporating or otherwise reflecting such confidential
                                            or nonpublic information regarding the Company or any Company Subsidiary, using its reasonable
                                            best efforts to ensure that such requests are complied with in accordance with the terms
                                            of such rights.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Further,
the Company covenants and agrees that it shall (i)&nbsp;take all necessary action to enforce any confidentiality, standstill, non-disclosure,
non-solicitation, or similar agreement, covenant, or restriction to which the Company or any Company Subsidiary is a party or may hereafter
become a party in accordance with <U>Section&nbsp;5.3</U> and (ii)&nbsp;not release any Person from, or waive, amend, release, assign,
suspend or otherwise modify any Person&rsquo;s obligations respecting the Company, or any Company Subsidiary, or any other provision
under any confidentiality, standstill, non-disclosure, non-solicitation, or similar agreement, covenant, or restriction to which the
Company or any Company Subsidiary is a party (it being acknowledged by Parent and Purchaser that the automatic termination or release
of any standstill restrictions of any such agreements as a result of the entering into an announcement of this Agreement shall not be
a violation of this <U>Section&nbsp;5.1(c)).</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.2</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Notification
of Acquisition Proposals</U>. If the Company or any of the Company Subsidiaries or any of its or their respective Affiliates or Representatives
receives or otherwise become aware of any written or oral inquiry, proposal, request for information or offer that constitutes, contemplates
or may reasonably be expected to constitute or lead to an Acquisition Proposal, or any request for copies of, access to, or disclosure
of, confidential information relating to the Company or any Subsidiary in relation to a possible Acquisition Proposal, the Company shall
promptly notify Parent and Parent&rsquo;s Counsel, at first orally, and then within twenty-four (24) hours, in writing, of such Acquisition
Proposal, inquiry, proposal, offer or request, a description of its material terms and conditions and the identity of all Persons making
the Acquisition Proposal, inquiry, proposal, offer or request and unredacted copies of all material or substantive documents, correspondence
or media (whether or not electronic) received in respect of, from or on behalf of any such Person. The Company shall keep Parent promptly
and fully informed on a reasonably current basis of the status, the terms of any discussions or negotiations (to the extent such discussions
and negotiations are permitted by <U>Section&nbsp;5.3</U>) and any developments and discussions relating to any Acquisition Proposal
(including any financing commitments related thereto), inquiry, proposal, offer or request, including any changes, modifications or other
amendments to or relating to any such Acquisition Proposal, inquiry, proposal, offer or request and promptly provide to Parent unredacted
copies of all documents, correspondence or media if in writing or electronic form, and if not in writing or electronic form, a description
of the terms of such correspondence between the Company and its Representatives and the Person making any such Acquisition Proposal,
inquiry, proposal, offer or request and its Representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.3</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Responding
to an Acquisition Proposal</U>. Notwithstanding <U>Section&nbsp;5.1</U>, if, at any time prior to obtaining the Required Shareholder
Approval, the Company receives a bona fide unsolicited written Acquisition Proposal that did not result, directly or indirectly, from
any breach of this <U>ARTICLE&nbsp;V</U>, any other provision of this Agreement or the Confidentiality Agreement, but subject to entering
into a confidentiality agreement with such Person containing a customary standstill provision and other terms that are not less favorable
to the Company than those contained in the Confidentiality Agreement (it being understood that such confidentiality agreement must not
contain any provision or term that would restrict, in any manner, the Company&rsquo;s ability to consummate the Arrangement or other
Transactions or comply with its disclosure obligations to Parent pursuant to this Agreement), a final executed copy of which shall be
provided to Parent prior to providing such Person with any such copies, access or disclosure, the Company and its Representatives may
(i)&nbsp;engage in or participate in discussions or negotiations with such Person regarding such Acquisition Proposal, and (ii)&nbsp;provide
copies of, access to or disclosure of information, properties, facilities, books or records of the Company or its Subsidiaries (and any
such copies, access or disclosure provided to such Person shall have already been (or simultaneously be) provided to Parent and Parent&rsquo;s
Representative), if and only if, in the case of both clauses (i)&nbsp;and (ii):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Company Board first determines in good faith, after consultation with its financial advisor(s)&nbsp;and outside legal counsel, that such
Acquisition Proposal constitutes or would reasonably be expected to constitute or lead to a Superior Proposal and that the failure to
take the actions described in clauses (i)&nbsp;and (ii)&nbsp;above would be inconsistent with its fiduciary duties under applicable Law;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">such
Person making the Acquisition Proposal was not restricted from making such Acquisition Proposal pursuant to an existing confidentiality,
standstill, nondisclosure, non-solicitation or similar agreement, restriction or covenant with the Company or any of the Company Subsidiaries;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Company has been, and continues to be, in compliance (i)&nbsp;with its obligations under <U>Section&nbsp;5.1</U> in all respects, and
(ii)&nbsp;with its obligations under <U>ARTICLE&nbsp;V</U> (other than <U>Section&nbsp;5.1</U>) in all material respects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;5.4</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Right
to Match</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Company receives an Acquisition Proposal that constitutes a Superior Proposal prior to obtaining the Required Shareholder Approval,
the Company Board may, or may cause the Company to, subject to compliance with <U>Section&nbsp;7.3</U>, terminate this Agreement to enter
into a definitive agreement with respect to such Superior Proposal, if and only if:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">i.</TD><TD>the Person making the Superior Proposal was not restricted from making
                                            such Superior Proposal pursuant to an existing confidentiality, standstill, non-disclosure,
                                            non-solicitation, or similar agreement, restriction, or covenant with the Company or any
                                            of the Company Subsidiaries;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD>the Company has been, and continues to be, in compliance (A)&nbsp;with
                                            its obligations under <U>Section&nbsp;5.1</U> in all respects, (B)&nbsp;with its obligations
                                            under <U>ARTICLE&nbsp;V</U> (other than <U>Section&nbsp;5.1</U>) in all material respects
                                            and (C)&nbsp;its obligations under <U>Section&nbsp;2.3</U> and <U>Section&nbsp;2.4</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iii.</TD><TD>the Company or its Representatives have delivered to Parent a written
                                            notice of the determination of the Company Board that such Acquisition Proposal constitutes
                                            a Superior Proposal and of the intention to enter into a definitive agreement with respect
                                            to such Superior Proposal (the &ldquo;<B><I>Superior Proposal Notice</I></B>&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">iv.</TD><TD>the Company or its Representatives have provided to Parent a copy
                                            of the proposed definitive agreements for the Superior Proposal (which shall include all
                                            schedules, appendices, exhibits and other attachments related thereto including copies of
                                            any financing commitments related thereto) and all ancillary documentation and supporting
                                            materials (including any financing documents subject to customary confidentiality provisions)
                                            and any other material documents or material correspondences (as well as any subsequent amendment
                                            or modification with respect to any of the foregoing) provided to or by the Company, and
                                            Company Subsidiary or their respective Affiliates and Representatives in connection therewith;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">v.</TD><TD>at least five (5)&nbsp;Business Days (the &ldquo;<B><I>Matching Period</I></B>&rdquo;)
                                            have elapsed from the date that is the later of the date on which Parent received the Superior
                                            Proposal Notice and the date on which Parent received a copy of all the materials referred
                                            to in <U>iv</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">vi.</TD><TD>during any Matching Period, the Company shall, if requested by Parent,
                                            negotiate in good faith with Parent and Parent&rsquo;s Representatives, regarding any revision
                                            to the terms of the Arrangement and other Transactions proposed by Parent in order for such
                                            Acquisition Proposal to cease to be a Superior Proposal;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">vii.</TD><TD>after the Matching Period, the Company Board has determined in
                                            good faith (A)&nbsp;after consultation with its financial advisor(s)&nbsp;and outside legal
                                            counsel, that such Acquisition Proposal continues to constitute a Superior Proposal (and,
                                            if applicable, compared to the terms of the Arrangement as proposed to be amended by Parent
                                            under <U>Section&nbsp;5.4(b)</U>) and (B)&nbsp;after consultation with its outside legal
                                            counsel and financial advisors, that the failure to take the relevant action would be inconsistent
                                            with its fiduciary duties under applicable Law;</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 1 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">viii.</TD><TD>prior to or concurrently with entering into such definitive agreement,
                                            the Company terminates this Agreement pursuant to <U>Section&nbsp;7.1</U>, and pays the Termination
                                            Fee pursuant to <U>Section&nbsp;7.3</U>; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ix.</TD><TD>the making of the Acquisition Proposal constituting a Superior Proposal
                                            did not result, directly or indirectly, from any breach of this <U>ARTICLE&nbsp;V</U> or
                                            any other provision of this Agreement or the Confidentiality Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">During
the Matching Period, or such longer period as the Company may approve in writing for such purpose: (i)&nbsp;the Company Board shall review
in good faith any offer made by Parent under <U>Section&nbsp;5.4(a)vi</U> to amend the terms of this Agreement and the Arrangement in
order to determine whether such proposal would, upon acceptance, result in the Acquisition Proposal previously constituting a Superior
Proposal ceasing to be a Superior Proposal; and (ii)&nbsp;the Company shall, and shall cause its Representatives to, negotiate in good
faith with Parent and Parent&rsquo;s Representatives to make such amendments to the terms of this Agreement and the Arrangement as would
enable Parent and Purchaser to proceed with the Transactions on such amended terms. If the Company Board determines that such Acquisition
Proposal would cease to be a Superior Proposal, the Company shall promptly (and in any event within twenty-four (24) hours of such determination)
so advise Parent and the Company and Parent shall amend this Agreement to reflect such offer made by Parent, and shall take and cause
to be taken all such actions as are necessary to give effect to the foregoing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
successive amendment to any Acquisition Proposal that results in an increase in, or modification of, the consideration (or value of such
consideration) to be received by the Shareholders or other material terms or conditions thereof shall constitute a new Acquisition Proposal
for the purposes of this <U>Section&nbsp;5.4</U> and Parent shall be afforded a new full five (5)&nbsp;Business Day Matching Period from
the later of the date on which Parent received the Superior Proposal Notice for the new Superior Proposal and the date on which Parent
received all of the materials referred to in <U>Section&nbsp;5.4(a)iv</U> with respect to such new Superior Proposal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company Board shall promptly (and in any event within twenty-four (24) hours) reaffirm the Company Board Recommendation without qualification
by press release after any Acquisition Proposal which is not determined to be a Superior Proposal is publicly announced or publicly disclosed
or the Company Board determines that a proposed amendment to the terms of this Agreement or the Arrangement as contemplated under <U>Section&nbsp;5.4(b)</U>&nbsp;would
result in an Acquisition Proposal no longer being a Superior Proposal. The Company shall provide Parent and its Representatives with
a reasonable opportunity to review the form and content of any such press release and shall make all reasonable amendments to such press
release as requested by Parent and its outside legal counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">If
the Company provides a Superior Proposal Notice to Parent on a date that is less than ten (10)&nbsp;Business Days before the Company
Meeting, the Company shall either proceed with or shall postpone the Company Meeting, as directed by Parent acting reasonably, to a date
determined by Parent that is not more than ten (10)&nbsp;Business Days after the scheduled date of the Company Meeting but in any event
the Company Meeting shall not be postponed to a date which would prevent the Effective Time from occurring on or prior to the End Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Options: NewSection; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Nothing
contained in this Agreement shall prohibit the Company Board from complying with Section&nbsp;2.17 of National Instrument 62- 104 - Take-Over
Bids and Issuer Bids and similar provisions under applicable Securities Laws relating to the provision of a directors&rsquo; circular
in respect of an Acquisition Proposal; or prohibit the Company or the Company Board from calling and/or holding a meeting of Shareholders
requisitioned by Shareholders in accordance with the CBCA or taking any other action to the extent expressly ordered or otherwise mandated
by a Governmental Body; <I>provided</I>, <I>however</I>, in each case that, notwithstanding that the Company Board shall be permitted
to make such disclosure, the Company Board shall not be permitted to make a Change in Recommendation solely as a result of such disclosure.
Any public disclosure made by or on behalf of the Company relating to any Acquisition Proposal shall state that the Company Board Recommendation
continues to be in effect, unless, prior to the time of such public disclosure, this Agreement has been terminated in compliance with
<U>ARTICLE&nbsp;V</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Without
limiting the generality of the foregoing, the Company shall advise its Subsidiaries and its and their Representatives of the prohibitions
set out in this <U>ARTICLE&nbsp;V</U> and any violation of the restrictions set forth in this <U>ARTICLE&nbsp;V</U> by the Company, its
Subsidiaries or its or their Representatives will be deemed to be a breach of this <U>ARTICLE&nbsp;V</U> by the Company for which the
Company will be responsible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VI<BR>
CONDITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The obligations of the Parties to consummate the
Arrangement, are subject to the satisfaction, at or prior to the Closing, of each of the following conditions, to the extent applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Conditions
to Obligation of Each Party to Consummate the Arrangement</U>. The respective obligations of each Party to consummate the Arrangement
shall be subject to the satisfaction (or waiver by Parent, on its own behalf and on behalf of Purchaser, or by the Company, in each case,
to the extent permitted by applicable Law) at or prior to the Effective Time of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Shareholder
Approval</U>. The Arrangement Resolution has been approved and adopted by the Shareholders at the Company Meeting in accordance with
the Interim Order.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Interim
Order and Final Order</U>. The Interim Order and the Final Order have each been obtained on terms consistent with this Agreement and
have not been set aside or modified in a manner unacceptable to either the Company or Parent, each acting reasonably, on appeal or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Legal Restraints</U>. No (i)&nbsp;injunction or similar order by any Governmental Body having competent jurisdiction over Parent, Purchaser,
the Company, or any of their respective Subsidiaries that prohibits the consummation of the Arrangement and the other Transactions shall
have been entered and shall continue to be in effect or (ii)&nbsp;Law shall have been enacted, entered, promulgated, enforced, or deemed
applicable by any Governmental Body having competent jurisdiction over Parent, Purchaser, the Company, or any of their respective Subsidiaries,
that, in any case, prohibits or makes illegal the Transactions (any such order, injunction, or Law in clause&nbsp;(i)&nbsp;or (ii), a
 &ldquo;<B><I>Legal Restraint</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Regulatory
Approvals</U>. (i)&nbsp;Any waiting period under the HSR Act and the filings specified in Section&nbsp;6.1(d)&nbsp;of the Company Disclosure
Schedule applicable to the Arrangement (and any extension thereof) shall have expired or been earlier terminated; (ii)&nbsp;the Competition
Act Approval shall have been received; (iii)&nbsp;all other authorizations, consents, orders, approvals, filings, and declarations, and
all expirations of waiting periods, required under the applicable Antitrust Laws and Foreign Direct Investment Laws with respect to the
Arrangement specified in Section&nbsp;6.1(d)&nbsp;of the Company Disclosure Schedule shall have been made, expired, terminated, or obtained,
as the case may be (all authorizations, consents, orders, approvals, filings, and declarations and the lapse of all such waiting periods,
including under the HSR Act, of such jurisdictions being the &ldquo;<B><I>Requisite Regulatory Approvals</I></B>&rdquo;); and (iv)&nbsp;all
Requisite Regulatory Approvals shall be in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Conditions
to Obligation of the Company to Consummate the Arrangement</U>. The obligation of the Company to consummate the Arrangement is further
subject to the satisfaction (or waiver by the Company to the extent permitted by applicable Law) of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
representations and warranties of Parent and Purchaser set forth in Schedule D (without regard to any qualification as to materiality
or Parent Material Adverse Effect in such representations and warranties) shall be true and correct both when made and at and as of the
Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier date, in which case as of such
date), except where the failures of such representations and warranties to be so true and correct would not, individually or in the aggregate,
reasonably be expect to have a Parent Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Parent
and Purchaser shall have performed in all material respects all obligations required to be performed by them under this Agreement at
or prior to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Parent
shall have delivered to the Company a certificate, dated as of the Closing Date and signed by a duly authorized officer thereof, certifying
to the effect that the conditions set forth in <U>Section&nbsp;6.2(a)</U>&nbsp;and <U>Section&nbsp;6.2(b)</U>&nbsp;have been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Purchaser
has, in accordance with <U>Section&nbsp;2.8</U>, deposited or caused to be deposited with the Depositary the Aggregate Arrangement Consideration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Conditions
to Obligations of Parent and Purchaser to Consummate the Arrangement</U>. The obligations of Parent and Purchaser to consummate the Arrangement
are further subject to the satisfaction (or waiver by Parent, on its own behalf and on behalf of Purchaser, to the extent permitted by
applicable Law) of the following conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;The
representations and warranties of the Company set forth in <U>Section&nbsp;3(a)</U>&nbsp;of Schedule C (except for <I>de minimis</I>
inaccuracies) shall be true and correct in all respects, both when made and at and as of the Closing Date, as if made at and as of such
time (except to the extent expressly made as of an earlier date, in which case as of such date); (ii)&nbsp;the representations and warranties
of the Company set forth <U>Section&nbsp;15(a)</U>, <U>Section&nbsp;31</U>, and <U>Section&nbsp;32</U> of Schedule C shall be true and
correct in all respects both when made and at and as of the Closing Date, as if made at and as of such time; (iii)&nbsp;<U>Section&nbsp;1</U>,
<U>Section&nbsp;2</U>, <U>Section&nbsp;3(b)</U>, <U>Section&nbsp;4</U>, <U>Section&nbsp;5</U> and <U>Section&nbsp;6</U> of Schedule C
(disregarding all materiality and Material Adverse Effect qualifications contained therein) shall be true and correct in all material
respects, both when made and at and as of the Closing Date, as if made at and as of such time (except to the extent expressly made as
of an earlier date, in which case as of such date); and (iv)&nbsp;the other representations and warranties of the Company set forth in
Schedule C (disregarding all materiality and Material Adverse Effect qualifications contained therein) shall be true and correct both
when made and at and as of the Closing Date, as if made at and as of such time (except to the extent expressly made as of an earlier
date, in which case as of such date), except with respect to this clause&nbsp;(iv)&nbsp;where the failure of such representations and
warranties to be so true and correct would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior
to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
the date of this Agreement there shall not have occurred a Material Adverse Effect that is continuing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company shall have delivered to Parent a certificate, dated as of the Closing Date, and signed by its Chief Executive Officer or another
senior officer, certifying to the effect that the conditions set forth in <U>Section&nbsp;6.3(a)</U>, <U>Section&nbsp;6.3(b)</U>, and
<U>Section&nbsp;6.3(c)</U>&nbsp;have been satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
aggregate number of Shares held by Shareholders that have validly exercised Dissent Rights in connection with the Arrangement shall not
exceed 10% of the number of Shares then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Frustration
of Closing Conditions</U>. No Party may rely, either as a basis for not consummating the Arrangement or terminating this Agreement and
abandoning the Arrangement, on the failure of any condition set forth in <U>Section&nbsp;6.1</U>, <U>Section&nbsp;6.2</U>, or <U>Section&nbsp;6.3</U>,
as the case may be, to be satisfied if such failure was caused principally by such Party&rsquo;s failure to perform any of its obligations
under this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;6.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Deemed
Satisfaction of Conditions</U> The conditions set forth in <U>Section&nbsp;6.1</U>, <U>Section&nbsp;6.2</U>, and <U>Section&nbsp;6.3
</U>will be conclusively deemed to have been satisfied, waived or released when the Certificate of Arrangement is issued by the CBCA
Director. For greater certainty, and notwithstanding the terms of any escrow arrangement entered into between the Purchaser and the Depositary,
all funds held in escrow by the Depositary pursuant to <U>Section&nbsp;2.8</U> hereof shall be deemed to be released from escrow when
the Certificate of Arrangement is issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VII<BR>
TERMINATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Termination
and Abandonment</U>. This Agreement may be terminated and abandoned at any time prior to the Effective Time, whether before or after
the Required Shareholder Approval:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
the mutual written consent of the Company and Parent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
either the Company or Parent if (i)&nbsp;the Effective Time shall not have occurred on or before October&nbsp;17, 2023 (the &ldquo;<B><I>End
Date</I></B>&rdquo;) and (ii)&nbsp;the Party seeking to terminate this Agreement pursuant to this <U>Section&nbsp;7.1(b)</U>&nbsp;shall
not have breached (and, in the case of Parent, Purchaser shall also not have breached) its obligations under this Agreement in any manner
that shall have principally caused the failure to consummate the Arrangement on or before such date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
either the Company or Parent if (i)&nbsp;any Governmental Body having competent jurisdiction over Parent, Purchaser, the Company shall
have issued a Legal Restraint, and such Legal Restraint shall have become final and nonappealable and (ii)&nbsp;the Party seeking to
terminate this Agreement pursuant to this <U>Section&nbsp;7.1(c)</U>&nbsp;shall not have breached or failed to perform its obligations
under this Agreement in any manner that shall have principally caused the imposition of such Legal Restraint or the failure of such Legal
Restraint to be resolved or lifted;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
either the Company or Parent if (i)&nbsp;the Company Meeting (including any adjournment, recess, or postponement thereof) shall have
concluded and the Required Shareholder Approval contemplated by this Agreement shall not have been obtained; and (ii)&nbsp;the Party
seeking to terminate this Agreement pursuant to this <U>Section&nbsp;7.1(d)</U>&nbsp;shall not have breached or failed to perform its
obligations under this Agreement in any manner that shall have principally caused the failure to obtain the Required Shareholder Approval</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
the Company, if Parent or Purchaser shall have breached any representation, warranty, covenant, or agreement in this Agreement, in each
case, which breach (i)&nbsp;would result in a failure of a condition set forth in <U>Section&nbsp;6.1</U>, <U>Section&nbsp;6.2(a)</U>,
or <U>Section&nbsp;6.2(b)</U>&nbsp;and (ii)&nbsp;is not cured in accordance with the terms of <U>Section&nbsp;4.9</U>; <I>provided</I>
that the Company is not then in breach of any representation, warranty, agreement, or covenant in this Agreement that would result in
a failure of a condition set forth in <U>Section&nbsp;6.1</U>, <U>Section&nbsp;6.3(a)</U>, or <U>Section&nbsp;6.3(b)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
Parent, if the Company shall have breached in any material respect any representation, warranty, covenant, or agreement in this Agreement,
in each case, which breach (i)&nbsp;would result in a failure of a condition set forth in <U>Section&nbsp;6.1</U>, <U>Section&nbsp;6.3(a)</U>,
or <U>Section&nbsp;6.3(b)</U>&nbsp;and (ii)&nbsp;is not cured in accordance with the terms of <U>Section&nbsp;4.9</U>; <I>provided</I>
that Parent or Purchaser is not then in breach of any representation, warranty, agreement, or covenant in this Agreement that would result
in a failure of a condition set forth in <U>Section&nbsp;6.1</U>, <U>Section&nbsp;6.2(a)</U>, or <U>Section&nbsp;6.2(b)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">prior
to the time the Required Shareholder Approval is obtained, by the Company in order to accept a Superior Proposal and substantially concurrently
enter into a binding written definitive acquisition agreement providing for the consummation of such transaction constituting a Superior
Proposal;&nbsp;<I>provided</I>, that the Company has complied in all respects with the requirements of <U>Section&nbsp;5.1</U> and in
all material respects with the requirements of&nbsp;<U>ARTICLE&nbsp;V</U> (other than <U>Section&nbsp;5.1</U>) with respect to such Superior
Proposal and, concurrently with such termination, pays (or causes to be paid) the fee specified in&nbsp;<U>Section&nbsp;7.3</U>; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">by
Parent, if the Company breaches <U>ARTICLE&nbsp;V</U> in any material respect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effect
of Termination/Survival</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Effect
of Termination</U>. In the event of the termination of this Agreement as provided in <U>Section&nbsp;7.1</U>, (a)&nbsp;the Terminating
Party shall give prompt written notice thereof to the other Parties, specifying the provision hereof pursuant to which such termination
is made, (b)&nbsp;this Agreement shall be of no further force or effect and the Transactions shall be abandoned, each as of the date
of termination, and (c)&nbsp;there shall be no liability on the part of any Parent Party or Company Party following any such termination;
<I>provided </I>that (i)&nbsp;this <U>Section&nbsp;7.2</U>, <U>Section&nbsp;7.3(a)</U>, and <U>ARTICLE&nbsp;VIII</U> shall survive the
termination of this Agreement and shall remain in full force and effect, (ii)&nbsp;the Confidentiality Agreement shall survive the termination
of this Agreement and shall remain in full force and effect, in each case, in accordance with its terms, and (iii)&nbsp;the termination
of this Agreement shall not relieve any Party from any liability for fraud or Willful Breach.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Survival of Representations and Warranties and Covenants</U>. None of the representations and warranties or covenants in this Agreement,
the Company Disclosure Schedule, or any certificate or schedule or other document delivered pursuant to this Agreement shall survive
the Arrangement, <I>except</I> that those covenants that by their terms survive the Effective Time, this <U>ARTICLE&nbsp;VII</U>, and
any applicable defined term in <U>Section&nbsp;1.1</U> shall survive the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;7.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Termination
Fee and Expenses</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Termination
Fee</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">i.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Termination
                                            Fee</U>. Notwithstanding anything to the contrary in this Agreement, if (A)&nbsp;the Company
                                            shall have terminated this Agreement pursuant to <U>Section&nbsp;7.1(g)</U>, (B)&nbsp;Parent
                                            shall have terminated this Agreement pursuant to <U>Section&nbsp;7.1(h)</U>, or (C)&nbsp;(1)&nbsp;after
                                            the date of this Agreement and prior to the termination of this Agreement, an Acquisition
                                            Proposal </FONT>shall have been made known to the Company or any of its Subsidiaries or publicly
                                            disclosed (in each case, whether or not conditional and whether or not withdrawn), (2)&nbsp;this
                                            Agreement is terminated by Parent or the Company pursuant to <U>Section&nbsp;7.1(b)</U>,
                                            <U>Section&nbsp;7.1(d)&nbsp;or Section&nbsp;7.1(f)</U>&nbsp;and (3)&nbsp;concurrently with
                                            or within twelve (12)&nbsp;months after such termination, the Company shall have entered
                                            into a definitive agreement providing for, or completed the implementation of, an Acquisition
                                            Proposal, then in the case of each of clauses (A), (B)&nbsp;and (C)&nbsp;above, the Company
                                            shall pay, by wire transfer of immediately available funds to an account designated by Parent,
                                            a fee of $75,000,000 in cash (the &ldquo;<B><I>Termination Fee</I></B>&rdquo;), such payment
                                            to be made concurrently with termination in the case of clause&nbsp;(A)&nbsp;above, within
                                            three (3)&nbsp;Business Days after such termination in the case of clause&nbsp;(B)&nbsp;above
                                            if terminated pursuant to <U>Section&nbsp;7.1(b)</U>&nbsp;or within two (2)&nbsp;Business
                                            Days of the Company Meeting if terminated pursuant to or <U>Section&nbsp;7.1(d)</U>, or concurrently
                                            with the completed implementation of the Acquisition Proposal, in the case of clause&nbsp;(C)&nbsp;above;
                                            <I>it being understood</I> that for all purposes of clause (C)&nbsp;above and the application
                                            of this <U>Section&nbsp;7.3(a)</U>, all references to 20% in the definition of &ldquo;Acquisition
                                            Proposal&rdquo; shall be deemed to be references to &ldquo;more than 50%&rdquo; and in no
                                            event shall the Company be required to pay the Termination Fee on more than one (1)&nbsp;occasion.
                                            Other than as specified in <U>Section&nbsp;7.2(a)</U>, upon the payment by the Company of
                                            the Termination Fee as and when required by this <U>Section&nbsp;7.3(a)</U>, none of the
                                            current, former, or future Company Parties shall have any further liability with respect
                                            to this Agreement or the Transactions to any Parent Party. If any applicable law (as determined
                                            in the good faith discretion of the Company) requires deduction or withholding of any Tax
                                            from any payment of the Termination Fee, then the Company shall be entitled to make such
                                            deduction or withholding and shall timely pay the full amount deducted or withheld to the
                                            relevant Governmental Body in accordance with applicable law the sum payable by the Company
                                            pursuant to this <U>Section&nbsp;7.3(a)(i)</U>&nbsp;shall be increased as necessary so that
                                            after such deduction or withholding has been made (including such deductions and withholdings
                                            applicable to additional sums payable under this <U>Section&nbsp;7.3(a)(i)</U>) Parent receives
                                            an amount equal to the Termination Fee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Expenses</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">i.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">If
                                            this Agreement has been terminated pursuant to <U>Section&nbsp;7.1(d)</U>, then the Company
                                            shall, within two (2)&nbsp;Business Days following the termination of this Agreement, pay,
                                            by wire transfer of immediately available funds to an account designated by Parent, expense
                                            reimbursement for reasonable, documented out-of-pocket third party transaction expenses incurred
                                            by Parent in connection with this Agreement, in an amount not to exceed $10,000,000 </FONT><I>provided
                                            </I>that in no event shall the Company be required to pay under <U>Section&nbsp;7.3(a)(i)</U>&nbsp;and
                                            this <U>Section&nbsp;7.3(b)(i)</U>, in the aggregate, an amount in excess of the Termination
                                            Fee. For greater certainty, any payment by the Company under this <U>Section&nbsp;7.3(b)(i)</U>&nbsp;will
                                            be credited against a payment under <U>Section&nbsp;7.3(a)(i)</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in">ii.</TD><TD>Except as set forth in the penultimate sentence of <U>Section&nbsp;4.3(c)</U>&nbsp;and
                                            <U>Section&nbsp;7.3(b)(i)</U>, all fees and expenses incurred in connection with this Agreement
                                            and the Transactions shall be paid by the Party incurring such expenses, whether or not the
                                            Transactions are consummated.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Acknowledgements</U>.
Each Party acknowledges that the agreements in this <U>Section&nbsp;7.3</U> are an integral part of this Agreement and that, without
these agreements, the Parties would not have entered into this Agreement. Accordingly, if the Company fails to promptly pay any amount
due pursuant to this <U>Section&nbsp;7.3</U>, the Company shall pay to Parent all fees, costs, and expenses of enforcement (including
attorneys&rsquo; fees and expenses as well as expenses incurred in connection with any action initiated by Parent), together with interest
on the amount of the Termination Fee at the prime lending rate as published in the <I>Wall Street Journal</I>, in effect on the date
such payment is required to be made. The Parties further acknowledge that the Termination Fee shall not constitute a penalty but is liquidated
damages for losses and damages described in <U>Section&nbsp;7.3(a)i</U>, in a reasonable amount that will compensate Parent in the circumstances
in which the Termination Fee is payable for the efforts and resources expended and opportunities foregone while negotiating this Agreement
and in reliance on this Agreement and on the expectation of the consummation of the Transactions, which amount would otherwise be impossible
to calculate with precision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLE&nbsp;VIII<BR>
GENERAL PROVISIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.1</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendment</U>.
Prior to the Effective Time, this Agreement may be amended with the approval of each of the Company Board and the board of directors
of Parent at any time. This Agreement may not be amended except by an instrument in writing signed on behalf of each of the Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.2</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Waiver</U>.
No failure on the part of any Party to exercise any power, right, privilege, or remedy under this Agreement, and no delay on the part
of any Party in exercising any power, right, privilege, or remedy under this Agreement, shall operate as a waiver of such power, right,
privilege, or remedy; and no single or partial exercise of any such power, right, privilege, or remedy shall preclude any other or further
exercise thereof or of any other power, right, privilege, or remedy. No Party shall be deemed to have waived any claim arising out of
this Agreement, or any power, right, privilege, or remedy under this Agreement, unless the waiver of such claim, power, right, privilege,
or remedy is expressly set forth in a written instrument duly executed and delivered on behalf of such Party; and any such waiver shall
not be applicable or have any effect except in the specific instance in which it is given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.3</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Entire
Agreement; Counterparts</U>. This Agreement and the other agreements, exhibits, annexes, and schedules referred to herein, including
the Confidentiality Agreement, the Exclusivity Agreement, and the Company Disclosure Schedule constitute the entire agreement and supersede
all prior agreements and understandings, both written and oral, among or between any of the Parties, with respect to the subject matter
hereof and thereof; <I>provided </I>that the Confidentiality Agreement shall not be superseded and shall remain in full force and effect;
<I>provided</I>, <I>further</I>, that, if the Effective Time occurs, the Confidentiality Agreement shall automatically terminate and
be of no further force and effect. This Agreement may be executed in several counterparts, each of which shall be deemed an original
and all of which shall constitute one (1)&nbsp;and the same instrument. The exchange of a fully executed Agreement (in counterparts or
otherwise) by PDF shall be sufficient to bind the Parties to the terms and conditions of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.4</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Applicable
Laws; Jurisdiction; Specific Performance; Remedies</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">This
Agreement shall be governed by, and construed in accordance with, the laws of the Province of Qu&eacute;bec and the federal laws of Canada
applicable therein, without giving effect to any law, rule, or provision that would cause the application of any Law other than the laws
of the Province of Qu&eacute;bec and the federal laws of Canada applicable therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
Party irrevocably attorns and submits to the non-exclusive jurisdiction of the Qu&eacute;bec courts situated in the City of Montreal
(the &ldquo;<B><I>Chosen Courts</I></B>&rdquo;) and waives objection to the venue of any proceeding in such court or that such court
provides an inconvenient forum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Parties agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in
the event that any Party does not perform its obligations under the provisions of this Agreement in accordance with its specific terms
or otherwise breaches such provisions. Subject to the following sentence, (i)&nbsp;the Parties shall be entitled to an injunction or
injunctions, specific performance, or other&nbsp;non-monetary&nbsp;equitable relief, to prevent breaches of this Agreement and to enforce
specifically the terms and provisions hereof in the Chosen Courts without proof of damages or otherwise, this being in addition to any
other remedy to which they are entitled under this Agreement; (ii)&nbsp;the provisions set forth in <U>Section&nbsp;7.3(a)</U>&nbsp;(A)&nbsp;are
not intended to and do not adequately compensate for the harm that would result from a breach of this Agreement and (B)&nbsp;shall not
be construed to diminish or otherwise impair in any respect any Party&rsquo;s right to specific performance, in each case, except if
Parent has been paid the Termination Fee in accordance with the terms of this Agreement; and (iii)&nbsp;the right of specific performance
is an integral part of the Transactions, and, without that right, neither the Company nor Parent would have entered into this Agreement.
Except if the Termination Fee has been paid pursuant to <U>Section&nbsp;7.3(a)</U>, no Party shall oppose the granting of an injunction,
specific performance, or other equitable relief on the basis that the other Parties have an adequate remedy at law or that an award of
specific performance is not an appropriate remedy for any reason at law or equity. Any Party seeking any injunction or other equitable
relief to prevent any breach of this Agreement or to enforce specifically the terms and provisions of this Agreement in accordance with
this <U>Section&nbsp;8.4(c)</U>&nbsp;shall not be required to provide any bond or other security in connection with any such order or
injunction. In the event that a Party initiates a Legal Proceeding seeking equitable relief pursuant to this <U>Section&nbsp;8.4(c)</U>,
the End Date shall automatically be extended to (x)&nbsp;the twentieth (20<SUP>th</SUP>) Business Day following the date on which such
Legal Proceeding is finally resolved or (y)&nbsp;such other date established by the Chosen Court presiding over such Legal Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">EACH
PARTY IRREVOCABLY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING BETWEEN OR AMONG THE PARTIES ARISING OUT OF, RELATING TO
THE SUBJECT MATTER OF THIS AGREEMENT OR THE TRANSACTIONS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.5</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Assignability</U>.
This Agreement shall be binding upon, and shall inure to the benefit of, the Parties and their respective successors and permitted assigns,
and shall be enforceable solely by the Parties hereto; <I>provided </I>that neither this Agreement nor any right hereunder may be assigned
without the prior written consent of the other Parties, and any attempted assignment of this Agreement or any such right without such
consent shall be void <I>ab initio</I> and of no effect; <I>provided</I>, <I>further</I>, that Parent or Purchaser may assign, in their
sole discretion, this Agreement or any or all of their rights, interests and obligations under this Agreement (i)&nbsp;in connection
with a merger or consolidation involving Parent or Purchaser or other disposition of all or substantially all of the assets of Parent,
Purchaser or the Company or (ii)&nbsp;in the case of Purchaser, to any Affiliate of Parent, (<I>provided </I>that no such assignment
permitted pursuant to this <U>Section&nbsp;8.5</U> shall relieve Parent of Purchaser of their respective obligations hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.6</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>No
Third-Party Beneficiary</U>. Nothing in this Agreement is intended to or shall confer upon any Person (other than the Parties) any power,
right, privilege, or remedy of any nature whatsoever under or by reason of this Agreement, except for: (a)&nbsp;the payment provisions
in the Plan of Arrangement (which, from and after the Effective Time,&nbsp;shall be for the express benefit of, and enforceable by, each
Shareholder or holder of Company Equity Awards as of the Effective Time) and <U>Section&nbsp;4.5</U> (which, from and after the Effective
Time, shall be for the benefit of the Indemnified Persons); and (b)&nbsp;the limitations on liability of the Company and the Company
Parties set forth in <U>Section&nbsp;7.3(a)</U>&nbsp;(which shall be for the express benefit of, and enforceable by, each of the Parties
hereto and their permitted assigns).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.7</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any notice or other communication required or permitted to be delivered to any Party under this Agreement shall be in writing and shall
be deemed properly delivered, given and received (a)&nbsp;upon receipt when delivered by hand, (b)&nbsp;four (4)&nbsp;Business Days after
being sent by certified or registered mail, postage prepaid, or one (1)&nbsp;Business Day after being sent by nationally recognized overnight
courier or express delivery service, (c)&nbsp;if sent by email transmission prior to 6:00 p.m.&nbsp;recipient&rsquo;s local time, upon
transmission (<I>provided</I> that the recipient confirms in writing its receipt thereof (excluding automated replies or &ldquo;bounce
back&rdquo; or similar message of non-delivery)), or (d)&nbsp;if sent by email transmission after 6:00 p.m.&nbsp;recipient&rsquo;s local
time, on the Business Day following the date of transmission (<I>provided</I> that the recipient confirms in writing its receipt thereof
(excluding automated replies or &ldquo;bounce back&rdquo; or similar message of non-delivery)); <I>provided</I> that, in each case, the
notice or other communication is sent to the physical address or email address set forth beneath the name of such Party as follows (or
to such other physical address or email address as such Party shall have specified in a written notice given to the other Parties):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">if to Parent or Purchaser (or following the Effective Time,
the Company):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">GSK plc<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">980 Great West Road<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Brentford, Middlesex, United Kingdom<BR>
Attention: Chief Financial Officer<BR>
</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Fax:</TD>
  <TD>[Redacted - personal information]</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">GSK plc<BR>
980 Great West Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Brentford, Middlesex, United Kingdom<BR>
Attention: Senior Vice President and General Counsel<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1in">Senior Vice President and Company Secretary</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Fax:</TD>
  <TD>[Redacted - personal information]</TD></TR>

<TR STYLE="vertical-align: top">
  <TD>Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul,
Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP<BR>
1285 Avenue of the Americas<BR>
New&nbsp;York, New&nbsp;York 10019-6064<BR>
Attention: Krishna Veeraraghavan<BR>
</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Stikeman Elliot LLP<BR>
1155 Ren&eacute;-L&eacute;vesque Blvd. West<BR>
41<SUP>st</SUP> Floor<BR>
Montr&eacute;al, Qu&eacute;bec H2B 3V2, Canada<BR>
Attention: Peter Castiel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1in">Robert Carelli<BR>
Oliver Godbout</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">if to the Company (prior to the Effective Time):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">BELLUS Health Inc.<BR>
275 Armand-Frappier Blvd.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Laval, Qu&eacute;bec, H7V 4A7, Canada</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attention: Roberto Bellini</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ramzi
Benamar</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">with a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Skadden, Arps, Slate, Meagher&nbsp;&amp; Flom LLP&nbsp;&amp;
Affiliates<BR>
500 Boylston Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Boston,
Massachusetts 02116</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Graham Robinson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT><FONT STYLE="font-size: 10pt">Faiz Ahmad</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><FONT STYLE="font-size: 10pt"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Davies Ward Philips&nbsp;&amp; Vineberg LLP<BR>
1501 McGill College Avenue<BR>
Suite&nbsp;2600<BR>
Montr&eacute;al, Qu&eacute;bec H3A 3N9, Canada<BR>
Attention: S&eacute;bastien Roy</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 94%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">

<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in">Email:</TD>
  <TD>[Redacted - personal information]</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.8</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity
or enforceability of the remaining terms and provisions of this Agreement or the validity or enforceability of the offending term or
provision in any other situation or in any other jurisdiction. If a final judgment of a court of competent jurisdiction declares that
any term or provision of this Agreement is invalid or unenforceable, the Parties shall not object to the court making such determination
having the power to limit such term or provision, to delete specific words or phrases, or to replace such term or provision with a term
or provision that is valid, enforceable, and that comes closest to expressing the intention of the invalid or unenforceable term or provision,
and this Agreement shall be valid and enforceable as so modified. In the event such court does not exercise the power available to it
in the prior sentence, this Agreement shall be deemed amended to replace such invalid or unenforceable term or provision with a valid
and enforceable term or provision that will most closely achieve the economic, business, and other purposes of such invalid or unenforceable
term or provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.9</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Obligation
of Parent. Parent shall cause Purchaser and, following the Effective Time, the Company, to comply with, duly perform, satisfy, and discharge,
on a timely basis, all of their respective covenants, obligations, and liabilities under this Agreement, and Parent shall be liable for
the due and timely performance, satisfaction, and discharge of each of the said covenants, obligations, and liabilities. Any consent
or waiver by Parent under this Agreement shall be deemed to also be a consent or waiver by Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.10</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Transfer
Taxes</U>. Except as expressly provided in the Plan of Arrangement, all transfer, documentary, sales, use, stamp, registration, value-added,
and other similar Taxes, and fees incurred in connection with this Agreement and the Transactions shall be paid by Parent and Purchaser
when due.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section&nbsp;8.11</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Waiver
of Conflicts; Non-Assertion of Attorney-Client Privilege</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Company Parties acknowledges that Paul, Weiss, Rifkind, Wharton&nbsp;&amp; Garrison LLP, Stikeman Elliott LLP, and the in-house
legal counsel of Parent (&ldquo;<B><I>Parent Counsel</I></B>&rdquo;) have, on or prior to the Closing, represented Parent, Purchaser,
and their Affiliates, and each of their respective officers, employees, and directors (each such Person, a &ldquo;<B><I>Designated Person</I></B>&rdquo;)
in one (1)&nbsp;or more matters relating to this Agreement, any other agreements contemplated hereby or the Transactions (including any
matter that may be related to a Legal Proceeding or dispute arising under or related to this Agreement or such other agreements or in
connection with such transactions) (each, an &ldquo;<B><I>Existing Representation</I></B>&rdquo;), and that, in the event of any post-Closing
matters (i)&nbsp;relating to this Agreement, any other agreements contemplated hereby or the Transactions (including any matter that
may be related to a Legal Proceeding or dispute arising under or related to this Agreement or such other agreements or in connection
with such transactions) and (ii)&nbsp;in which the Company or any of its Subsidiaries or equity holders, on the one hand, and one or
more Designated Persons, on the other hand, are or may be adverse to each other (each, a &ldquo;<B><I>Post-Closing Matter</I></B>&rdquo;),
the Designated Persons reasonably anticipate that Parent Counsel will represent them in connection with such matters. Accordingly, the
Company hereby (A)&nbsp;waives and shall not assert, and agrees after the Closing to cause its Affiliates to waive and to not assert,
any conflict of interest arising out of or relating to the representation by one (1)&nbsp;or more Parent Counsel of one (1)&nbsp;or more
Designated Persons in connection with one (1)&nbsp;or more Post Closing Matters (each, a &ldquo;<B><I>Post-Closing Representation</I></B>&rdquo;),
and (B)&nbsp;agrees that, in the event that a Post-Closing Matter arises, Parent Counsel may represent one (1)&nbsp;or more Designated
Persons in a Post-Closing Matter even though the interests of such Person(s)&nbsp;may be directly adverse to the Company or any of its
Affiliates, and even though Parent Counsel may (x)&nbsp;have represented Parent, Purchaser or their respective Subsidiaries or Affiliates
in a matter substantially related to such dispute or (y)&nbsp;be currently representing Parent, Purchaser or any of their respective
Affiliates. Without limiting the foregoing, the Company (on behalf of itself and its Affiliates) consents to the disclosure by Parent
Counsel, in connection with one (1)&nbsp;or more Post-Closing Representations, to the Designated Persons of any information learned by
Parent Counsel in the course of one (1)&nbsp;or more Existing Representations, whether or not such information is subject to the attorney-client
privilege of the Company and their respective Affiliates (other than Parent, Purchaser, and their respective Subsidiaries) or Parent
Counsel&rsquo;s duty of confidentiality as to the Company and its respective Affiliates (other than Parent, Purchaser, and their Subsidiaries)
and whether or not such disclosure is made before or after the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company waives and shall not assert, and agrees after the Closing to cause its Subsidiaries to waive and to not assert, any attorney-client
privilege, attorney work-product protection or expectation of client confidence with respect to any pre-Closing communication between
any Parent Counsel, on the one hand, and any Designated Person or Purchaser (collectively, the &ldquo;<B><I>Pre-Closing Designated Persons</I></B>&rdquo;),
or any advice given to any Pre-Closing Designated Person by any Parent Counsel, occurring prior to the Closing during one (1)&nbsp;or
more Existing Representations (collectively, &ldquo;<B><I>Pre-Closing Privileges</I></B>&rdquo;) in connection with any Post-Closing
Representation, including in connection with a dispute between any Designated Person and one (1)&nbsp;or more of the Company and its
respective Subsidiaries, it being the intention of the parties hereto that all rights to such Pre-Closing Privileges, and all rights
to waive or otherwise control such Pre-Closing Privilege, shall be retained by Parent, and shall not pass to or be claimed or used by
the Company, except as provided in the last sentence of this <U>Section&nbsp;8.11(b)</U>. Furthermore, the Company acknowledges and agrees
that any advice given to or communication with any of the Designated Persons prior to the Closing shall not be subject to any joint privilege
(whether or not Purchaser also received such advice or communication prior to the Closing) and shall be owned solely by such Designated
Persons. Notwithstanding the foregoing, in the event that a dispute arises between the Company, on the one hand, and a third party other
than a Designated Person, on the other hand, the Company shall cause its Subsidiaries to assert the Pre-Closing Privileges on behalf
of the Designated Persons to prevent disclosure of privileged materials to such third party; <I>provided</I>, <I>however</I>, that such
privilege may be waived only with the prior written consent of Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature page&nbsp;follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 64; Value: 48 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>IN
WITNESS WHEREOF</B></FONT>, the Parties have caused this Agreement to be executed as of the date first above written.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSK
    PLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><I>/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Redfern</FONT></I></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David
    Redfern</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    Corporate Development</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14934792
    CANADA INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><I>/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    W. Cummins</FONT></I></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher
    W. Cummins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Secretary</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><I>/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    S. Tillbrook</FONT></I></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark
    S. Tillbrook</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BELLUS
    HEALTH INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><I>/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roberto
    Bellini</FONT></I></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Roberto
    Bellini</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page&nbsp;to the Arrangement Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF ARRANGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNDER SECTION&nbsp;192<BR>
OF THE <I>CANADA BUSINESS CORPORATIONS ACT</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 66; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXECUTION VERSION</B></P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
A</B></FONT><B><BR>
PLAN OF ARRANGEMENT</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PLAN OF ARRANGEMENT UNDER SECTION&nbsp;192<BR>
OF THE <I>CANADA BUSINESS CORPORATIONS ACT</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;1<BR>
INTERPRETATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Definitions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unless indicated otherwise, where used in this
Plan of Arrangement, capitalized terms used but not defined shall have the meanings specified in the Arrangement Agreement and the following
terms shall have the following meanings (and grammatical variations of such terms shall have corresponding meanings):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Affected Securities</I></B>&rdquo;
means, collectively, the Shares and the Company Equity Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Affected Securityholders</I></B>&rdquo;
means, collectively, the Company&rsquo;s shareholders and the holders of any Company Equity Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Aggregate Arrangement Consideration</I></B>&rdquo;
means an aggregate amount of cash in U.S. dollars equal to (i)&nbsp;the number of Shares that are outstanding (excluding Shares in respect
of which Dissent Rights have been validly exercised) immediately prior to the Effective Time, multiplied by (ii)&nbsp;the Arrangement
Consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Amalco</I></B>&rdquo; has the meaning
set forth in <U>Section&nbsp;2.3(1)</U>&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Amalgamation</I></B>&rdquo; has the
meaning set forth in <U>Section&nbsp;2.3(1)</U>&nbsp;hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement</I></B>&rdquo; means
an arrangement of the Company under section 192 of the CBCA on the terms and subject to the conditions set out in this Plan of Arrangement,
subject to any amendments or variations to this Plan of Arrangement made in accordance with the terms of Arrangement Agreement and this
Plan of Arrangement or made at the direction of the Court in the Final Order with the prior written consent of the Company and Parent,
each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement Agreement</I></B>&rdquo;
means the arrangement agreement made as of April&nbsp;17, 2023 among the Company, the Purchaser and Parent, including all schedules annexed
thereto, as it may be amended, modified or supplemented from time to time in accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement Consideration</I></B>&rdquo;
means US$14.75 per Share in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Arrangement Resolution</I></B>&rdquo;
means the special resolution approving this Plan of Arrangement to be considered at the Company Meeting, substantially in the form of
Schedule B to the Arrangement Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Articles of Arrangement</I></B>&rdquo;
means the articles of arrangement of the Company in respect of the Arrangement, required by the CBCA to be sent to the CBCA Director
after the Final Order is made, which shall include this Plan of Arrangement and otherwise be in a form and content satisfactory to the
Company and Parent, each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Business Day</I></B>&rdquo; means
a day except (i)&nbsp;a Saturday, a Sunday, or any other day on which (a)&nbsp;commercial banks in Montreal, Qu&eacute;bec are authorized
or required by Laws to be closed or (b)&nbsp;banks are required or authorized by Law to be closed in the City of London, United Kingdom,
and (ii)&nbsp;the period from December&nbsp;24 to January&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>CBCA</I></B>&rdquo; means the <I>Canada
Business Corporations Act</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>CBCA Director</I></B>&rdquo; means
the director appointed pursuant to section 260 of the CBCA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Certificate of Arrangement</I></B>&rdquo;
means the certificate of arrangement to be issued by the CBCA Director pursuant to subsection 192(7)&nbsp;of the CBCA in respect of the
Articles of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Circular</I></B>&rdquo; means the
notice of the Company Meeting and accompanying management information circular, including all schedules, appendices and exhibits to,
and information incorporated by reference in, such management information circular, to be sent to the Shareholders in connection with
the Company Meeting, as amended, supplemented or otherwise modified from time to time in accordance with the terms of the Arrangement
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Code</I></B>&rdquo; means the Internal
Revenue Code of 1986.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company</I></B>&rdquo; means Bellus
Health Inc. and, after the occurrence of the amalgamation contemplated in <U>Section&nbsp;2.3(1)</U>, references to &ldquo;Company&rdquo;
shall be to Amalco.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Deferred Share Unit</I></B>&rdquo;
means a deferred share unit granted by the Company pursuant to the Company Deferred Share Unit Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Deferred Share Unit Plan</I></B>&rdquo;
means the Company&rsquo;s Deferred Share Unit Plan for Designated Members of the Boards, and Designated Employees of Bellus Health Inc.
and its Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Equity Awards</I></B>&rdquo;
means the Company Options and the Company Deferred Share Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Equity Plans</I></B>&rdquo;
means the Company Deferred Share Unit Plan and the Company Option Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Meeting</I></B>&rdquo; means
the special meeting of the Shareholders, including any adjournment or postponement thereof in accordance with the terms of the Arrangement
Agreement, to be called and held in accordance with the Interim Order to consider the Arrangement Resolution and for any other purpose
as may be set out in the Circular and agreed to in writing by Parent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Option</I></B>&rdquo; means
an option to purchase Shares granted pursuant to the Company Option Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Company Option Plan</I></B>&rdquo;
means the Company&rsquo;s Amended and Restated Stock Option Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Court</I></B>&rdquo; means the Qu&eacute;bec
Superior Court.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Depositary</I></B>&rdquo; means Computershare
Investor Services Inc. or such other Person as the Company and Parent may mutually agree to engage and appoint to act as depositary in
relation to the Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Dissent Rights</I></B>&rdquo; has
the meaning set forth in <U>Section&nbsp;3.1</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Dissenting Holder</I></B>&rdquo;
means a registered holder of Shares as of the record date of the Company Meeting who has validly exercised its Dissent Rights and has
not withdrawn or been deemed to have withdrawn such exercise of Dissent Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Effective Date</I></B>&rdquo; means
the date shown on the Certificate of Arrangement giving effect to the Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Effective Time</I></B>&rdquo; means
12:01 a.m.&nbsp;(Montreal time) on the Effective Date, or such other time as specified in writing by the Parent to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Encumbrance</I></B>&rdquo; means
any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, encroachment, claim, infringement, interference, option,
right of first refusal, right of first offer, lease, covenant, condition, restriction, preemptive right, community property interest,
or other similar restriction (including any restriction on the voting of any security, any restriction on the transfer of any security
or other asset, any restriction on the receipt of any income derived from any asset, any restriction on the use of any asset, and any
restriction on the possession, exercise, or transfer of any other attribute of ownership of any asset) and any conditional sales agreement,
title retention agreement or lease in the nature thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Exercise Price</I></B>&rdquo; means,
in respect of a Company Option (a)&nbsp;that has an exercise price denominated in US$, such US$ denominated exercise price; or (ii)&nbsp;that
has an exercise price denominated in Canadian dollars, the U.S. Equivalent of such Canadian dollar denominated exercise price.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Final Order</I></B>&rdquo; means
the final order of the Court in a form acceptable to the Company and Parent, each acting reasonably, approving the Arrangement, as such
order may be amended by the Court (with the consent of both the Company and Parent, each acting reasonably) at any time prior to the
Effective Date or, if appealed, then, unless such appeal is withdrawn or denied, as affirmed or as amended (provided that any such amendment
is acceptable to both the Company and Parent, each acting reasonably) on appeal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Governmental Body</I></B>&rdquo;
means any (i)&nbsp;nation, state, supra-national body, commonwealth, province, territory, county, municipality, district, or other jurisdiction
of any nature, (ii)&nbsp;federal, state, provincial, local, municipal, foreign, or other government, (iii)&nbsp;governmental or quasi-governmental
authority of any nature, including any governmental division, department, agency, bureau, commission, commissioner, instrumentality,
official, ministry, fund, foundation, center, organization, unit, body, or Entity, (iv)&nbsp;any court, arbitrator, or other tribunal,
or (v)&nbsp;any stock exchange, including Nasdaq, NYSE, LSE and TSX.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Interim Order</I></B>&rdquo; means
the interim order of the Court made pursuant to section 192 of the CBCA in a form acceptable to Company and Parent, each acting reasonably,
providing for, among other things, the calling and holding of the Company Meeting, as such order may be amended by the Court with the
consent of Company and Parent, each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Law</I></B>&rdquo; means any federal,
state, provincial, local, municipal, foreign, multinational, or other law, statute, constitution, principle of common law, resolution,
ordinance, code, edict, decree, rule, regulation, ruling, or other legal requirement issued, enacted, adopted, promulgated, implemented,
or otherwise put into effect by or under the authority of any Governmental Body or under the authority of TSX, LSE, NYSE or Nasdaq (including
the NASDAQ Marketplace Rules&nbsp;as promulgated by Nasdaq, as amended).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Letter of Transmittal</I></B>&rdquo;
means the letter of transmittal sent to Shareholders for use in connection with the Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parties</I></B>&rdquo; means Parent,
Purchaser, and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Person</I></B>&rdquo; means any individual,
Entity, or Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Plan of Arrangement</I></B>&rdquo;
means this plan of arrangement proposed under section 192 of the CBCA, and any amendments or variations made in accordance with the Arrangement
Agreement and <U>Section&nbsp;5.1</U> or made at the direction of the Court in the Final Order with the prior written consent of the
Company and Parent, each acting reasonably.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Parent</I></B>&rdquo; means GSK
plc, a public limited company formed under the laws of England and Wales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Shares</I></B>&rdquo; means the common
shares in the capital of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Shareholders</I></B>&rdquo; means
the registered and/or beneficial holders of the Shares, as the context requires.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Subco</I></B>&rdquo; means Bellus
Health Cough Inc., a corporation existing under the laws of Canada.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Tax</I></B>&rdquo; means any tax
or similar charge of any kind whatsoever (including any income tax, franchise tax, capital gains tax, gross receipts tax, value-added
tax, goods and services tax, harmonized sales tax, retail sales tax, surtax, estimated tax, employment tax, unemployment tax, social
security, excise tax, ad valorem tax, transfer tax, stamp tax, sales tax, use tax, property tax, business tax, withholding tax, escheat
tax, alternative tax, alternative minimum tax, real or personal property tax or payroll tax, and including any health insurance, parental
insurance or government pension plan premiums or contributions and including any liability relating to any deemed overpayment of Taxes
under Section&nbsp;125.7 of the Tax Act or other amount received in respect of any COVID-19 measure), including any installment of Taxes,
interest, fine, penalty, or addition thereto, in each case, imposed, assessed, or collected by or under the authority of any Governmental
Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>Tax Act</I></B>&rdquo; means the
<I>Income Tax Act </I>(Canada) and the regulations promulgated thereunder, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;<B><I>US Equivalent</I></B>&rdquo; means,
in respect of Company Options which have an exercise price denominated in Canadian dollars, the amount of such exercise price expressed
in U.S. dollars calculated on the basis of the daily exchange rate posted by the Bank of Canada for conversions of Canadian dollars to
U.S. dollars on the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">1.2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Rules&nbsp;of Interpretation</U>. In this Plan of Arrangement unless otherwise specified:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD><U>Headings,&nbsp;etc</U>. The bold-faced headings in this Plan of
                                            Arrangement are for convenience of reference only, shall not be deemed to be a part of this
                                            Plan of Arrangement, and shall not be referred to in connection with the construction or
                                            interpretation of this Plan of Arrangement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD><U>Currency</U><B STYLE="font-style: normal; font-weight: normal">. </B>All references to dollars or to $ are references
                                            to U.S. dollars, unless specified otherwise. For greater certainty, the Arrangement Consideration
                                            is expressed in U.S. dollars and is not subject to any currency conversion pursuant to the
                                            foregoing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD><U>Gender and Number</U>. For purposes of this Plan of Arrangement,
                                            whenever the context requires: the singular number shall include the plural, and vice versa;
                                            and one gender shall include all other genders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD><U>Certain Phrases,&nbsp;etc</U>. As used in this Plan of Arrangement,
                                            (i)&nbsp;the words &ldquo;include&rdquo; and &ldquo;including,&rdquo; and variations thereof,
                                            shall not be deemed to be terms of limitation, but rather shall be deemed to be followed
                                            by the words &ldquo;without limitation&rdquo; (ii)&nbsp;&ldquo;the aggregate of&rdquo;, &ldquo;the
                                            total of&rdquo;, &ldquo;the sum of&rdquo;, or a phrase of similar meaning means &ldquo;the
                                            aggregate (or total or sum), without duplication, of,&rdquo; and (iii)&nbsp;unless stated
                                            otherwise, &ldquo;Article&rdquo; &ldquo;Section&rdquo;, and &ldquo;Schedule&rdquo; followed
                                            by a number or letter mean and refer to the specified Article&nbsp;or Section&nbsp;of or
                                            Schedule to this Plan of Arrangement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD><U>Statutory and Agreement References</U>. Any reference to (i)&nbsp;any
                                            Contract (including the Arrangement Agreement) are to the Contract as amended, modified,
                                            supplemented, restated, or replaced from time to time (in the case of any Contract, to the
                                            extent permitted by the terms thereof and, if applicable, the terms of the Arrangement Agreement);
                                            (ii)&nbsp;any Governmental Body includes any successor to that Governmental Body; and (iii)&nbsp;any
                                            applicable Law refers to such applicable Law as amended, modified, supplemented, or replaced
                                            from time to time (and, in the case of statutes, include any rule&nbsp;and regulation promulgated
                                            under such statute) and references to any section of any applicable Law includes any successor
                                            to such section.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD><U>Computation of Time</U>. A period of time is to be computed as
                                            beginning on the day following the event that began the period and ending at 4:30 p.m.&nbsp;on
                                            the last day of the period, if the last day of the period is a Business Day, or at 4:30 p.m.&nbsp;on
                                            the next Business Day if the last day of the period is not a Business Day. If the date on
                                            which any action is required or permitted to be taken under this Plan of Arrangement by a
                                            Person is not a Business Day, such action shall be required or permitted to be taken on the
                                            next succeeding day which is a Business Day.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(7)</TD><TD><U>Time References</U>. References to time herein or in any Letter
                                            of Transmittal are to local time, Montreal, Qu&eacute;bec.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;2<BR>
THE ARRANGEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Arrangement
Agreement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Plan of Arrangement is made pursuant to the
Arrangement Agreement, constitutes an arrangement under Section&nbsp;192 of the CBCA and is made pursuant to, and is subject to the provisions
of, the Arrangement Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Binding
Effect</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Plan of Arrangement and the Arrangement,
upon the filing of the Articles of Arrangement and the issuance of the Certificate of Arrangement, will become effective, and be binding
on the Purchaser, the Parent, the Company, all registered and beneficial owners of Shares (including Dissenting Holders) and Company
Equity Awards, the register and transfer agent of the Company, the Depositary and all other applicable Persons, at and after, the Effective
Time without any further act or formality required on the part of any Person. The Certificate of Arrangement shall be conclusive evidence
that this Plan of Arrangement has become effective and that each of the provisions of Section&nbsp;2.3 has become effective in the sequence
set out therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Arrangement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">At the Effective Time each of the following events
shall occur and shall be deemed to occur sequentially as set out below without any further authorization, act or formality, in each case,
unless stated otherwise, effective as at five-minute intervals starting at the Effective Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>The Company and Subco shall amalgamate (the&nbsp;&ldquo;<B>Amalgamation</B>&rdquo;)
                                            to form one corporation (&ldquo;<B>Amalco</B>&rdquo;) with the same effect as if they had
                                            amalgamated pursuant to Section&nbsp;181 and Section&nbsp;184 of the CBCA and a certificate
                                            of amalgamation had been issued under the CBCA, and shall, after thereafter continue as one
                                            corporation in accordance with the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD><B>Name</B>: The name of Amalco shall be Bellus Health Inc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD><B>Registered office</B>: The registered office of Amalco shall be the
                                            registered office of the Company immediately prior to the Amalgamation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD><B>Restrictions on Business</B>: None.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD><B>Articles</B>: The Articles of Arrangement are deemed to be the articles
                                            of amalgamation of Amalco and the Certificate of Arrangement is deemed to be the certificate
                                            of amalgamation of Amalco.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD><B>Restrictions on Transfer</B>: None.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD><B>Number of Directors</B>: Amalco shall have a minimum of one director
                                            and a maximum of 15 directors, until changed in accordance with the CBCA.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD><B>First Directors</B>: The directors of Amalco will be the same as
                                            the directors of the Company immediately prior to the Amalgamation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD><B>Appointment of Additional Directors</B>: The directors may appoint
                                            one or more additional directors who shall hold office for a term expiring not later than
                                            the close of the next annual meeting of shareholders, but the total number of directors so
                                            appointed may not exceed one third of the number of directors elected at the previous annual
                                            meeting of shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD><B>Share Capital</B>: The share provisions and authorized share capital
                                            of Amalco shall be the same as the share provisions and authorized share capital of the Company
                                            immediately prior to the Amalgamation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD><B>Shares and Company Equity Awards</B>: All shares of Subco shall be
                                            cancelled without any repayment of capital in respect thereof; no shares will be issued by
                                            Amalco in connection with the Amalgamation and all Shares and Company Equity Awards of the
                                            Company existing prior to the Amalgamation shall be unaffected and shall continue as Shares
                                            or Company Equity Awards of Amalco, as applicable</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD><B>Stated Capital</B>: The stated capital account of the Shares will
                                            be equal to the stated capital account in respect of the Shares of the Company immediately
                                            prior to the Amalgamation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD><B>By-Laws:</B> The by-laws of Amalco shall be the same as those of
                                            the Company implemented immediately prior to the Amalgamation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD><B>Effect of Amalgamation</B>: The provisions of subsection 186(a)&nbsp;to
                                            (g)&nbsp;of the CBCA shall apply to the Amalgamation with the result that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD>the property of each the Company and Subco continues to be the property
                                            of Amalco;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD>Amalco continues to be liable for the obligations of each the Company
                                            and Subco;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD>an existing cause of action, claim or liability to prosecution against
                                            the Company or Subco is unaffected;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD>a civil, criminal or administrative action or proceeding pending
                                            by or against the Company or Subco may be continued to be prosecuted by or against Amalco;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD>a conviction against, or ruling, order or judgment in favour of or
                                            against, the Company or Subco may be enforced by or against Amalco.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>each Company Option, whether vested or unvested, outstanding immediately
                                            prior to the Effective Time, shall, <FONT STYLE="font-family: Times New Roman, Times, Serif">notwithstanding
                                            the terms of the Company Option Plan and any and all award or similar agreements relating
                                            to the Company Option and without any further action by or on behalf of the holder thereof</FONT>,
                                            be deemed to have fully vested and be deemed to be assigned and surrendered by such holder
                                            to the Company in exchange for a cash payment equal to the excess, if any, of the Arrangement
                                            Consideration over the Exercise Price of such Company Option, less any applicable withholdings
                                            pursuant to Section&nbsp;4.3, and such Company Option shall be immediately cancelled. For
                                            greater certainty, if the Exercise Price of any Company Option is equal to or greater than
                                            the Arrangement Consideration, such Company Option shall be cancelled at the Effective Time
                                            without any cash payment or other consideration being made in respect thereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>each Company Deferred Share Unit, whether vested or unvested, outstanding
                                            immediately prior to the Effective Time, shall, notwithstanding the terms of the Company
                                            Deferred Share Unit Plan and any and all award or similar agreements relating to the Company
                                            Deferred Share Unit and without <FONT STYLE="font-family: Times New Roman, Times, Serif">any
                                            further action by or on behalf of a holder thereof</FONT>, be deemed to have fully vested
                                            and be deemed to be assigned and surrendered by such holder to the Company in exchange for
                                            a cash payment equal to the Arrangement Consideration, less any withholdings pursuant to
                                            Section&nbsp;4.3, and such Company Deferred Share Unit shall be immediately cancelled;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>(a)&nbsp;each holder of Company Equity Awards shall cease to be the
                                            holder of such Company Equity Awards and to have any rights as holder of Company Equity Awards
                                            other than the right to <FONT STYLE="font-family: Times New Roman, Times, Serif">receive
                                            the consideration to which they are entitled pursuant to 2.3(2)&nbsp;and/or Section&nbsp;2.3(3),
                                            as applicable, at the time and in the manner specified in 2.3(2), Section&nbsp;2.3(3)&nbsp;and
                                            Section&nbsp;4.1, as applicable, (b)&nbsp;such holder&rsquo;s name shall be removed from
                                            each applicable register; (c)&nbsp;the Company Equity Plan and any and all award or similar
                                            agreements relating to the Company Equity Awards shall be terminated and shall be of no further
                                            force and effect;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>each of the Shares held by Dissenting Holders in respect of which
                                            Dissent Rights have been validly exercised shall be deemed to have been transferred without
                                            any further act or formality to Purchaser, and:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>such Dissenting Holders shall cease to be the holders of such Shares
                                            and to have any rights as holder of Shares other than the right to be paid fair value by
                                            Purchaser for such Shares as set out in <U>Section&nbsp;3.1</U>;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>such Dissenting Holders&rsquo; names shall be removed from the registers
                                            of Shareholders maintained by or on behalf of the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Purchaser shall be deemed to be the transferee of such Shares free and
                                            clear of all Encumbrances, and shall be entered in the register of Shares maintained by or
                                            on behalf of the Company and shall be deemed to be the legal and beneficial owner thereof;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD>each Share outstanding immediately prior to the Effective Time, other
                                            than Shares held by a Dissenting Holder who has validly exercised such holder&rsquo;s Dissent
                                            Rights shall, without any further action by or on behalf of a holder of Shares, be deemed
                                            to be assigned and transferred by the holder thereof to the Purchaser in exchange for the
                                            Arrangement Consideration, and:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>the holders of such Shares shall cease to be the holders of such Shares
                                            and to have any rights as holders of such Shares other than the right to be paid the Arrangement
                                            Consideration per Share in accordance with this Plan of Arrangement less any withholdings
                                            pursuant to Section&nbsp;4.3;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>such holders&rsquo; names shall be removed from the register of the
                                            Shares maintained by or on behalf of the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD>Purchaser shall be deemed to be the transferee of such Shares (free
                                            and clear of all Encumbrances) and shall be entered in the register of the Shares maintained
                                            by or on behalf of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rounding
of Cash Consideration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the aggregate cash amount a holder of Shares
is entitled to receive under the Arrangement would otherwise include a fraction of $0.01, then the aggregate cash amount such holder
of Shares shall be entitled to receive shall be rounded down to the nearest whole $0.01.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Interest
</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under no circumstances shall interest accrue or
be paid by any Person to Shareholders, holders of Company Equity Awards or other Persons pursuant to this Plan of Arrangement in respect
of Shares or Company Equity Awards, regardless of any delay in making any payment contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">2.6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Arrangement Consideration.</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If, on or after the date of the Arrangement Agreement,
the Company sets a record date for any dividend or other distribution on the Shares that is prior to the Effective Time or the Company
pays any dividend or other distribution on the Shares prior to the Effective Time, then the Arrangement Consideration shall be reduced
by the amount of such dividends or distributions, as applicable, on a dollar-for-dollar basis to provide to the Shareholders, as applicable,
the same economic effect, and so that the aggregate economic cost to the Parent and its respective Subsidiaries, taking into account
any reduction in cash or other assets of the Company or its Company Subsidiaries as a result thereof, is the same, in each case as contemplated
by this Plan of Arrangement and the Arrangement Agreement prior to such action, and the Arrangement Consideration as so adjusted, from
and after the date of such event, shall be the Arrangement Consideration for all purposes of this Plan of Arrangement; provided, that
nothing in this Section&nbsp;2.6 shall, or shall be construed to, permit the Company to take any action that is restricted by any other
provision of this Plan of Arrangement or the Arrangement Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;3<BR>
RIGHT OF DISSENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rights
of Dissent</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Registered Shareholders as of the record date
of the Company Meeting may exercise dissent rights with respect to all Shares held by such holders (&ldquo;<B><I>Dissent Rights</I></B>&rdquo;)
in connection with the Arrangement pursuant to and in the manner set forth in section 190 of the CBCA, as modified by the Interim Order,
the Final Order and this <U>Section&nbsp;3.1</U>; <I>provided</I> that, notwithstanding subsection 190(5)&nbsp;of the CBCA, the written
objection to the Arrangement Resolution referred to in subsection 190(5)&nbsp;of the CBCA must be received by the Company not later than
5:00 p.m.&nbsp;(Montreal time) two (2)&nbsp;Business Days immediately preceding the date of the Company Meeting (as it may be adjourned
or postponed from time to time). Dissenting Holders who duly exercise their Dissent Rights shall be deemed to have transferred the Shares
held by them to Purchaser free and clear of all Encumbrances, as provided in <U>Section&nbsp;2.3(5)</U>&nbsp;and if they:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>ultimately are entitled to be paid fair value for such Shares: (i)&nbsp;shall
                                            be deemed not to have participated in the transactions in <U>Article&nbsp;2</U> (other than
                                            <U>Section&nbsp;2.3(5))</U>; (ii)&nbsp;will be entitled to be paid the fair value of such
                                            Shares, less any applicable withholdings, which fair value, notwithstanding anything to the
                                            contrary contained in the CBCA, shall be determined as of the close of business on the day
                                            before the Arrangement Resolution was adopted; and (iii)&nbsp;will not be entitled to any
                                            other payment or consideration, including any payment that would be payable under the Arrangement
                                            had such holders not exercised their Dissent Rights; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>ultimately are not entitled, for any reason, to be paid fair value
                                            for their Shares, shall be deemed to have participated in the Arrangement on the same basis
                                            as non-Dissenting Holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">3.2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Recognition
of Dissenting Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>In no circumstances shall Parent or the Company or any other Person
                                            be required to recognize a Person exercising Dissent Rights unless such Person (a)&nbsp;is
                                            the registered holder of those Shares in respect of which such rights are sought to be exercised
                                            as of the record date of the Company Meeting and as of the deadline for exercising such Dissent
                                            Rights; (b)&nbsp;has voted or instructed a proxyholder to vote such Shares against the Arrangement
                                            Resolution; and (c)&nbsp;has strictly complied with the procedures for exercising Dissent
                                            Rights and has not withdrawn such dissent prior to the Effective Time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>For greater certainty, in no case shall Parent or the Company or any
                                            other Person be required to recognize Dissenting Holders as Shareholders in respect of which
                                            Dissent Rights have been validly exercised after the completion of the transfer under <U>Section&nbsp;2.3(5)</U>,
                                            and the names of such Dissenting Holders shall be removed from the registers of Shareholders
                                            at the same time as the event described in <U>Section&nbsp;2.3(5)</U>&nbsp;occurs.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>In addition to any other restrictions under section 190 of the CBCA,
                                            none of the following shall be entitled to exercise Dissent Rights: (i)&nbsp;holders of Company
                                            Equity Awards; and (ii)&nbsp;Shareholders that have failed to vote or to instruct a proxyholder
                                            to vote all the voting rights carried by the Shares held by such Shareholders against the
                                            Arrangement Resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>Holders of Shares who withdraw, or are deemed to withdraw, their right
                                            to exercise Dissent Rights shall be deemed to have participated in the Arrangement, as of
                                            the Effective Time, and shall be entitled to the Arrangement Consideration for all Shares
                                            held, less any applicable withholdings pursuant to Section&nbsp;4.3.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;4<BR>
CERTIFICATES AND PAYMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Payment
of Consideration</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>Prior to the filing of the Articles of Arrangement, Purchaser shall
                                            deposit, or arrange to be deposited for the benefit of Shareholders (other than Dissenting
                                            Holders) sufficient funds to satisfy the Aggregate Arrangement Consideration payable to Shareholders
                                            as required by this Plan of Arrangement, which funds shall be held by the Depositary in escrow
                                            as agent and nominee for such Shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>Upon surrender to the Depositary for cancellation of a certificate
                                            which immediately prior to the Effective Time represented outstanding Shares that were transferred
                                            pursuant to <U>Section&nbsp;2.3(6)</U>, together with a duly completed and executed Letter
                                            of Transmittal and such additional documents and instruments as the Depositary may reasonably
                                            require, the registered holder of the Shares represented by such surrendered certificate
                                            shall be entitled to receive in exchange therefor, and the Depositary shall deliver to such
                                            holder, the Arrangement Consideration which such holder has the right to receive under this
                                            Plan of Arrangement for such Shares, without interest, less any amounts withheld pursuant
                                            to <U>Section&nbsp;4.3</U>, and any certificate so surrendered shall forthwith be cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>As soon as practicable after the Effective Time (and in any event,
                                            no later than ten (10)&nbsp;days thereafter), the Company shall process the cash payments
                                            described in Section&nbsp;2.3(2)&nbsp;and Section&nbsp;2.3(3)&nbsp;through the Company&rsquo;s
                                            payroll systems or payroll providers (or issue a check for any such payment if such payment
                                            cannot be made through such payroll system or payroll provider), to each holder of a Company
                                            Option or a Company Deferred Share Unit as reflected on the register maintained by or on
                                            behalf of the Company in respect of Company Options and of Company Deferred Share Units,
                                            representing the amount, if any, which such holder of Company Options, or Company Deferred
                                            Share Units, as applicable, has the right to receive under this Plan of Arrangement for such
                                            Company Options and Company Deferred Share Units, as applicable, less any amount withheld
                                            pursuant to <U>Section&nbsp;4.3</U>. Notwithstanding that amounts under this Plan of Arrangement
                                            are payable in U.S. dollars, the Company is entitled to make the payments contemplated in
                                            this Section&nbsp;4.1(3)&nbsp;in the applicable currency in respect of which the Company
                                            customarily makes payment to such holder by using the applicable Bank of Canada daily exchange
                                            rate in effect on the Effective Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>Until surrendered as contemplated by this <U>Section&nbsp;4.1</U>,
                                            each certificate that immediately prior to the Effective Time represented Shares, shall be
                                            deemed after the Effective Time to represent only the right to receive upon such surrender
                                            the Arrangement Consideration which the holder is entitled to receive in lieu of such certificate
                                            as contemplated in this <U>Section&nbsp;4.1</U>, less any amounts withheld pursuant to <U>Section&nbsp;4.3</U>.
                                            Any such certificate formerly representing Shares not duly surrendered on or before the sixth
                                            anniversary of the Effective Date shall cease to represent a claim by or interest of any
                                            former holder of Shares of any kind or nature against or in the Company, Parent or Purchaser.
                                            On such date, all Arrangement Consideration to which such former holder was entitled shall
                                            be deemed to have been surrendered to Purchaser, and shall be paid over by the Depositary
                                            to Purchaser or as directed by Purchaser.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD>Any payment made by the Depositary (or the Company or any of its Subsidiaries,
                                            as applicable) pursuant to this Plan of Arrangement that has not been deposited or has been
                                            returned to the Depositary (or the Company or any of its Subsidiaries, as applicable) or
                                            that otherwise remains unclaimed, in each case, on or before the sixth anniversary of the
                                            Effective Time, and any right or claim to payment hereunder that remains outstanding on the
                                            sixth anniversary of the Effective Time shall cease to represent a right or claim of any
                                            kind or nature and the right of the holder to receive the applicable consideration for the
                                            Affected Securities pursuant to this Plan of Arrangement shall terminate and be deemed to
                                            be surrendered and forfeited to Purchaser or the Company, as applicable, for no consideration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(6)</TD><TD>No holder of Affected Securities shall be entitled to receive any
                                            Arrangement Consideration with respect to Shares or cash payment with respect to the Company
                                            Equity Awards other than the Arrangement Consideration or the cash payment, if any, which
                                            such holder is entitled to receive in accordance with <U>Section&nbsp;2.3</U> and this <U>Section&nbsp;4.1
                                            </U>and, for greater certainty, no such holder will be entitled to receive any interest,
                                            dividends, premium or other payment in connection therewith other than, in respect of Shares,
                                            any declared but unpaid dividends with a record date prior to the Effective Date. No dividend
                                            or other distribution declared or made after the Effective Time with respect to any securities
                                            of the Company with a record date on or after the Effective Date shall be delivered to the
                                            holder of any unsurrendered certificate which, immediately prior to the Effective Date, represented
                                            outstanding Shares that were transferred pursuant to <U>Section&nbsp;2.3</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Lost
Certificates</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event any certificate which immediately
prior to the Effective Time represented one (1)&nbsp;or more Shares that were transferred pursuant to <U>Section&nbsp;2.3</U> shall have
been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such certificate to be lost, stolen
or destroyed and who was listed immediately prior to the Effective Time as the registered holder thereof on the register of Shareholders
maintained by or on behalf of the Company, the Depositary will issue in exchange for such lost, stolen or destroyed certificate, the
cash payment to which such holder is entitled to receive for such Shares under this Plan of Arrangement. When authorizing such payment
in exchange for any lost, stolen or destroyed certificate, the Person to whom such cash is to be delivered shall as a condition precedent
to the delivery of such cash, give a bond satisfactory to Parent and the Depositary, if requested (each acting reasonably) in such sum
as Parent may direct (acting reasonably), or otherwise indemnify Parent, the Purchaser and the Company in a manner satisfactory to Parent
and the Company, each acting reasonably, against any claim that may be made against Parent, the Purchaser or the Company with respect
to the certificate alleged to have been lost, stolen or destroyed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Withholding
Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Parent, Purchaser, the Company, Subco and the
Depositary, as applicable, shall be entitled to deduct and withhold from any amount otherwise payable or deliverable to any Person under
this Plan of Arrangement (including any amounts payable pursuant to <U>Section&nbsp;3.1</U>), such amounts as Parent, Purchaser, the
Company, Subco or the Depositary, as applicable, are required to deduct and withhold, or reasonably believe to be required to deduct
and withhold, from such amount otherwise payable or deliverable under any provision of any applicable Laws in respect of Taxes (including,
but not limited to, the Tax Act and the Code). Any such amounts will be deducted, withheld and remitted from the amount otherwise payable
or deliverable pursuant to this Plan of Arrangement and shall be treated for all purposes under this Plan of Arrangement as having been
paid to the Person in respect of which such deduction, withholding and remittance was made; <I>provided</I> that such deducted and withheld
amounts are actually remitted to the appropriate Governmental Body.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>No
Encumbrances</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any exchange or transfer of securities pursuant
to this Plan of Arrangement shall be free and clear of any Encumbrances or other claims of third parties of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">4.5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Paramountcy</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From and after the Effective Time: (a)&nbsp;this
Plan of Arrangement shall take precedence and priority over any and all Affected Securities issued or outstanding prior to the Effective
Time, (b)&nbsp;the rights and obligations of the Affected Securityholders (registered or beneficial), the Company, Parent, the Purchaser,
the Depositary and any transfer agent or other depositary therefor in relation thereto, shall be solely as provided for in this Plan
of Arrangement, and (c)&nbsp;all actions, causes of action, claims or proceedings (actual or contingent and whether or not previously
asserted) based on or in any way relating to any Affected Securities shall be deemed to have been settled, compromised, released and
determined without liability except as set forth in this Plan of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;5<BR>
AMENDMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Amendments
to Plan of Arrangement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD>The Company and Parent may amend, modify and/or supplement this Plan
                                            of Arrangement at any time and from time to time prior to the Effective Time, <I>provided
                                            </I>that each such amendment, modification and/or supplement must (i)&nbsp;be set out in
                                            writing, (ii)&nbsp;be approved by the Company and Parent, each acting reasonably, (iii)&nbsp;filed
                                            with the Court and, if made following the Company Meeting, approved by the Court, and (iv)&nbsp;communicated
                                            to the Shareholders if and as required by the Court.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD>Any amendment, modification or supplement to this Plan of Arrangement
                                            may be proposed by the Company or Parent at any time prior to the Company Meeting (provided
                                            that the Company or Parent, as applicable, shall have consented in writing thereto) with
                                            or without any other prior notice or communication, and if so proposed and accepted by the
                                            Persons voting at the Company Meeting (other than as may be required under the Interim Order),
                                            shall become part of this Plan of Arrangement for all purposes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD>Any amendment, modification or supplement to this Plan of Arrangement
                                            that is approved or directed by the Court following the Company Meeting shall be effective
                                            only if (i)&nbsp;it is consented to in writing by each of the Company and Parent (in each
                                            case, acting reasonably), and (ii)&nbsp;if and as required by the Court, after communication
                                            to the Shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD>Notwithstanding anything to the contrary contained herein, any amendment,
                                            modification or supplement to this Plan of Arrangement may be made by the written consent
                                            of each of the Company and Parent at any time and from time to time without the approval
                                            of or communication to the Court or the Shareholders, <I>provided</I> that each such amendment,
                                            modification and/or supplement concerns a matter which, in the reasonable opinion of Parent,
                                            is of an administrative nature or required to better give effect to the implementation of
                                            this Plan of Arrangement and is not adverse to the economic interest of any Shareholders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">5.2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Termination</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Plan of Arrangement may be withdrawn prior
to the Effective Time in accordance with the terms of the Arrangement Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Article&nbsp;6<BR>
FURTHER ASSURANCES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-size: 10pt">6.1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Further
Assurances</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding that the transactions and events
set out in this Plan of Arrangement shall occur and shall be deemed to occur in the order set out in this Plan of Arrangement without
any further act or formality, each of the Parties shall make, do and execute, or cause to be made, done and executed, all such further
acts, deeds, agreements, transfers, assurances, instruments or documents as may reasonably be required by either of them in order to
further document or evidence any of the transactions or events set out in this Plan of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
B</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARRANGEMENT RESOLUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 82; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE B<BR>
ARRANGEMENT RESOLUTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>BE IT RESOLVED THAT:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">1.</TD><TD>The arrangement (the &ldquo;<B><I>Arrangement</I></B>&rdquo;) under section 192 of the Canada Business Corporations Act (the &ldquo;<B><I>CBCA</I></B>&rdquo;)
of [Bravo] (the &ldquo;<B><I>Company</I></B>&rdquo;), pursuant to the arrangement agreement (as it may from time to time be amended, modified
or supplemented, the &ldquo;<B><I>Arrangement Agreement</I></B>&rdquo;) among the Company, [the Purchaser] and [the Parent] dated [&#9679;],
2023, all as more particularly described and set forth in the management information circular of the Company dated [&#9679;], 2023 (the
 &ldquo;<B><I>Circular</I></B>&rdquo;) accompanying the notice of this meeting (as the Arrangement may be modified or amended in accordance
with its terms), and all transactions contemplated thereby are hereby authorized, approved and adopted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">2.</TD><TD>The plan of arrangement of the Company (as it has been or may be amended, modified or supplemented in accordance with the Arrangement
Agreement and its terms (the &ldquo;<B><I>Plan of Arrangement</I></B>&rdquo;)), the full text of which is set out in Appendix [&#9679;]
to the Circular, is hereby authorized, approved and adopted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">3.</TD><TD>The (i)&nbsp;Arrangement Agreement and related transactions contemplated therein, (ii)&nbsp;actions of the directors of the Company
in approving the Arrangement and the Arrangement Agreement, (iii)&nbsp;actions of the directors and officers of the Company in executing
and delivering the Arrangement Agreement, and any amendments, modifications or supplements thereto, and causing the performance by the
Company of its obligations thereunder, and (iv)&nbsp;the Company&rsquo;s application for an interim order from the Qu&eacute;bec Superior
Court (the &ldquo;<B><I>Court</I></B>&rdquo;) are hereby confirmed, ratified, authorized and approved.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">4.</TD><TD>Notwithstanding that this resolution has been passed (and the Arrangement adopted) by the shareholders of the Company (the &ldquo;<B><I>Shareholders</I></B>&rdquo;)
or that the Arrangement has been approved by the Court, the directors of the Company are hereby authorized and empowered to, at their
discretion, without notice to or approval of the Shareholders: (i)&nbsp;amend, modify or supplement the Arrangement Agreement or the Plan
of Arrangement to the extent permitted by their respective terms; and (ii)&nbsp;subject to the terms of the Arrangement Agreement, not
to proceed with the Arrangement and related transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">5.</TD><TD>The Company is hereby authorized to apply for a final order from the Court to approve the Arrangement on the terms set forth in the
Arrangement Agreement and the Plan of Arrangement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">6.</TD><TD>Any officer or director of the Company is hereby authorized and directed for and on behalf of the Company to make or cause to be made
an application to the Court for an order approving the Arrangement and to execute and deliver, or cause to be executed and delivered,
for filing with the Director under the CBCA, the articles of arrangement and such other documents and instruments as are necessary or
desirable to give effect to the Arrangement in accordance with the Arrangement Agreement, such determination to be conclusively evidenced
by the execution and delivery of such articles of arrangement and any such other documents or instruments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">7.</TD><TD>Any officer or director of the Company is hereby authorized and directed for and on behalf of the Company to execute or cause to be
executed and to deliver or cause to be delivered all such other documents and instruments and to perform or cause to be performed all
such other acts and things as such person determines may be necessary or desirable to give full effect to the foregoing resolutions and
the matters authorized thereby, such determination to be conclusively evidenced by the execution and delivery of such document or instrument
or the doing of any such act or thing.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
C</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Due
Organization; Subsidiaries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is a corporation duly incorporated, validly existing, and in good standing under the CBCA and has all necessary power and authority
to (i)&nbsp;conduct its business in the manner in which its business is currently being conducted and (ii)&nbsp;own, lease and operate
its assets and properties in the manner in which its assets and properties are currently owned and used. The Company is duly qualified,
registered, licensed or otherwise authorized to do business and is in good standing, in each jurisdiction where the nature of its business
requires such qualification, registration, licensing or other authorization, and has all the authorizations required to own, lease and
operate its properties and assets, except where the failure to be so qualified, registered, licensed or otherwise authorized to do business,
or be in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company does not own any capital stock of, any equity interest of or any equity interest of any nature in, any other equity-linked or
similar interest in, any equity interest of any nature or interest convertible into or exchangeable or exercisable for any equity-linked
or similar interest in any other Entity other than the Company Subsidiaries. The Company has not agreed and is not obligated to make,
and is not bound by any Contract under which it may become obligated to make, any future investment in or capital contribution to any
other Entity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;1(c)&nbsp;of
the Company Disclosure Schedule&nbsp;identifies each Subsidiary of the Company (each, a &ldquo;<B><I>Company Subsidiary</I></B>,&rdquo;
and collectively, the &ldquo;<B><I>Company Subsidiaries</I></B>&rdquo;) and indicates its jurisdiction of organization. Each Company
Subsidiary is a corporation or other business entity duly incorporated, formed, or organized (as applicable), validly existing, and in
good standing (to the extent a concept of &ldquo;good standing&rdquo; is applicable) under the Laws of its jurisdiction of incorporation,
formation, or organization and has full corporate or other organizational power and authority required to own, lease, or operate, as
appropriate, the assets and properties that it purports to own, lease, and operate and to carry on its business as now conducted, and
is qualified to do business in each jurisdiction where such qualification is necessary, except, in each case, where any failure thereof
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. All outstanding shares of capital
stock or voting securities of, or other equity interests in, each Company Subsidiary have been duly authorized, validly issued, fully
paid, nonassessable, as applicable, and are owned by the Company, by another Company Subsidiary, or by the Company and another Company
Subsidiary, free and clear of all Encumbrances other than restrictions imposed by applicable Securities Laws or the organizational documents
of any such Company Subsidiary or any Permitted Encumbrances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Constating
Documents</U>. The Company has made available to Parent or Parent&rsquo;s Representatives accurate and complete copies of the Constating
Documents of the Company and of each Company Subsidiary, including all amendments thereto, as in effect on the date of this Agreement.
None of the Company or any Company Subsidiary is in violation of any provision of its Constating Documents, except for violations that
would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect or be expected to prevent or materially
delay the ability of the Company to consummate the Arrangement by the End Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 84; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Capitalization</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
authorized capital of the Company consists of (i)&nbsp;an unlimited number of Shares, of which 126,684,403 Shares have been issued or
are outstanding as of the close of business on April&nbsp;13, 2023 (the &ldquo;<B><I>Reference Date</I></B>&rdquo;), and (ii)&nbsp;an
unlimited number of shares of preferred shares, none of which are issued or outstanding as of the close of business on the Reference
Date. No Shares were held in treasury as of the close of business on the Reference Date. All of the outstanding Shares have been duly
authorized and validly issued and are fully paid and nonassessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date of this Agreement: (i)&nbsp;no outstanding Share is entitled or subject to any preemptive right, right of repurchase or forfeiture,
right of participation, right of maintenance, or any similar right; (ii)&nbsp;no outstanding Share is subject to any right of first refusal
in favor of the Company; (iii)&nbsp;no outstanding bond, debenture, note, or other Indebtedness of the Company has a right to vote on
any matter on which the Company&rsquo;s shareholders have a right to vote; and (iv)&nbsp;no Company Contract relates to the voting or
registration of, or restricts any Person from purchasing, selling, pledging, or otherwise disposing of (or from granting any option or
similar right with respect to), any Share. The Company is not under any obligation, nor is it bound by any Contract pursuant to which
it may become obligated, to repurchase, redeem, or otherwise acquire any outstanding Share. The Shares constitute the only outstanding
class of securities of the Company registered under the Securities Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;3(c)&nbsp;of
the Company Disclosure Schedule sets forth a correct and complete list of all Company Equity Awards outstanding as of the date of business
on the Reference Date, including with respect to each Company Equity Award: (i)&nbsp;the name of the holder thereof; (ii)&nbsp;the number
of Shares subject (or allocated) to such Company Equity Award; (iii)&nbsp;the grant or issuance date; (iv)&nbsp;any applicable vesting
schedule and (v)&nbsp;with respect to each Company Option (A)&nbsp;the exercise price and (B)&nbsp;the expiration date. As of the close
of business on the Reference Date, 12,132,072 Shares are subject to issuance upon exercise of Company Options granted and outstanding
under the Company Equity Plans. The Company has provided to Parent or Parent&rsquo;s Representatives copies of all Company Equity Plans
covering the Company Equity Awards outstanding and the forms of all award agreements evidencing such Company Equity Awards, in each case,
as of the date of this Agreement. Each Company Equity Award was issued in compliance in all material respects with applicable Law. Other
than as set forth in this <U>Section&nbsp;3(c)</U>&nbsp;of this Schedule C or Section&nbsp;3(c)&nbsp;of the Company Disclosure Schedule,
there is no issued, reserved for issuance, outstanding, or authorized share options, restricted share unit award, restricted share award,
share appreciation, deferred unit phantom share, profit participation, or similar right, or equity or equity-based award with respect
to the Company to which the Company is a party or by which the Company is bound.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in this <U>Section&nbsp;3(d)</U>&nbsp;of this Schedule C, as of the close of business on the Reference Date, there is no:
(i)&nbsp;outstanding securities or other equity interest in the capital of the Company; (ii)&nbsp;outstanding subscription, option, call,
warrant, right (whether or not currently exercisable), agreement or commitment of any character to acquire any share or other equity
interest, restricted share unit, share-based performance unit, deferred unit or any other right that is linked to, or the value of which
is in any way based on or derived from the value of any share or other security of the Company, in each case, issued by the Company or
to which the Company is bound; (iii)&nbsp;outstanding security, instrument, bond, debenture, note, or obligation that is or may become
convertible into or exchangeable for any share or other securities of the Company; or (iv)&nbsp;shareholder rights plan (or similar plan
commonly referred to as a &ldquo;poison pill&rdquo;) or Contract under which the Company is or may become obligated to sell or otherwise
issue any share or any other security.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authority;
Execution and Binding Obligation</U>. The Company has the requisite corporate power and authority to enter into and perform its obligations
under this Agreement. The execution, delivery and performance by the Company of its obligations under this Agreement and the consummation
of the Arrangement and the other transactions contemplated hereby have been duly authorized by all necessary corporate action on the
part of the Company and no other corporate proceedings on the part of the Company are necessary to authorize this Agreement, the consummation
of the Arrangement and the other transactions contemplated hereby, other than the Required Shareholder Approval, the Interim Order and
the Final Order. This Agreement has been duly executed and delivered by the Company, and constitutes a legal, valid and binding agreement
of the Company, enforceable against it in accordance with its terms, subject only to the Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Non-Contravention;&nbsp;Consents</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery of this Agreement by the Company do not, and the performance of this Agreement by the Company and the consummation
by the Company of the Transactions will not, (i)&nbsp;conflict with or violate the Company&rsquo;s Constating Documents or any similar
organizational document of any Company Subsidiary, (ii)&nbsp;assuming that all consents, approvals, and other authorizations described
in <U>Section&nbsp;5(b)</U>&nbsp;of this Schedule C have been obtained and that all filings and other actions described in <U>Section&nbsp;5(b)</U>&nbsp;of
this Schedule C have been made or taken and the Required Shareholder Approval has been obtained, conflict with or violate any Law applicable
to the Company or by which any property or asset of the Company or Company Subsidiary is bound, or (iii)&nbsp;result in any breach or
violation of or constitute a default (or an event which, with notice or lapse of time or both, would become a default) by the Company
or any Company Subsidiary under, or give to others any right of termination, amendment, acceleration, or cancellation of, or result in
the loss of any benefit under, or the creation of any Encumbrance on the properties or assets of the Company or Company Subsidiary pursuant
to, any Material Contract, except, with respect to each of the foregoing clauses (ii)&nbsp;and (iii), for any such conflict, violation,
breach, default, or other occurrence that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect or reasonably be expected to prevent or materially delay the ability of the Company to consummate the Arrangement by the End Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery of this Agreement by the Company do not, and the performance of this Agreement by the Company and the consummation
by the Company and the Company Subsidiaries of the Transactions will not, require any consent, approval, authorization, or permit of,
filing or registration with, notification or report to, or expiration of waiting periods from, any Governmental Body except for (i)&nbsp;any
filing required under the rules&nbsp;and regulations of Nasdaq, LSE, NYSE and TSX, (ii)&nbsp;filings with the SEC or the Securities Authorities,
(iii)&nbsp;the filing of the Articles of Arrangement with the applicable Governmental Body, (iv)&nbsp;the Interim Order and the Final
Order; (v)&nbsp;filings with the Director under the CBCA, (vi)&nbsp;the premerger notification and waiting period requirements of the
HSR Act, and (vii)&nbsp;any consent, approval, order, authorization, authority, transfer, waiver, disclaimer, registration, declaration,
or filing set forth in Section&nbsp;5(b)&nbsp;of the Company Disclosure Schedule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company represents and warrants that since January&nbsp;1, 2021, it has not waived any confidentiality, standstill, non-disclosure, non-solicitation
or similar agreement, restriction or covenant to which the Company or any Subsidiary is a party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Vote
Required</U>. The Required Shareholder Approval is the only vote of the holders of any class or series of the Company&rsquo;s capital
stock, or any holder of any other security of the Company, necessary to adopt this Agreement and approve the Arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Shareholders&rsquo;
and Similar Agreements</U>. None of the Company or any of the Company Subsidiaries is a party or subject to, or affected by, any shareholder
agreement, pooling, voting, or other similar arrangement or understanding relating to the ownership or voting of any securities of the
Company or any of the Company Subsidiaries. There are no irrevocable proxies or voting Contracts with respect to any securities issued
by the Company or any of the Company Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Minute
Books</U>. The corporate minute books of the Company and the Company Subsidiaries have been maintained in accordance with applicable
Laws, and are complete and accurate, in all material respects. True and correct copies of the minutes of meetings of the Board and its
standing committees (and written resolutions in lieu thereof) since January&nbsp;1, 2020 have been made available to the Parent and its
Representatives, other than minutes of meetings relating to the evaluation of the transactions contemplated by this Agreement and the
negotiation of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Board
and Transaction Committee Approval</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD>The Transaction Committee has unanimously recommended that the Company
                                            Board approve the Arrangement and that the Shareholders vote in favor of the Arrangement
                                            Resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD>The Board, acting on the unanimous recommendation in favor of the Arrangement
                                            by the Transaction Committee, after receiving advice from its financial adviser and outside
                                            legal counsel in evaluating the Arrangement, has unanimously: (i)&nbsp;determined that the
                                            consideration to be received by the Shareholders pursuant to the Arrangement and this Agreement
                                            is fair to Shareholders and that the Arrangement is in the best interests of the Company,
                                            (ii)&nbsp;resolved to recommend that the Shareholders vote in favor of the Arrangement Resolution,
                                            and (iii)&nbsp;authorized the entering into of this Agreement and the performance by the
                                            Company of its obligations under this Agreement, and no action has been taken to amend or
                                            supersede such determinations, resolutions, or authorizations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Auditors</U>.
KPMG LLP is and was, during the periods covered the Company Publicly Filed Documents, independent with respect to the Company within
the meaning of the relevant rules&nbsp;and related interpretations prescribed by the relevant professional bodies in Canada and the United
States and in accordance with applicable Securities Laws; there has not been any reportable event (within the meaning of NI 51-102) with
such auditors with respect to audits of the Company and the Company Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transactions
with Directors, Officers, Employees,&nbsp;etc</U>. Neither the Company nor any of the Company Subsidiaries is indebted to any of its
directors, officers or employees or any of their respective associates or Affiliates (except for amounts due in the ordinary course in
respect of salaries, bonuses, Company Options, Company Deferred Share Units and director&rsquo;s fees or the reimbursement of ordinary
course expenses). Other than in the ordinary course or as set forth in Section&nbsp;11 of the Company Disclosure Schedule, there are
no Contracts with, or advances, loans, guarantees, liabilities or other obligations to, on behalf or for the benefit of, any shareholder,
director, officer or employee of the Company or any of the Company Subsidiaries, or any of their respective Affiliates or associates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Securities
Law Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is a &ldquo;reporting issuer&rdquo; (or the equivalent) under Securities Laws in all Canadian provinces. The Shares are listed
and posted for trading on the TSX and Nasdaq. None of the Company or any of the Company Subsidiaries is subject to any continuous or
periodic, or other disclosure requirements under any securities laws in any jurisdiction, except, in the case of the Company, for Securities
Laws. The Company is not in default in any material respect of any requirements of any Securities Laws or the rules&nbsp;and regulations
of the TSX or Nasdaq. The Shares are registered under Section&nbsp;12 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has not taken any action to cease to be a &ldquo;reporting issuer&rdquo; (or the equivalent) in any of the provinces of Canada
nor has the Company received notification from any Securities Authority seeking to revoke the &ldquo;reporting issuer&rdquo; (or the
equivalent) status of the Company. No delisting, suspension of trading or cease trade or other order or restriction with respect to any
securities of the Company is pending, in effect or, to the knowledge of the Company, has been threatened, and the Company is not currently
subject to any formal review, inquiry, investigation or other proceeding relating to any such order or restriction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has timely filed or furnished all material forms, reports, schedules, statements and other documents required to be filed under
Securities Laws with the appropriate Securities Authority, the TSX or Nasdaq since January&nbsp;1, 2020 (<B><I>&ldquo;Company Public
Filing Documents&rdquo;</I></B>). The documents comprising the Company Public Filing Documents, as of their respective dates (or, if
amended or superseded by a subsequent Company Public Filing Document prior to the date of this Agreement, on the date of such subsequent
Company Public Filing Document) complied as filed in all material respects with applicable Law and did not, as of the date filed (or,
if amended or superseded by a subsequent filing prior to the date of this Agreement, on the date of such filing), contain any Misrepresentation.
The Company has not filed any confidential material change report or other confidential filing with any Securities Authority which at
the date of this Agreement remains confidential. As of the date of this Agreement, there are no outstanding or unresolved comments in
comment letters from any Securities Authority with respect to any of the Company Publicly Filed Documents. Neither the Company nor any
of its Subsidiaries is subject to any ongoing proceeding by any Securities Authority or the TSX and no such proceeding is threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is and has been since its initial public offering, a &ldquo;foreign private issuer&rdquo; within the meaning of Rule&nbsp;405
under the U.S. Securities Act and Rule&nbsp;3b-4 under the Exchange Act. The Company has no reason to believe it will not qualify as
a &ldquo;foreign private issuer&rdquo; at any time prior to the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company is not an investment company registered or required to be registered under the United States Investment Company Act of 1940.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
the knowledge of the Company, no related party of the Company (within the meaning of MI 61-101) together with its associated entities,
beneficially owns or exercises control or direction over 1% or more of the outstanding Shares, except related parties who will not receive
a &ldquo;collateral benefit&rdquo; (within the meaning of such instrument) as a consequence of the Transactions contemplated by this
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Financial
Statements</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
consolidated financial statements (including related notes and schedules) contained or incorporated by reference in the Company Publicly
Filed Documents: (i)&nbsp;complied as to form in all material respects with the published rules&nbsp;and regulations of the Securities
Authorities, applicable thereto; (ii)&nbsp;were prepared in accordance with IFRS applied on a consistent basis throughout the periods
covered (except as may be indicated in the notes to such financial statements) and applicable Law; and (iii)&nbsp;fairly present, in
all material respects, the assets, liabilities (whether accrued, absolute, contingent or otherwise), consolidated financial position,
results of operations or financial performance and cash flows of the Company and its Subsidiaries and as of the respective dates thereof
and for the periods covered thereby (subject, in the case of the unaudited financial statements, to normal and recurring year-end adjustments
that are not, individually or in the aggregate, material). The Company does not intend to correct or restate, nor, to the knowledge of
the Company, is there any basis for any correction or restatement of, any aspect of any of the financial statements referred to in this
Paragraph.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary is a party to or has any obligation or other commitment to become a party to any securitization
transaction, off-balance sheet partnership, or any similar Contract (including any Contract arising out of or relating to any transaction
or relationship between or among the Company and any Company Subsidiary, on the one hand, and any unconsolidated Affiliate, including
any structured finance, special purpose, or limited purpose Entity, on the other hand, or any &ldquo;off-balance sheet arrangement&rdquo;
(within the meaning of Item 303(a)&nbsp;of Regulation S-K promulgated under the Exchange Act)) where the result, purpose, or intended
effect of such Contract is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any
Company Subsidiary in the Company&rsquo;s published financial statements or other Company Publicly Filed Documents</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Disclosure
Controls and Internal Controls over Financial Reporting</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has established and maintains disclosure controls and procedures (as such term is defined in NI 52-109) designed to provide reasonable
assurance that information required to be disclosed by the Company in its annual filings, interim filings or other reports required to
be filed or submitted by it under Securities Laws is recorded, processed, summarized and reported within the time periods required by
applicable Securities Laws. Such disclosure controls and procedures include controls and procedures designed to ensure that information
required to be disclosed by the Company in its annual filings, interim filings or other reports required to be filed or submitted under
applicable Securities Laws is accumulated and communicated to the Company&rsquo;s management, including its chief executive officer and
chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has established and maintains a system of internal control over financial reporting (as such term is defined in NI 52-109) designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with IFRS.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
the knowledge of the Company, there is no (i)&nbsp;material weakness (as such term is defined in NI 52-109) or significant deficiency
relating to the design, implementation or maintenance of the Company&rsquo;s internal control over financial reporting or (ii)&nbsp;fraud,
whether or not material, that involves Representatives, consultants or independent contractors who have a significant role in the internal
control over financial reporting of the Company. To the knowledge of the Company, neither of the Company, any of its Subsidiaries, nor
any of its or their respective Representatives has received or otherwise obtained knowledge of any proceeding regarding accounting, internal
accounting controls or auditing matters, including any proceeding alleging that the Company or any of its Subsidiaries has engaged in
questionable accounting or auditing practices, or any expression of concern from its Representatives regarding questionable accounting
or auditing matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Absence
of Changes</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
December&nbsp;31, 2022 through the date of this Agreement, there has not occurred any Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as contemplated by this Agreement, from December&nbsp;31, 2022 through the date of this Agreement, (i)&nbsp;the Company and the Company
Subsidiaries have operated their respective businesses in all material respects in the ordinary course of business (except for discussions,
negotiations, and transactions related to this Agreement or other potential strategic transactions) and (ii)&nbsp;except as set forth
in Section&nbsp;15(b)(ii)&nbsp;of the Company Disclosure Schedule, neither the Company nor any Company Subsidiary has taken any action
that would have required the consent of Parent under <U>Section&nbsp;4.2(b)</U>&nbsp;of this Agreement had such action occurred or been
taken by the Company or any Company Subsidiary after the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Title
to Assets</U>. The Company and each Company Subsidiary has good and valid title to all material assets owned by it as of the date of
this Agreement, including all material assets reflected on the Company&rsquo;s consolidated balance sheet as of December&nbsp;31, 2022
in the audited consolidated financial statements of the Company for the year ended December&nbsp;31, 2022 included in the Company Publicly
Filed Documents (the &ldquo;<B><I>Balance Sheet</I></B>&rdquo;), except (a)&nbsp;for assets sold or otherwise disposed of in the ordinary
course of business since December&nbsp;31, 2022 and (b)&nbsp;where such failure would not, individually or in the aggregate, reasonably
be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Real
Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any of its Subsidiaries own any real property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be material, the Company or one of the Company Subsidiaries holds a good, valid and existing leasehold interest in all the
real property that is licensed, leased, subleased, used or otherwise occupied by the Company or such Company Subsidiary, as applicable,
from another Person (the &ldquo;<B><I>Leased Real Property</I></B>&rdquo;), free and clear of all Encumbrances other than Permitted Encumbrances.
The Company or one of the Company Subsidiaries are the sole holders of good and valid leaseholder interests in and to all of the Leased
Real Property. Section&nbsp;17(b)&nbsp;of the Company Disclosure Schedule sets forth each Company Lease (including all amendments, extensions,
renewals guaranties and other agreements with respect thereto) that is material to the business of the Company and its Subsidiaries,
taken as a whole, as of the date of this Agreement and identifies the street address of the applicable Leased Real Property subject thereto.
As of the date of this Agreement, neither the Company nor any Company Subsidiary has received any written notice regarding any violation
or breach or default under any Company Lease that has not since been cured, except for violations or breaches that are not, individually
or in the aggregate, reasonably likely to have a Material Adverse Effect, nor to the knowledge of the Company, has any other party to
any Company Lease breached such Company Lease in any material respects. All material rents, additional rents and other amounts due to
date pursuant to each Company Lease has been paid, except, in each case that would not individually or in the aggregate, have a Material
Adverse Effect. The Company has made available to Parent accurate and complete copies of all Company Leases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Leased Real Property collectively constitutes all of the material real property necessary to operate the business of the Company as currently
conducted in all respects material to the business of the Company and its Subsidiaries, taken as a whole. All buildings, structures,
fixtures, material items of equipment or other material tangible assets owned or leased to the Company or any of its Subsidiaries (including
the Leased Real Property) are adequate for the conduct of the business of the Company and its Subsidiaries in the manner in which such
businesses are currently being operated and are in good operating condition and repair (other than ordinary wear and tear) and do not
require any material renovations to continue to operate the businesses of the Company and its Subsidiaries in the ordinary course of
business, in each case, except as would not be reasonably expected to be material to the Company and its Subsidiaries, taken as a whole.
No casualty event has occurred with respect to any Leased Real Property that has not been remedied in all material respects, except as
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect, no rezoning, condemnation or eminent domain or similar
event or proceeding is pending or threatened in writing, or to the knowledge of the Company, orally, with respect to any Leased Real
Property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Intellectual
Property</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;18(a)&nbsp;of
the Company Disclosure Schedule&nbsp;sets forth a complete and accurate list of all Company Registered IP, and indicates whether each
such item of Company Registered IP is (i)&nbsp;owned exclusively by the Company or any Company Subsidiary, (ii)&nbsp;owned jointly by
the Company or any Company Subsidiary, on the one hand, and one (1)&nbsp;or more third parties, on the other hand, or (iii)&nbsp;exclusively
or co-exclusively licensed to the Company or any Company Subsidiary by a third party.&nbsp;The Company and the Company Subsidiaries exclusively
own all rights, title and interest in and to all Owned IP and are licensed or otherwise have, in each case, pursuant to a valid Contract,
the right to use all other Intellectual Property Rights (the &ldquo;<B><I>Licensed Company IP</I></B>&rdquo;) as the same are used in
or necessary for the conduct of the Company&rsquo;s and the Company Subsidiaries&rsquo; businesses as currently conducted and as currently
contemplated to be conducted, including with respect to any contemplated commercialization of any Company Product, in each case, without
payments to third parties (other than payments for non-exclusive licenses for generally commercially available off-the-shelf software)
and free and clear of any Encumbrances (other than Permitted Encumbrances); provided that the foregoing is not a representation or warranty
with respect to infringement, misappropriation or other violation of Intellectual Property Rights. All Company Registered IP is subsisting,
valid and enforceable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">None
of the Company or any Company Subsidiary, the operation of the business of the Company or any Company Subsidiary, or any Company Product
(i)&nbsp;has infringed, misappropriated (or resulted from the misappropriation of) or otherwise violated, (ii)&nbsp;is infringing, misappropriating
(or resulting from the misappropriation of) or otherwise violating, or (iii)&nbsp;will infringe, misappropriate (or result from the misappropriation
of) or otherwise violate through the commercialization or use of any Company Products as such Company Products currently exist or are
contemplated to exist, in each case (i), (ii)&nbsp;and (iii), any Intellectual Property Rights of any Person. To the knowledge of the
Company, no Person has infringed, misappropriated or otherwise violated, or is infringing, misappropriating or otherwise violating, any
Company IP. There is currently no, and there has not been during the three (3)&nbsp;years immediately prior to the date of this Agreement,
any Legal Proceeding pending (or, to the knowledge of the Company, threatened) alleging that: (x)&nbsp;the Company or any Company Subsidiary
or the operation of the businesses of the Company or any Company Subsidiary infringes, misappropriates or otherwise violates any Intellectual
Property Right of another Person; or (y)&nbsp;any issued Patents or registered Trademarks (in each case, included in the Company IP)
are invalid or unenforceable or that any Patent or Trademark applications (in each case, included in the Company IP) will, upon issuance,
be invalid or unenforceable, including any opposition, cancellation, post-grant review, <I>inter partes</I> review or other similar proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Company Subsidiaries have taken reasonable measures to protect and maintain the confidentiality of all Trade Secrets
included in the Company IP or with respect to which the Company owes another Person a duty of confidentiality, and no such Trade Secrets
have been disclosed by or on behalf of the Company or any Company Subsidiary to any person except pursuant to written non-disclosure
agreements or other binding confidentiality obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each Company Subsidiary has diligently prosecuted, and is diligently prosecuting, all Patent applications it has filed or
of which it otherwise possesses the right to control prosecution, other than with respect to any Patent applications that do not relate
to or cover any Company Product and that the Company, in the exercise of its commercially reasonable business judgment, decided not to
continue prosecuting. The Company and each Company Subsidiary has diligently prepared, and is diligently preparing, to file Patent applications
for all material inventions in a manner and within a sufficient time period to avoid statutory disqualifications of any Patent application.
All issuance, renewal, maintenance and other payments and all documents or other materials required to be paid or filed with the applicable
Intellectual Property Rights office or other Governmental Body with respect to any Patents or Patent applications included in the Company
IP have been timely paid in full or filed in a timely manner, as applicable. The Company and each Company Subsidiary has complied with
all applicable Laws, including any duties of candor to applicable patent offices, in connection with the filing, prosecution and maintenance
of all Patents and, to the extent applicable, Patent applications included in the Company IP and all other material Company IP. Each
Patent and Patent application included in the Company IP properly identifies each inventor of the claims thereof as determined in accordance
with the applicable Law of the jurisdiction in which such Patent or Patent application is issued or is pending. The Company and each
Company Subsidiary has made available to Parent, as of the date of this Agreement, copies of all technical reports and data (including
comparative data) required for, or otherwise relevant to, the filing or prosecution of all Patents and Patent applications included in
the Company Registered IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">None
of the Company IP is subject to any pending or outstanding injunction, directive, order, judgment, or other disposition of a dispute
that adversely restricts the use of any such Company IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each Company Subsidiary has obtained from all parties (including current or former employees, officers, advisors, directors,
consultants and contractors) who have created or developed (or are creating or developing) Intellectual Property Rights for or on behalf
of the Company or any Company Subsidiary, written, valid and enforceable assignment-of-rights agreements for the benefit of the Company
or the applicable Company Subsidiary pursuant to which each such party effectively assigns to the Company or the applicable Company Subsidiary
all rights, in and to such Intellectual Property Rights created by such party in connection with such party&rsquo;s employment with or
engagement by the Company or any Company Subsidiary, and no such Person has any right to further remuneration or consideration with respect
to any such Intellectual Property Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary is a member or promoter of, or a contributor to, or has made any written or binding commitments
to or agreements with or regarding, any patent pool, industry standards body, standard-setting organization or other similar organization,
in each case that requires or obligates the Company or any of its Affiliates to grant or offer to any other person any license or other
right to any Company IP. The Company and the Company Subsidiaries have complied with any and all obligations to the extent applicable
pursuant to the Bayh-Dole Act, 35 U.S.C. &sect;200-212, or other similar obligations under the Laws of any jurisdiction, including with
respect to any Patents included in the Company IP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Company IP was developed with funding from, or using the facilities, personnel or other resources of, any university, college, other
educational institution, research center or Governmental Body as a result of which (i)&nbsp;the applicable university, college, other
educational institution, research center or Governmental Body (or any person working for or on behalf of any of the foregoing) has, or
will be entitled to have, any right, title or interest (including any &ldquo;march in&rdquo; or co-ownership rights) in or to any Company
IP or, to the knowledge of the Company, in or to any Licensed Company IP that is material to the Company or any Company Subsidiary (including
any claim or option to any of the foregoing) or (ii)&nbsp;any repayment obligations are imposed that will be triggered as a result of
the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
this Agreement nor the Transactions will result (whether directly or indirectly) in, by virtue of any contract, agreement, order or judgment
binding upon the Company or any Company Subsidiary: (i)&nbsp;Parent or its Subsidiaries granting to any third party any right to or with
respect to any Intellectual Property Rights owned by or licensed to Parent or its Subsidiaries; or (ii)&nbsp;Parent or its Subsidiaries
being bound by, or subject to, any non-compete or other restriction on the operation or scope of its businesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>IT
Systems; Privacy; Data Protection and Data Security</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">None
of the Company or any Company Subsidiary processing data on behalf of the Company and the Company Subsidiaries has, since January&nbsp;1,
2020, experienced any unauthorized access to or other breach of security with respect to the information technology systems owned, operated
or controlled by the Company or any Company Subsidiary (the &ldquo;<B><I>IT Systems</I></B>&rdquo;). The IT Systems (i)&nbsp;are adequate
and sufficient for the conduct of the businesses of the Company and each Company Subsidiary as currently conducted; (ii)&nbsp;since January&nbsp;1,
2020, have not malfunctioned or failed (except for malfunctions or failures that have been fully remedied as of the date of this Agreement);
and (iii)&nbsp;to the knowledge of the Company, are free from all bugs and other defects and do not contain any &ldquo;virus&rdquo;,
 &ldquo;worm&rdquo;, &ldquo;spyware&rdquo;, &ldquo;ransomware&rdquo; or other malicious software. The Company, and each Company Subsidiary
processing data on behalf of the Company and the Company Subsidiaries has in place at least industry standard security controls, incident
response plans and disaster recovery plans and procedures for the IT Systems. The Company, and each Company Subsidiary processing data
on behalf of the Company and the Company Subsidiaries takes appropriate and at least industry standard actions to protect, maintain,
audit, monitor and test the confidentiality, integrity, availability, redundancy, backup, continuous operation and security of the IT
Systems, and to correct any problems that are identified.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2020: (a)&nbsp;the Company, and the Company Subsidiaries processing data on behalf of the Company and the Company Subsidiaries
have complied with (i)&nbsp;all Privacy Laws, (ii)&nbsp;all external and internal privacy and information security policies, and (iii)&nbsp;the
requirements of any Contract concerning information security and data privacy to which the Company and the Company Subsidiaries are a
party; (b)&nbsp;the Company, and the Company Subsidiaries processing data on behalf of the Company and the Company Subsidiaries have
adopted and followed at least industry standard physical, technical, organizational, and administrative security measures and policies
to protect all Personal Information in their custody or control; (c)&nbsp;the Company, and the Company Subsidiaries processing data on
behalf of the Company and the Company Subsidiaries have not experienced a data breach or incident resulting in loss or unauthorized access
to Personal Information; and (d)&nbsp;the Company, and the Company Subsidiaries processing data on behalf of the Company and the Company
Subsidiaries have not been the subject of any complaint, claim, or investigation related to their collection, use, storage, or processing
of Personal Information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Immediately
following the Closing of the Transactions, Parent and its Subsidiaries will have the same rights to use the Personal Information currently
in the possession or control of the Company and its Subsidiaries that the Company and its Subsidiaries had prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Contracts</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;20
of the Company Disclosure Schedule&nbsp;identifies each of the following Company Contracts to which the Company is a party as of the
date of this Agreement other than any Company Contract that is or constitutes (1)&nbsp;a nondisclosure agreement that does not incorporate
any license grants under or to any Intellectual Property Rights entered into (x)&nbsp;in the ordinary course of business or (y)&nbsp;in
connection with discussions, negotiations, and transactions related to this Agreement or other Acquisition Proposals (each of the following
Company Contracts shall be deemed to constitute a &ldquo;<B><I>Material Contract</I></B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract that limits the freedom or right of the Company or any Company Subsidiary (or that, following the Effective Time, would
limit the right or the ability of Parent or its Affiliates) to sell, distribute, produce or manufacture any Company Product or any other
product, project or service, acquire or obtain any material products or services from any other Person or to otherwise conduct it business,
including by (A)&nbsp;materially limiting the freedom or right of the Company or a Company Subsidiary (or following the Effective Time,
Parent or its Affiliates) to engage in any line of business or to compete with any other Person in any location or line of business or
(B)&nbsp;containing any &ldquo;most favored nation&rdquo; terms and conditions (including with respect to pricing) or exclusivity obligations
or restrictions, granted by the Company or any Company Subsidiary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract (other than any Employee Plan) that, following the consummation of the Transactions would bind or purport to bind any
Affiliate of the Company (other than the Company or any Company Subsidiary) or apply to the assets or business thereof;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract (other than any Employee Plan) that requires by its terms or is reasonably likely to require, during the remaining
term of such Company Contract, the payment or delivery of cash or other consideration by or to the Company in an amount having an
expected value in excess of [Redacted &ndash; commercially sensitive information] in the fiscal year ending December&nbsp;31, 2023
or in any single fiscal year thereafter;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract pursuant to which the Company or any Company Subsidiary is granted any license, covenant-not-to-assert or other
right (including any right to receive royalties or other payments) with respect to any Intellectual Property Rights, other than
non-exclusive licenses entered into in the ordinary course of business (A)&nbsp;for non-customized, commercially available
off-the-shelf software at a cost of no more than [Redacted &ndash; commercially sensitive information] in the aggregate or
(B)&nbsp;granted pursuant to material transfer agreements, clinical trial agreements, non-disclosure agreements, services agreements
or other agreements in which grants of rights to use Intellectual Property Rights are incidental to and not material to performance
under such agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract: (A)&nbsp;granting any third party any license, covenant-not-to-assert or other right (including any right to receive
royalties or other payments) with respect to any Company IP or any other Intellectual Property Rights that are material to the Company
or any Company Subsidiary (excluding any non-exclusive licenses granted in the ordinary course of business pursuant to material transfer
agreements, clinical trial agreements, non-disclosure agreements, services agreements or other agreements in which grants of rights to
use Intellectual Property Rights are incidental to and not material to performance under such agreement); or (B)&nbsp;that would purport,
after the Effective Time, to grant any third party any license, covenant-not-to-assert or other right (including any right to receive
royalties or other payments) with respect to any Intellectual Property Rights owned by or licensed to Parent or its Subsidiaries;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract (A)&nbsp;that relates to any material Research Program (including the generation or collection of data from any material
Research Program), or any research, development, distribution, sale, supply, license, importation, exportation, marketing, co-promotion
or manufacturing activities that are material to the business of the Company or any Company Subsidiary as currently conducted or as contemplated
to be conducted or (B)&nbsp;under which clinical, pre-clinical or non-clinical data is or may be generated, for use in connection with
or relating to any Company Product or Research Program;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract (other than any Employee Plan) relating to Indebtedness in excess of $100,000 (whether incurred, assumed, guaranteed,
or secured by any asset) of the Company or any Company Subsidiary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract (A)&nbsp;constituting or providing for the formation, creation, operation, management or control of a joint venture,
partnership, limited liability company, strategic alliance, or similar arrangement that includes the sharing of profits and losses with
another Person or (B)&nbsp;pursuant to which the Company has made or is obligated to make a material investment in any Person or project;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract requiring the Company to perform or conduct research, clinical trials or development for the benefit of any Person other
than the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
material Company Contract that is a supply or manufacturing Contract;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract that prohibits the payment of dividends or distributions in respect of the capital stock of the Company, the pledging
of the capital stock or other equity interests of the Company, or prohibits the issuance of any guaranty by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract that is currently in effect and has been filed (or is required to be filed) by the Company pursuant to the Securities
Laws;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract with any Affiliate, director, executive officer (as such term is defined in the Exchange Act), holder of 5% or more
of the Shares or, to the knowledge of the Company, any of their Affiliates (other than the Company) or immediate family members (other
than (A)&nbsp;offer letters that do not contain contractual severance obligations and (B)&nbsp;Company Contracts pursuant to Company
Equity Awards);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xiv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract relating to a Company Related Party Transaction (other than (A)&nbsp;offer letters that do not contain contractual severance
obligations and (B)&nbsp;Company Contracts pursuant to Company Equity Awards);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract for the license, lease, or sublease of any material real property;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract that relates to the acquisition or disposition by the Company or any Company Subsidiary, involving consideration in
excess of [Redacted &ndash; commercially sensitive information], of any Person or other business organization, division, or business of any Person (whether by merger or consolidation,
by the purchase of a controlling equity interest in or substantially all of the assets of such Person, or by any other manner);</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xvii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract that relates to the acquisition or disposition of (a)&nbsp;Intellectual Property Rights relating to any Company Product
or the research, development, distribution, sale, supply, license, importation, exportation, marketing, co-promotion or manufacturing
thereof or (b)&nbsp;other Intellectual Property Rights material to the Company or any Company Subsidiary;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xviii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract with an academic institution, research center or Governmental Body that (A)&nbsp;relates to (or is reasonably likely
to involve) the development or creation of any Intellectual Property Rights or (B)&nbsp;grants any academic institution, research center
or Governmental Body any right or option with respect to any Intellectual Property Rights;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xix)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Any
Company Contract that constitutes a Collective Bargaining Agreement;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xx)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract pursuant to which the Company or any Company Subsidiary (A)&nbsp;has continuing guarantee,&nbsp;&ldquo;earn-out,&rdquo;
or similar contingent payment obligations (other than indemnification or performance guarantee obligations provided for in the ordinary
course of business), including (x)&nbsp;milestone or similar payments, including upon the achievement of regulatory or commercial milestones
or (y)&nbsp;payment of royalties or other amounts calculated based upon any revenue or income of the Company, or (B)&nbsp;grants to any
Person any right of first refusal, right of first negotiation, option to purchase, option to exclusively license, or any other similar
rights with respect to any product or service of the Company or any Intellectual Property Rights;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
Company Contract since January&nbsp;1, 2020, the primary purpose of which is to provide for indemnification or guarantee of the obligations
of any other Person that would be material to the business of the Company and the Company Subsidiaries, taken as a whole, other than
any such Company Contracts entered into in the ordinary course of business;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
settlement, conciliation or similar agreement (A)&nbsp;pursuant to which the Company or any Company Subsidiary is obligated after January&nbsp;1,
2020 to pay consideration in excess of $100,000 or (B)&nbsp;that would otherwise materially limit the operation of the Company and the
Company Subsidiaries, taken as a whole, as currently operated; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(xxiii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">any
hedging, swap, derivative, or similar Company Contract.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date of this Agreement, the Company has made available to Parent or Parent&rsquo;s Representatives an accurate and complete copy
of each Material Contract (except with such redactions as may be clearly marked on such copies). Except as would not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect: (i)&nbsp;neither the Company nor, to the knowledge of the
Company, the other party is in material breach of or material default under any Material Contract and, neither the Company, nor, to the
knowledge of the Company, the other party has taken or failed to take any action that with or without notice, lapse of time, or both
would constitute a material breach of or material default under any Material Contract, (ii)&nbsp;each Material Contract is, with respect
to the Company and, to the knowledge of the Company, the other party, a valid agreement, binding, and in full force and effect, (iii)&nbsp;to
the knowledge of the Company, each Material Contract is enforceable by the Company in accordance with its terms, subject to the Enforceability
Exceptions, and (iv)&nbsp;since January&nbsp;1, 2020, through the date of this Agreement, the Company has not received any written notice
regarding any violation or breach or default under any Material Contract that has not since been cured. To the Company&rsquo;s knowledge,
since January&nbsp;1, 2020, no counterparty to any Material Contract has (a)&nbsp;canceled or otherwise terminated, or threatened in
writing to cancel or otherwise terminate, its relationship with the Company or any Company Subsidiary or (b)&nbsp;decreased materially
or threatened to decrease materially or limit materially, the amount of business that any such counterparty presently engages in or presently
conducts with the Company and its Subsidiaries. As of the date of this Agreement, the Company has not waived in writing any rights under
any Material Contract, the waiver of which would have, or would reasonably be expected to have, individually or in the aggregate, a Material
Adverse Effect. Since January&nbsp;1, 2020, through the date of this Agreement, the Company has not received any written notice alleging
any material violation or breach or default under any Material Contract that has not since been cured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Liabilities</U>.
As of the date of this Agreement, neither the Company nor any Company Subsidiary has any liability of the type required to be disclosed
as a liability on a consolidated balance sheet prepared in accordance with IFRS, except for: (i)&nbsp;liabilities disclosed on the Balance
Sheet; (ii)&nbsp;liabilities or obligations incurred pursuant to the terms of this Agreement; (iii)&nbsp;liabilities for performance
of obligations of the Company or any Company Subsidiary under Contracts binding thereon (other than resulting from any breach or acceleration
thereof) made available to Parent or Parent&rsquo;s Representatives or entered into in the ordinary course of business; (iv)&nbsp;liabilities
incurred in the ordinary course of business since December&nbsp;31, 2022; and (v)&nbsp;liabilities that would not, individually or in
the aggregate, reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compliance
with Laws</U>. The Company, the Company Subsidiaries, each Entity under their control and their respective officers, directors, employees,
agents and third parties acting on their behalf have each been, since January&nbsp;1, 2018, in compliance with all applicable Laws, except
where the failure to be in compliance would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. To the knowledge of the Company, since January&nbsp;1, 2018, neither the Company nor any Company Subsidiary has been given written
notice of, or been charged with, any unresolved violation of any Law, except, in each case, for any such violation that would not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect. To the knowledge of the Company, no investigation or review
by any Governmental Body with respect to the Company, any Company Subsidiary, any Entity under their control or any of their respective
officers, directors, employees, agents and third parties acting on their behalf is pending or, as of the date of this Agreement, threatened,
nor has any Governmental Body indicated an intention to conduct the same, except for such investigations or reviews the outcome of which
would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company and its Subsidiaries
are, and have been since January&nbsp;1, 2018, in material compliance with applicable Sanctions or applicable export control Laws or
U.S., European Union or United Kingdom anti-boycott requirements (the &ldquo;<B><I>Trade Control Laws</I></B>&rdquo;). Neither the Company
nor any of its Subsidiaries, nor any of their respective directors, officers, managers, employees, nor, to the knowledge of the Company,
agents or third party representatives, is or has been: (i)&nbsp;a Sanctioned Person; (ii)&nbsp;operating in, organized in, conducting
business with, or otherwise engaging in dealings with or for the benefit of any Sanctioned Person or in any Sanctioned Country in connection
with the business of the Company or any of its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Regulatory
Matters</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each Company Subsidiary possesses all material approvals, authorizations, certificates, registrations, licenses, exemptions,
permits, clearances, and consents (including all investigational new drug applications (as defined in 21 C.F.R. &sect; 312.20 <I>et seq.</I>,
establishment registrations (as defined in 21 C.F.R. &sect; 207), and product listings (as defined in 21 C.F.R. &sect; 207), all supplements
or amendments thereto, and all comparable approvals, authorizations, certificates, registrations, licenses, exemptions, permits, clearances,
and consents provided for in other applicable Laws) (&ldquo;<B><I>Regulatory Authorizations</I></B>&rdquo;) from the U.S. Food and Drug
Administration (the &ldquo;<B><I>FDA</I></B>&rdquo;) and all other applicable Regulatory Authorities relating to the Company&rsquo;s
and each Company Product or that are necessary for the Company or any Company Subsidiary to conduct its business in all material respects
as presently conducted. Except as would not reasonably be expected to have a Material Adverse Effect, (i)&nbsp;all such Regulatory Authorizations
are (A)&nbsp;in full force and effect, (B)&nbsp;validly registered and on file with applicable Regulatory Authorities and (C)&nbsp;in
compliance with all formal filing and maintenance requirements and (ii)&nbsp;the Company and each Company Subsidiary has fulfilled and
performed all of its material obligations with respect to such Regulatory Authorizations, and no event has occurred which allows, or
after notice or lapse of time would allow, revocation or termination thereof. Except as would not reasonably be expected to be material
to the business of the Company and the Company Subsidiaries, taken as a whole, (1)&nbsp;the Company and each Company Subsidiary has filed,
maintained or furnished to the FDA, Health Canada, or other applicable Governmental Bodies or other applicable Regulatory Authorities
all required filings, declarations, listings, registrations, submissions, amendments, modifications, notices and responses to notices,
applications and supplemental applications, reports (including all adverse event/experience reports) and (2)&nbsp;all such submissions
were complete and accurate and in compliance in all material respects with applicable Laws when filed (or were corrected or completed
in a subsequent filing).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">(i)&nbsp;The
Company and each Company Subsidiary has never marketed, sold, distributed, promoted or advertised any pharmaceutical products (including
the Company Products) and (ii)&nbsp;the Company and each Company Subsidiary is, and since January&nbsp;1, 2018 has been, in material
compliance with applicable Laws, including the FDCA and its implementing regulations, relating to the development, testing, manufacturing,
holding, marketing, selling, distributing, labeling, promoting, advertising, importing or exporting of pharmaceutical products, including
without limitation, (i)&nbsp;requirements for obtaining Regulatory Authorizations, (ii)&nbsp;requirements for establishment registration
and product listing; (iii)&nbsp;payment of all application and program fees invoiced for the Company Products, (iv)&nbsp;label and labeling
requirements and (vi)&nbsp;applicable promotion and advertising requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
non-clinical studies and clinical investigations, preclinical studies or tests sponsored or conducted by or on behalf of the Company
or any Company Subsidiary are being conducted in material compliance with applicable Laws, including Good Laboratory Practices, Good
Clinical Practices, the FDCA, and all other Laws regarding developing, testing, labeling, manufacturing, storage, marketing, promotion,
sale, commercialization, safety, quality, shipment, import, export, or distribution the products of the Company. None of the FDA, Health
Canada, any other Regulatory Authority, or any institutional review board has sent any written notices or other correspondence with respect
to any proposed, ongoing or completed clinical, preclinical or non-clinical studies or tests requiring the termination, suspension or
material modification of such studies or tests. With respect to each Company Product, the Company has made available to Parent complete
and accurate copies of all material clinical, preclinical and nonclinical data in the possession of and reasonably available to the Company
or any Company Subsidiary and all material written correspondence that exists as of the date of this Agreement between the Company and
any of its subsidiaries and the FDA, Health Canada, or any other Regulatory Authority performing functions similar to those performed
by the FDA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary nor, to the knowledge of the Company, any officers, employees or agents of the Company or any
Company Subsidiary, has (i)&nbsp;made an untrue statement of a material fact or fraudulent statement to the FDA, Health Canada, or any
other Regulatory Authority, (ii)&nbsp;failed to disclose a material fact required to be disclosed to the FDA or Health Canada or (iii)&nbsp;committed
any other act, made any statement or failed to make any statement, that (in any such case) establishes a reasonable basis for the FDA
to invoke its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy. As of the date of this Agreement,
neither the Company nor any Company Subsidiary is the subject of any pending or, to the Company&rsquo;s knowledge, threatened investigation
by the FDA pursuant to its Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities Final Policy. Neither the Company
nor any Company Subsidiary nor, to the knowledge of the Company, any officers, employees, agents or clinical investigators of the Company
or any Company Subsidiary has been suspended or debarred or convicted of any crime or engaged in any conduct that would reasonably be
expected to result in (A)&nbsp;debarment under 21 U.S.C. Section&nbsp;335a or any similar Law or (B)&nbsp;exclusion under 42 U.S.C. Section&nbsp;1320a-7
or any similar Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not reasonably be expected to be material to the business of the Company and the Company Subsidiaries, taken as a whole, (i)&nbsp;the
Company, each Company Subsidiary and any contractor or other Person acting on their behalf is obtaining and since January&nbsp;1, 2018,
has obtained (or caused to be obtained) informed consent by or on behalf of each human subject who participated in the Company&rsquo;s
ongoing clinical studies; (ii)&nbsp;in using or disclosing patient information received by the Company in connection with the Company&rsquo;s
ongoing clinical studies, the Company, each Company Subsidiary and any contractor or other Person acting on their behalf have complied
with all Laws and regulatory rules&nbsp;or requirements, in each case to the extent applicable, including, without limitation, the Health
Insurance Portability and Accountability Act of 1996, the FDCA and the rules&nbsp;and regulations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
the extent required by applicable Laws, all manufacturing operations conducted with respect to any Company Product used in human clinical
trials have been conducted in accordance with the FDCA, Laws, and Good Manufacturing Practices, except where the failure to comply would
not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2018, no Company Product has been recalled, withdrawn, suspended or discontinued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2018, no preclinical studies sponsored or conducted by or on behalf of the Company for the purpose of supporting a regulatory
filing have had any material adverse safety findings that the Company would reasonably expect to have a material adverse impact on clinical
studies, and all material preclinical toxicology reports or preclinical toxicology studies conducted by or on behalf of the Company for
the purpose of supporting a regulatory filing have been disclosed to the FDA, Health Canada, and all other applicable Regulatory Authorities
to the extent required by applicable Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each Company Subsidiary is, and since January&nbsp;1, 2018 has been, in material compliance with all applicable Healthcare
Laws. Neither the Company nor any Company Subsidiary is subject to any enforcement, regulatory or administrative proceedings regarding
alleged non-compliance with any Healthcare Laws and, to the knowledge of the Company, no such enforcement, regulatory or administrative
proceeding has been threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and the Company Subsidiaries have adopted and maintain a compliance program that is intended to assist the Company and the Company
Subsidiaries to be in material compliance with all Law, standards and guidelines relevant to its business, including all Healthcare Laws,
and includes each of the following elements: (i)&nbsp;a code of conduct and other applicable policies and procedures; (ii)&nbsp;training
on the code of conduct, policies and procedures for all employees; (iii)&nbsp;an auditing and monitoring function; (iv)&nbsp;an anonymous
reporting process for potential violations of Law or the compliance program; (v)&nbsp;designation of a compliance officer; and (vi)&nbsp;a
mechanism for ensuring the effectiveness of the compliance program. None of the Company and its Subsidiaries or, to the Knowledge of
the Company, any of its officers, directors, employees, contractors or agents has materially violated any such compliance program.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Business Practices</U>. Within the previous five (5)&nbsp;years, none of the Company, any Company Subsidiary, or, to the knowledge of
the Company, any Representative of the Company (each, a &ldquo;<B><I>Company Representative</I></B>&rdquo;), or any other Person (in
each case, acting for or on behalf of the Company or any Company Subsidiary) has violated any provision of any Anti-Corruption Law or
any rule&nbsp;or regulation promulgated thereunder, applicable anti-money laundering Law and any rule&nbsp;or regulation promulgated
thereunder, or any applicable Law of similar effect, or has, in violation of Anti-Corruption Laws: (a)&nbsp;directly or indirectly paid,
offered, or promised to make or offer any contribution, gift, entertainment, or other expense, (b)&nbsp;made, offered, or promised to
make or offer any payment, loan, or transfer of anything of value, including any reward, advantage, or benefit of any kind to or for
the benefit of foreign or domestic governmental officials or employees, or to foreign or domestic political parties, candidates thereof,
or campaigns, (c)&nbsp;paid, offered, or promised to make or offer any bribe, payoff, influence payment, kickback, rebate, or other similar
payment of any nature, (d)&nbsp;established or maintained any fund of corporate monies or other properties, (e)&nbsp;created or caused
the creation of any false or inaccurate books and records of the Company or any Company Subsidiary related to any of the foregoing, or
(f)&nbsp;taken or caused to be taken any other action in connection with the business of the Company or any Company Subsidiary, except,
in each case, as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company has
established and maintains policies and procedures reasonably designed to comply with Anti-Corruption Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Governmental
Authorizations</U>. The Company and each of the Company Subsidiaries hold all Governmental Authorizations necessary to enable the Company
and each such Company Subsidiary to conduct its respective business in the manner in which its business is currently being conducted,
except where the failure to hold such Governmental Authorizations would not, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect. The material Governmental Authorizations held by the Company and the Company Subsidiaries are, in
all material respects, valid and in full force and effect. The Company and the Company Subsidiaries are each in compliance with the terms
and requirements of such Governmental Authorizations, to the extent applicable to them, except where failure to be in compliance would
not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. There are no Legal Proceedings pending
or threatened in writing, or to the knowledge of the Company, orally, that seek the revocation, cancellation or adverse modification
of any Governmental Authorization, except where such revocation, cancellation or adverse modification would not have a Material Adverse
Effect. Since January&nbsp;1, 2018, neither the Company nor any Company Subsidiary has received any written notice of any material noncompliance
or alleged material noncompliance with any material Governmental Authorization. The Company does not engage in (a)&nbsp;the design, fabrication,
development, testing, production or manufacture of &ldquo;critical technologies&rdquo; within the meaning of Section&nbsp;721 of the
Defense Production Act of 1950, as amended, including all implementing regulations thereof (the &ldquo;<B><I>DPA</I></B>&rdquo;); (b)&nbsp;the
ownership, operation, maintenance, supply, manufacturing or servicing of &ldquo;covered investment critical infrastructure&rdquo; within
the meaning of the DPA (where such activities are covered by column 2 of Appendix A to 31 C.F.R. Part&nbsp;800); or (c)&nbsp;to the Company&rsquo;s
knowledge, the maintenance or collection, directly or indirectly, of &ldquo;sensitive personal data&rdquo; of U.S. citizens within the
meaning of the DPA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">26.</FONT>&#9;&#8239;&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt"><U>Tax
Matters</U>. </FONT>&#8239;&#8239;&#8239;&nbsp;<FONT STYLE="font-size: 10pt">Except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect: (i)&nbsp;each of the income and other Tax Returns required to be filed by the
Company or any Company Subsidiary with any Governmental Body have been filed on or before the applicable due date (taking into account
any extension of such due date), and all such Tax Returns are true, accurate, and complete in all respects, (ii)&nbsp;all Taxes due and
payable by or required to have been paid by the Company or any Company Subsidiary (whether or not shown as due and owing on such Tax
Returns), including instalments on account of Taxes for the current year, have been timely paid by the Company or the Company Subsidiary,
as applicable, (iii)&nbsp;the Company and each Company Subsidiary have not received, or been credited with, a refund of Taxes or a deemed
overpayment of Taxes under Section&nbsp;125.7 of the Tax Act (or other amount in respect of any COVID-19 measure) to which they were
not entitled, (iv)&nbsp;the Company and each Company Subsidiary have provided adequate accruals in accordance with IFRS in the most recently
published consolidated financial statements of the Company for any Taxes of the Company and each Company Subsidiary for the period covered
by such financial statements that have not been paid, whether or not shown as being due on any Tax Returns, (v)&nbsp;since December&nbsp;31,
2020 the Company and each Company Subsidiary have only incurred liabilities for Taxes in the ordinary course of business, and (vi)&nbsp;the
Company and each Company Subsidiary have withheld and collected and paid over to the appropriate Governmental Body all Taxes required
to have been withheld or collected and paid over by them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect: (i)&nbsp;no deficiency or proposed
adjustment (other than a deficiency or proposed adjustment that is being contested in good faith by appropriate proceedings and for which
appropriate reserves have been established in the consolidated financial statements of the Company to the extent required by IFRS) for
any Tax has been asserted or assessed by any Taxing Authority in writing against the Company or any Company Subsidiary, which deficiency
has not been paid, settled, or withdrawn, (ii)&nbsp;no examination or audit of, or other Legal Proceeding with respect to, any Tax Return
of the Company or any Company Subsidiary is currently in progress or pending, or, to Company&rsquo;s or any Company Subsidiary&rsquo;s
knowledge, threatened, (iii)&nbsp;there is no Encumbrance for Taxes (other than Permitted Encumbrances) upon any asset of the Company
or any Company Subsidiary, (iv)&nbsp;no written claim has been made since January&nbsp;1, 2020 by any Governmental Body in a jurisdiction
in which the Company or any Company Subsidiary, as applicable, does not file Tax Returns (or pay a specified type of Tax) that it is
or may be subject to Tax by, or required to file Tax Returns in, that jurisdiction, and (v)&nbsp;except in connection with extensions
of time to file Tax Returns obtained in the ordinary course of business, there are no outstanding waivers of (A)&nbsp;any limitation
periods or agreements providing for an extension of time for the filing of any Tax Return by the Company or a Company Subsidiary, (B)&nbsp;the
payment of any Tax by the Company or a Company Subsidiary, or (C)&nbsp;any reassessment or assessment period of the Company or a Company
Subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary is a party to any Tax sharing, allocation, or indemnification agreement or arrangement that would
have a continuing effect after the Closing Date (other than such agreements or arrangements that form part of a commercial agreement
or arrangement entered into in the ordinary course of business, the primary subject matter of which is not Tax). Neither the Company
nor any Company Subsidiary (i)&nbsp;has been a member of an affiliated group (within the meaning of Section&nbsp;1504(a)&nbsp;of the
Code) filing a consolidated U.S. federal income Tax Return (other than a group the common parent of which is or was the Company or any
Company Subsidiary) or (ii)&nbsp;except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect,&nbsp;has any liability for the Taxes of another Person (other than the Company or any Company Subsidiary) under Treasury Regulations&nbsp;Section&nbsp;1.1502-6&nbsp;(or
any similar provision of any state, local, or foreign Law, including Section&nbsp;160 of the Tax Act), as a transferee or successor or
otherwise, by operation of Laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary will be required to include any material item of income in, or exclude any material item of deduction
from, taxable income for any taxable period beginning after the Closing Date as a result of: (i)&nbsp;any change in method of accounting
for a taxable period ending on or prior to the Closing Date made prior to the Closing, (ii)&nbsp;any &ldquo;closing agreement&rdquo;
executed prior to the Closing or any agreement with any Taxing Authority entered into or any ruling received or requested from any Taxing
Authority on or prior to the Closing Date, (iii)&nbsp;solely with respect to the Company U.S. Subsidiary, any intercompany transaction
or excess loss account described in Treasury Regulations under Section&nbsp;1502 of the Code entered into or existing prior to the Closing,
(iv)&nbsp;any prepaid amount received on or prior to the Closing or any deferred revenue accrued or existing on or before the Closing
Date, or (v)&nbsp;any instalment sale or open transaction disposition occurring on or before the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary is the beneficiary of any material Tax exemption, Tax holiday or other similar Tax reduction agreement
or order of a territorial or non-U.S. Governmental Body.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2021, the Company U.S. Subsidiary has not been either a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled
corporation&rdquo; in a distribution of stock intended to qualify to be governed in whole or in part under Section&nbsp;355 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company U.S. Subsidiary has not entered into any &ldquo;listed transaction&rdquo; within the meaning of Treasury Regulations&nbsp;Section&nbsp;1.6011-4(b)(2).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary has deferred the payment of any material Taxes under any COVID-19 measures which Taxes have not
been paid as of the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company and each Company Subsidiary have complied in all material respects with the transfer pricing provisions of all applicable Laws,
including the contemporaneous documentation, retention, and filing requirements thereof. The Company U.S. Subsidiary has complied in
all material respects with the provisions of Section&nbsp;482 of the Code and the Treasury Regulations promulgated thereunder (and any
corresponding provision of state or local Laws). The Company and each Company Subsidiary have made or obtained records or documents that
satisfy in all material respects the requirements of paragraphs 247(4)(a)&nbsp;to (c)&nbsp;of the Tax Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;26(j)&nbsp;of
the Company Disclosure Schedule sets forth the entity classification of the Company and each Company Subsidiary for U.S. federal income
tax purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
are no circumstances existing which could result in the application of Section&nbsp;17, Section&nbsp;78, Sections 80 to 80.04 or Subsection
90(6)&nbsp;of the Tax Act, or any equivalent provision under provincial Law, to the Company or any Company Subsidiary. Except as in accordance
with past practices, the Company and each Company Subsidiary have not claimed nor will they claim any reserve under any provision of
the Tax Act or any equivalent provincial provision, if any amount could be included in the income of the Company or any Company Subsidiary
for any period ending after the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">For
the purposes of the Tax Act, any applicable Tax treaty and any other relevant Tax purposes (i)&nbsp;the Company is resident in, and is
not a non-resident of, Canada, and is a &ldquo;taxable Canadian corporation&rdquo;; and (ii)&nbsp;each Company Subsidiary is resident
in the jurisdiction in which it was formed, and is not resident in any other country.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">All
research and development investment tax credits and other tax credits (<B><I>&ldquo;ITCs</I></B>&rdquo;) claimed by the Company and each
Company Subsidiary were claimed in material accordance with the Tax Act (any corresponding provisions of any other applicable Tax Laws)
and the Company and each Company Subsidiary have materially satisfied at all times the relevant criteria and conditions entitling them
to such ITCs. All refunds of ITCs received or receivable by the Company and each Company Subsidiary in any taxation year were claimed
in material accordance with the Tax Act (any corresponding provisions of any other applicable Tax Laws) and the Company and each Company
Subsidiary materially satisfied at all times the relevant criteria and conditions entitling them to claim a refund of such ITCs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">27.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Employee
Matters; Employee Plans</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Company has provided, as of the date hereof, a complete and correct list of (i)&nbsp;all current employees of the Company and its Subsidiaries,
indicating each individual&rsquo;s (A)&nbsp;identification number, (B)&nbsp;title or position, (C)&nbsp;full time, part time or temporary
status, (D)&nbsp;hire date, (E)&nbsp;work location, (F)&nbsp;employing entity, (G)&nbsp;classification as exempt or non-exempt (eligible
for overtime or not), (H)&nbsp;hourly rate of pay or base annual salary, (I)&nbsp;whether the employee is on leave, the expected return
to work date and whether the employee is receiving any benefits and (ii)&nbsp;all current individual consultants and independent contractors
who provide services to the Company or any of its Subsidiaries, including each individual&rsquo;s (A)&nbsp;job title, (B)&nbsp;start
date, (C)&nbsp;work location, (D)&nbsp;nature of services and (E)&nbsp;current compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary is a party to any Collective Bargaining Agreement, is currently negotiating a Collective Bargaining
Agreement or has an obligation to bargain with any union, labor organization or employee association. Since January&nbsp;1, 2020, except
as would not be reasonably expected to result in a material liability for the Company, (i)&nbsp;there has not been any unfair labor practice
charge, labor arbitration, grievance, strike, slowdown, work stoppage, lockout, picketing, question concerning labor representation or
union organizing activity, or any threat thereof, or any similar activity or dispute, affecting the Company, any Company Subsidiary or
any of their respective employees; and (ii)&nbsp;there is not now pending, and no Person has threatened to commence, any such unfair
labor practice charge, labor arbitration, grievance, strike, slowdown, work stoppage, lockout, picketing, question concerning labor representation
or union organizing activity, or any similar activity or dispute.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
is no, and since January&nbsp;1, 2020, has been no, Legal Proceeding pending or threatened arising out of or relating to the employment
or engagement of any Company Associate, including arising out of or relating to any Employee Plan, except as would not be reasonably
expected to result in a material liability for the Company. Each of the Company and its Subsidiaries is, and since January&nbsp;1, 2020
has been, in compliance in all respects with all Laws related to labor and employment, including, without limitation, employment practices,
employment standards, classification (including classification of employees vs. independent contractors and classification of employees
as &ldquo;exempt&rdquo; vs. &ldquo;non-exempt&rdquo;), payment of wages and hours of work, collective bargaining, background checks,
leaves of absence, plant closing notification, pay equity, French language, privacy rights, labor disputes, termination of employment,
workers&rsquo; compensation, workplace health and safety, retaliation, immigration, harassment and discrimination matters, in each case
except as would not be reasonably expected to result in a material liability for the Company. Each current Company Associate has all
work permits, immigration permits, visas or other authorizations required by applicable Law for such Company Associate given the duties
and nature of such Company Associate&rsquo;s services, except as would not be reasonably expected to result in material liability for
the Company. Each of the Company and its Subsidiaries has met all requirements under Laws relating to employment and termination of employment,
and neither the Company nor any of its Subsidiaries currently employs any person who is not permitted to work in the jurisdiction in
which such person is employed, in each case except as would not be reasonably expected to result in a material liability for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2020, no Company Associate has been improperly included or excluded from any Employee Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">In
the last five (5)&nbsp;years, no allegations of sexual, psychological or other unlawful harassment or discrimination have been made against
any Company Associate at the level of Vice President or above, except as would not be reasonably expected to result in a material liability
for the Company. During such period, neither the Company nor any Company Subsidiary has been involved in any Legal Proceedings or settlements
involving such matters or persons.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">There
are no charges or orders pending under occupational health and safety Laws (&ldquo;<B><I>OHSA</I></B>&rdquo;) in respect of the Company
or any Company Subsidiary, and there are no appeals of any orders under OHSA applicable to the Company or any Company Subsidiary currently
outstanding, in each case, except as would not be reasonably expected to result in a material liability for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Section&nbsp;27(g)&nbsp;of
the Company Disclosure Schedule contains a complete, correct and current list of each Employee Plan and separately identifies each Employee
Plan by jurisdiction (with any such Employee Plan that is subject to the Laws of Canada, a &ldquo;<B><I>Canadian Plan</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">With
respect to each material Employee Plan, the Company has provided to Parent complete, correct and current copies of the following (or,
to the extent no such copy exists, an accurate description thereof), to the extent applicable: (i)&nbsp;all plan documents and all material
amendments thereto, and all related trust or other funding documents; (ii)&nbsp;any currently effective determination letter or opinion
letter received from the IRS or the Taxing Authority; (iii)&nbsp;the most recent annual actuarial valuation and the most recent Form&nbsp;5500
or any other applicable form and all schedules thereto; (iv)&nbsp;the most recent summary plan description or member booklet (in English
and French where prepared in both languages) and any material modifications thereto; and (v)&nbsp;since January&nbsp;1, 2020, for the
most recent year, all material, non-routine correspondence from any Governmental Body regarding the operation or the administration of
the Employee Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any ERISA Affiliate has during the past six years maintained, sponsored, contributed to or been required to maintain,
sponsor or contribute to or otherwise had any liability, whether absolute or contingent, with respect to (i)&nbsp;a plan subject to Title
IV of ERISA or Code Section&nbsp;412, including any &ldquo;single employer&rdquo; defined benefit plan or any &ldquo;multiemployer plan&rdquo;
each as defined in Section&nbsp;4001 of ERISA, (ii)&nbsp;a &ldquo;multiple employer plan&rdquo; as defined in Section&nbsp;413(c)&nbsp;of
the Code or Section&nbsp;210 of ERISA, or (iii)&nbsp;a &ldquo;multiple employer welfare arrangement&rdquo; within the meaning of Section&nbsp;3(40)
of ERISA.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in Section&nbsp;27(j)&nbsp;of the Company Disclosure Schedule, no Employee Plan is a &ldquo;retirement compensation plan,&rdquo;
a &ldquo;registered pension plan,&rdquo; a &ldquo;multi-employer plan,&rdquo; a &ldquo;deferred profit sharing plan,&rdquo; an &ldquo;employee
life and health trust&rdquo;, an &ldquo;employee trust&rdquo; or an &ldquo;employees profit sharing plan,&rdquo; in each case within
the meaning of the Tax Act. No Employee Plan is (i)&nbsp;intended or characterized by the Company or any Company Subsidiary to be, or
(ii)&nbsp;has ever been found or alleged by a Governmental Body to be a &ldquo;salary deferral arrangement&rdquo; within the meaning
of the Tax Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Each
of the Employee Plans that is intended to be qualified under Section&nbsp;401(a)&nbsp;of the Code is so qualified and has obtained a
favorable determination letter (or opinion letter, if applicable) as to its qualified status under the Code and there are no facts or
circumstances that could reasonably be expected to cause the loss of such qualification. Each of the Employee Plans is now, and has since
January&nbsp;1, 2020, been operated in compliance with its terms and all applicable Laws, including but not limited to ERISA and the
Code, except as would not be reasonably expected to result in a material liability for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be reasonably expected to result in a material liability for the Company (i)&nbsp;each Canadian Plan has been administered
and operated in compliance with its terms and applicable Law, (ii)&nbsp;each Canadian Plan required to be filed, registered or approved
by a non-U.S. Governmental Body has been so filed, registered or approved and has been maintained in good standing with applicable regulatory
authorities, and no event has occurred since the date of the most recent approval or application therefor relating to any such Canadian
Plan that could reasonably be expected to affect any such approval relating thereto or increase the costs relating thereto, (iii)&nbsp;each
Canadian Plan that is required to be funded under applicable Law is fully funded or fully insured on a termination basis (determined
using reasonable actuarial assumptions) and (iv)&nbsp;if a Canadian Plan is intended to qualify for special Tax treatment (or permitted
to have been approved to obtain any beneficial Tax or other status), such Canadian Plan meets all requirements for such treatment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
to the extent required under Section&nbsp;601 <I>et seq</I>. of ERISA or Section&nbsp;4980B of the Code (or any other similar state or
local Law), neither the Company nor any Employee Plan, or other Canadian Plans has any present or future obligation to provide post-employment
welfare benefits to or make any payment to, or with respect to, any Company Associate pursuant to any retiree medical benefit plan or
other retiree welfare plan or Employee Plan, except to the extent required by applicable employment standards legislation. No Canadian
Plan provides or promises Company Associates health and welfare benefit beyond their retirement or other termination of service (including
pursuant to individual contracts of employment or severance), except to the extent required by applicable employment standards legislation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary maintains any obligations (whether pursuant to an Employee Plan or otherwise) to gross-up or reimburse
any individual for any Taxes incurred by such individual, including those payable under Sections 409A or 4999 of the Code, except as
would not be reasonably expected to result in a material liability for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as set forth in the Plan of Arrangement with respect to the treatment of Company Equity Awards, none of the execution and delivery of
this Agreement, the performance of this Agreement or the consummation of the Transactions could (either alone or in combination with
another event) result in (i)&nbsp;the Company or any Company Subsidiary becoming liable for any of the following: (A)&nbsp;severance
or termination pay owed to a Company Associate upon any termination of employment or service after the date of this Agreement, or any
increase thereof, (B)&nbsp;any payment, compensation or benefit becoming due, or any increase thereof, (C)&nbsp;the acceleration of the
time of payment or vesting of any payment, compensation or benefit and (D)&nbsp;any funding (through a grantor trust or otherwise) of
any compensation or benefit, (ii)&nbsp;any other liability or obligation pursuant to any of the Employee Plans or (iii)&nbsp;the payment
of any amount that could, individually or in combination with any other payment or benefit, constitute an &ldquo;excess parachute payment&rdquo;
within the meaning of Section&nbsp;280G of the Code or result in the payment of an excise tax by any Person under Section&nbsp;4999 of
the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Neither
the Company nor any Company Subsidiary has incurred any liability or obligation under the Worker Adjustment and Retraining Notification
Act and the regulations promulgated thereunder or any similar state, provincial, local, or foreign Law (the &ldquo;<B><I>WARN Act</I></B>&rdquo;)
that remains unsatisfied except as would not be reasonably expected to result in a material liability for the Company. Within the last
three (3)&nbsp;months, there has not been any plant closing or mass layoff, or term of similar import under any applicable similar Law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">No
Legal Proceedings (other than routine claims for benefits in the ordinary course) are pending or threatened against any Employee Plan,
the assets of any of the trusts under any such plan or the plan sponsor or administrator, or against any fiduciary of any Employee Plan
with respect to the operation thereof, and no fact or circumstance exists that would reasonably be expected to give rise to any such
Legal Proceeding except as would not be reasonably expected to result in a material liability for the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Where
applicable, each of the Company and the Company Subsidiaries are and have been in compliance with the Voluntary Retirement Savings Plans
Act (Qu&eacute;bec).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be reasonably expected to result in a material liability for the Company, all data necessary to administer each Employee
Plan in accordance with its terms and conditions and all Laws is in possession of the of the Company or the Company Subsidiaries and
such data are materially complete, correct, and in a form which is sufficient for the proper administration of each Employee Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as would not be reasonably expected to result in a material liability for the Company, no insurance policy or any other agreement affecting
any Employee Plan requires or permits a retroactive increase in contributions, premiums or other payments due under such insurance policy
or agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Environmental
Matters</U>. Except for those matters that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect: (a)&nbsp;the Company and each Company Subsidiary is, and has been, in compliance with all applicable Environmental Laws, which
compliance includes obtaining, maintaining or complying with all Governmental Authorizations required under Environmental Laws for the
operation of its business; (b)&nbsp;as of the date of this Agreement, there is no investigation, suit, claim, action or Legal Proceeding
relating to or arising under any Environmental Law that is pending or, to the knowledge of the Company, threatened in writing against
the Company or any Company Subsidiary or, to the knowledge of the Company, the Leased Real Property; (c)&nbsp;as of the date of this
Agreement, neither the Company nor any Company Subsidiary has received any written notice, report, or other information of or entered
into any legally binding agreement, order, settlement, judgment, injunction, or decree involving uncompleted, outstanding, or unresolved
violations, liabilities, or requirements on the part of the Company or any Company Subsidiary relating to or arising under Environmental
Laws; (d)&nbsp;to the knowledge of the Company: (i)&nbsp;no Person has been exposed to any Hazardous Material at a property or facility
of the Company or any Company Subsidiary at levels in excess of applicable permissible exposure levels; and (ii)&nbsp;there is and has
been no Hazardous Material present or Released on, at, under, or from any property or facility, including the Leased Real Property, in
a manner and concentration that would reasonably be expected to result in any claim against or liability of the Company or any Company
Subsidiary under any Environmental Law; and (e)&nbsp;neither the Company nor any Company Subsidiary has assumed, undertaken, or otherwise
become subject to any known liability of another Person arising under Environmental Laws other than any indemnity in Material Contracts
or other licenses, leases, or sub-leases for real property.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Insurance</U>.
All material insurance policies with respect to the business and assets of the Company and the Company Subsidiaries (a)&nbsp;are set
forth in Section&nbsp;29(a)&nbsp;of the Company Disclosure Schedule and (b)&nbsp;the Company has delivered or made available to Parent
accurate and complete copies of all such insurance policies and a description of all material self-insurance programs and arrangements
relating to the business, assets and operations of the Company and the Company Subsidiaries existing as of the date of this Agreement.
Except as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (a)&nbsp;the Company
and its Subsidiaries maintain or are otherwise covered by insurance in such amounts and against such risks as is sufficient to comply
with applicable Law and Contracts to which the Company or any Company Subsidiary is bound; and (b)&nbsp;as of the date of this Agreement,
all insurance policies with respect to the business and assets of the Company and the Company Subsidiaries are in full force and effect
(except for any expiration thereof in accordance with its terms), all premiums due thereon have been paid in full, no written notice
of cancellation or modification has been received, and there is no existing default or event that, with the giving of notice or lapse
of time or both, would constitute a default by any insured thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">30.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Legal
Proceedings; Orders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date of this Agreement, there is no Legal Proceeding pending or, to the knowledge of the Company, threatened in writing, against
the Company or any Company Subsidiary, or any property or asset of the Company or any Company Subsidiary, or to the knowledge of the
Company, against any present or former officer, director or employee of the Company or any Company Subsidiary in such individual&rsquo;s
capacity as such, other than any Legal Proceeding that would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect or to prevent or materially delay the ability of the Company to consummate the Arrangement by the End Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Since
January&nbsp;1, 2018, neither the Company nor, to the knowledge of the Company, any of its contract manufacturers for any Company Products,
have received any FDA Form&nbsp;483 or other notices of violations, inspectional observations, warning letters, untitled letters or other
written administrative, regulatory or enforcement notice from any Regulatory Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">As
of the date of this Agreement, there is no order, writ, injunction, or judgment to which the Company or any Company Subsidiary is subject
that would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">To
the knowledge of the Company, as of the date of this Agreement, no investigation or review by any Governmental Body with respect to the
Company is pending or is being threatened, other than any investigations or reviews that would not reasonably be expected to be material
to the business of the Company and the Company Subsidiaries, taken as a whole.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Opinions
of Financial Advisors</U>. The Company Board (in such capacity) has received the opinions of each of Centerview Partners LLC (the &ldquo;<B><I>Company
Financial Advisor</I></B>&rdquo;), and Bloom Burton Securities Inc. (<B><I>&ldquo;Bloom Burton&rdquo;</I></B>), on or prior to the date
of this Agreement, that, as of the date of each such opinion and based on and subject to the matters set forth therein, including the
various assumptions made, procedures followed, matters considered and qualifications and limitations set forth therein, the Arrangement
Consideration to be paid to the Shareholders (other than any Shares (i)&nbsp;held by the Company, (ii)&nbsp;owned by Parent or any of
its Subsidiaries (including Purchaser) in each case as of immediately prior to the Effective Time of the Arrangement, or (iii)&nbsp;held
by Dissenting Holders) pursuant to this Agreement is fair from a financial point of view to such holders. The Company shall provide a
copy of such written opinions to Parent solely for informational purposes promptly after receipt thereof by the Company Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Financial
Advisors</U>. Except for the Company Financial Advisor pursuant to the Company Financial Advisor Engagement Letter and Bloom Burton pursuant
to Bloom Burton Engagement Letter, no broker, finder, investment banker, financial advisor, or other Person is entitled to any brokerage,
finder&rsquo;s, or other similar fee or commission, or the reimbursement of expenses in connection therewith, in connection with the
Transactions based upon arrangements made by or on behalf of the Company. The Company has, prior to the execution and delivery of this
Agreement, made available to Parent true, correct, and complete copies of the Company&rsquo;s engagement letters with each of the Company
Financial Advisor (the &ldquo;<B><I>Company Advisor Engagement Letter</I></B>&rdquo;) and Bloom Burton (the <B><I>&ldquo;Bloom Burton
Engagement Letter&rdquo;</I></B>) relating to the Transactions as in effect on the date of this Agreement and shall not have been amended
as of the Effective Time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Related
Party Transactions</U>. Except as disclosed in Section&nbsp;33 of the Company Disclosure Schedule, for Contracts made solely among the
Company and its Subsidiaries or for Contracts entered into in the ordinary course of business on terms not materially less favorable
to Company or its Subsidiaries than are available from an arm&rsquo;s length party, there are no Contracts between the Company or any
of its Subsidiaries and any Person with whom Company or its Subsidiaries is not dealing, as of the date of this Agreement, at arm&rsquo;s
length (within the meaning of the Tax Act) (each of the foregoing, a &ldquo;<B><I>Company Related Party Transaction</I></B>&rdquo;).
To the knowledge of the Company, except as disclosed in Section&nbsp;33 of the Company Disclosure Schedule, no related party of the Company
(within the meaning of MI 61-101) together with its associated entities, beneficially owns or exercises control or direction over 1%
or more of the outstanding Shares, except for related parties who will not receive a &ldquo;collateral benefit&rdquo; (within the meaning
of such instrument) as a consequence of the transactions contemplated by this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Major
Suppliers</U>. Section&nbsp;34 of the Company Disclosure Schedule sets forth an accurate and complete list of (i)&nbsp;each supplier
who was one (1)&nbsp;of the ten (10)&nbsp;largest suppliers of the Company and its Subsidiaries (taken as a whole) for each of 2021 and
2022, based on amounts paid or payable to such suppliers as of the date of this Agreement and (ii)&nbsp;each supplier involved in the
conduct of any clinical trials operated by the Company or any of its Subsidiaries ((i)&nbsp;and (ii)&nbsp;each, a &ldquo;<B><I>Major
Supplier</I></B>&rdquo;). Neither the Company nor any Company Subsidiary has any pending material dispute with any Major Supplier. Since
January&nbsp;1, 2020, neither the Company now any Company Subsidiary has received any written notice or, to the knowledge of the Company,
other communication from any Major Supplier to the effect that such Major Supplier will likely not continue as a supplier of any of the
Company or any Company Subsidiary or to the effect that such Major Supplier intends to terminate or materially modify any existing Contract
with the Company or any of its Subsidiaries in any manner materially adverse to the Company and its Subsidiaries, including by materially
reducing the scale of the business conducted with, the Company or any of its Subsidiaries. To the Company&rsquo;s knowledge, each Major
Supplier conducts its business in respect of the Company in material compliance with all applicable Laws (including Healthcare Laws)
and the Company exercises appropriate oversight of all Major Suppliers compliance with such Laws. The Company has not subjected any Major
Suppliers to, and to the Company&rsquo;s knowledge no Major Supplier has been subjected by any Regulatory Authority to, any corrective
or preventative actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
D</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND
PURCHASER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Due
Organization</U>. Parent is duly organized, validly existing and in good standing pursuant to the Laws of its jurisdiction of organization
and has the requisite power and authority to (a)&nbsp;conduct its business in the manner in which its business is currently being conducted,
(b)&nbsp;own and use its assets in the manner in which its assets are currently owned and used, and (c)&nbsp;perform its obligations
under all Contracts by which it is bound, except as would not, individually or in the aggregate, reasonably be expected to have a Parent
Material Adverse Effect. Parent has made available to the Company accurate and complete copies of the certificate of the Constating Documents
of Parent and Purchaser, including all amendments thereto. None of Parent or Purchaser is in violation of any provision of its Constating
Documents, except for violations that would not, individually or in the aggregate, be reasonably expected to have a Parent Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Purchaser</U>.
Purchaser is a corporation duly organized, validly existing and in good standing pursuant to the Laws of its jurisdiction of organization
and has the requisite power and authority to (a)&nbsp;conduct its business in the manner in which its business is currently being conducted,
(b)&nbsp;own and use its assets in the manner in which its assets are currently owned and used, and (c)&nbsp;perform its obligations
under all Contracts by which it is bound, except as has not had and would not have, individually or in the aggregate, a Parent Material
Adverse Effect. Purchaser was formed solely for the purpose of engaging in the Transactions and activities incidental thereto and prior
to the Effective Time, Purchaser will not have engaged in any business activity or conducted any operation other than in connection with
the Transactions or as contemplated by this Agreement and those incident to its formation. Parent, as of the date of this Agreement and
as of the Effective Time will directly or indirectly be, the sole beneficial stockholder of Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Authority;
Execution and Binding Obligation</U>. This Agreement has been duly executed and delivered by each of the Purchaser and the Parent, and
constitutes a legal, valid and binding agreement of each of the Purchaser and the Parent enforceable against each of the Purchaser and
the Parent in accordance with its terms subject only to the Enforceability Exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Non-Contravention;&nbsp;Consents</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery of this Agreement by Parent and Purchaser do not, and the performance of this Agreement by Parent and Purchaser
and the consummation by Parent and Purchaser of the Transactions will not, (i)&nbsp;conflict with or violate either Parent&rsquo;s or
Purchaser&rsquo;s Constating Documents, (ii)&nbsp;assuming that all consents, approvals, and other authorizations described in <U>Section&nbsp;4(b)</U>&nbsp;of
Schedule D have been obtained and that all filings and other actions described in Section&nbsp;4(b)&nbsp;of the Company Disclosure Schedule
have been made or taken, conflict with or violate any Law applicable to Parent or Purchaser or by which any property or asset of Parent
or Purchaser is bound, or (iii)&nbsp;result in any breach or violation of, or constitute a default (or an event that, with notice or
lapse of time or both, would become a default) by Parent or any Subsidiary of Parent (including Purchaser) under, or give to others any
right of termination, amendment, acceleration, or cancellation of, or result in the loss of any benefit to which Parent or Purchaser
is entitled under, or the creation of any Encumbrance (other than Permitted Encumbrances) on the properties or assets of the Company
or Company Subsidiaries pursuant to, any Contract or other instrument or obligation to which Parent or Purchaser is a party or by which
Parent or Purchaser or any property or asset of either of them is bound, except, with respect to each of the foregoing clauses (ii)&nbsp;and
(iii), for any such conflicts, violations, breaches, defaults, rights, terminations, amendments, cancellations, accelerations, Encumbrances
or other occurrences that would not have a Parent Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 112; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
execution and delivery of this Agreement by each of Parent and Purchaser do not, and the performance by each of Parent and Purchaser
of their respective covenants and obligations pursuant to this Agreement and the consummation by Parent and Purchaser of the Transactions
will not, require any consent, approval, authorization, or permit of, or filing with or notification to, any Governmental Body on the
part of Parent, Purchaser or any of their Affiliates with respect to any of the foregoing except for (i)&nbsp;applicable requirements
and any filing required under the rules&nbsp;and regulations of NYSE, Nasdaq, TSX or LSE, as applicable, (ii)&nbsp;filings with the SEC
or the Securities Authorities, (iii)&nbsp;the filing of Articles the Articles of Arrangement with the applicable Governmental Body; (iv)&nbsp;the
Interim Order and the Final Order, (v)&nbsp;filings with the Director under the CBCA, (vi)&nbsp;the premerger notification and waiting
period requirements of the HSR Act, (vii)&nbsp;any consent, approval, order, authorization, authority, transfer, waiver, disclaimer,
registration, declaration, or filing set forth in Section&nbsp;4(b)&nbsp;of the Company Disclosure Schedule, and (viii)&nbsp;any other
consent, approval, order, authorization, authority, transfer, waiver, disclaimer, registration, declaration, or filing that, in each
case, if not obtained or made, would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse
Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Absence
of Litigation</U>. There is no Legal Proceeding pending or, to the knowledge of Parent, threatened in writing against Parent or Purchaser,
except as would not, individually or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect. To the knowledge
of Parent or Purchaser, as of the date of this Agreement, neither Parent nor Purchaser is subject to any final and binding continuing
order of, consent decree, settlement agreement, or similar written agreement with, or continuing investigation by, any Governmental Body,
or any order, writ, judgment, injunction, decree, determination, or award of any Governmental Body, except as would not, individually
or in the aggregate, reasonably be expected to have a Parent Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Funds</U>.
Parent has, and will at the Closing have, cash resources in immediately available funds and in an amount sufficient to consummate the
Transactions, including payment of the Arrangement Consideration and any fee and expense of, or payable by, Parent or Purchaser in connection
with the Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Ownership
of Shares</U>. Neither Parent nor Purchaser holds or beneficially owns any securities of the Company or any of its Affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Brokers
and Other Advisors</U>. Except for PJT Partners,&nbsp;Inc., there is no broker, investment banker, financial advisor is entitled to any
broker&rsquo;s, finder&rsquo;s, financial advisor&rsquo;s, or other similar fee or commission in connection with the Transactions based
upon arrangements made by or on behalf of Parent or any Subsidiary of Parent except for Persons, if any, whose fees, and expenses shall
be paid by Parent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Investment
Canada Act</U>. Each of Parent and Purchaser (i)&nbsp;is, and at the time of Closing will be, a trade agreement investor that is not
a state-owned enterprise, and (ii)&nbsp;is not, and at the time of Closing will not be, a Russian investor, all within the meaning and
for the purposes of the <I>Investment Canada Act (Canada)</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">D-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Schedule
E</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>D&amp;O SUPPORT AND VOTING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 114; Options: NewSection Last; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt">E-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>tm2313190d1_ex99-3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 99.3</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0"><B>D&amp;O SUPPORT AND VOTING AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">April 17, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>14934792 CANADA INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">980 Great West Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Brentford, Middlesex, United Kingdom</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>GSK PLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">980 Great West Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Brentford, Middlesex, United Kingdom</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Dear Sirs/Madams:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 0.5in"><B>Re:</B></TD>
  <TD><B>Support and Voting Agreement</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The undersigned understands that <B>14934792
CANADA INC.</B> (the &ldquo;<B>Purchaser</B>&rdquo;), <B>GSK PLC </B>(the &ldquo;<B>Parent</B>&rdquo;) and <B>BELLUS HEALTH INC. </B>(the
 &ldquo;<B>Company</B>&rdquo;) wish to enter into an arrangement agreement dated as of the date hereof (the &ldquo;<B>Arrangement
Agreement</B>&rdquo;) contemplating an arrangement (the &ldquo;<B>Arrangement</B>&rdquo;) of the Company under Section 192 of the <I>Canada
Business Corporations Act</I>, the result of which shall be the acquisition by the Purchaser of all the outstanding shares in the
capital of the Company (the &ldquo;<B>Shares</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">All capitalized terms used but not otherwise defined herein
shall have the respective meanings ascribed to them in the Arrangement Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">1.</TD><TD>The undersigned hereby agrees, solely in his or her capacity as a securityholder of the Company and not in his or her capacity as
an officer or director of the Company, from the date hereof until the earlier of (i) the Effective Time and (ii) the termination of the
Arrangement Agreement in accordance with its terms:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="padding-right: 3pt">to vote or to cause to be voted all of the Subject Securities (as defined below) entitled to vote, including
any other such securities of the Company directly or indirectly acquired by or issued to the undersigned after the date hereof, in favour
of the approval of the Arrangement Resolution and any other matter necessary for the consummation of the transactions contemplated by
the Arrangement Agreement;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="padding-right: 3pt">no later than ten (10) days prior to the Company Meeting, to deliver or to cause to be delivered to the
Company duly executed proxies or voting instruction forms voting in favour of the approval of the Arrangement Resolution, such proxy or
voting instruction forms not to be revoked or withdrawn without the prior written consent of the Parent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">not to, directly or indirectly (including through any of its Representatives): (i)&nbsp; solicit, assist, initiate,
knowingly encourage or otherwise knowingly facilitate (including by way of furnishing or providing copies of, access to, or disclosure
of, any confidential or non-public information, properties, facilities, books or records of the Company or any Company Subsidiary or entering
into any form of agreement, arrangement or understanding) any inquiry, proposal, discussion, negotiation or offer that constitutes or
may reasonably be expected to constitute or lead to, an Acquisition Proposal, (ii) enter into, continue or otherwise initiate, solicit,
knowingly encourage, engage or participate in or knowingly facilitate (including by the furnishing any confidential or nonpublic information
regarding the Company or any Company Subsidiary) any discussions or negotiations with any Person (other than with Parent, Purchaser, Parent&rsquo;s
Representatives or any Person acting jointly or in concert with Parent or Purchaser) regarding any inquiry, proposal or offer that constitutes
or may reasonably be expected to constitute or lead to, an Acquisition Proposal, (iii) accept, approve, endorse or recommend, or publicly
propose to accept, approve, endorse or recommend, any Acquisition Proposal; (iv) withdraw support, or propose publicly to withdraw support,
from the transactions contemplated by the Arrangement Agreement, (iv) enter, or propose publicly to enter, into any agreement related
to any Acquisition Proposal; (v) act jointly or in concert with others with respect to voting securities of the Company for the purpose
of opposing or competing with the Purchaser and the Parent in connection with the Arrangement Agreement, or (vi) join in the requisition
of any meeting of the securityholders of the Company for the purpose of considering any resolution related to any Acquisition Proposal;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="padding-right: 4pt">except as contemplated by the Arrangement Agreement and this letter agreement, not to, directly or indirectly,
(i) sell, transfer, gift, assign, grant a participation interest in, option, pledge, hypothecate, grant a security or voting interest
in or otherwise convey or encumber (each, a &ldquo;<B>Transfer</B>&rdquo;), or enter into any agreement, option or other arrangement (including
any profit sharing arrangement, forward sale or other monetization arrangement) with respect to the Transfer of any of its Subject Securities
to any Person; (ii) grant or agree to grant any proxy, power of attorney or other right to vote the Subject Securities, or enter into
any voting trust or pooling agreement or arrangement in respect of the Subject Securities; or (iii)&nbsp; agree to take
any of the actions described in the foregoing clauses (i) and (ii); <I>provided </I>that the undersigned may (x) exercise and/or
settle Company Equity Awards to acquire additional Shares, and (y) Transfer Subject Securities to a corporation, family trust,
registered retirement savings plan or other entity directly or indirectly owned or controlled by the undersigned or under common
control with or controlling the undersigned provided that (A) such Transfer shall not relieve or release the undersigned of or from
his or her obligations under this letter agreement, including, without limitation, the obligation of the undersigned to vote or
cause to be voted all Subject Securities at the Company Meeting in favour of the approval of the Arrangement Resolution and any
other matter necessary for the consummation of the transactions contemplated by the Arrangement Agreement, (B) prompt written notice
of such Transfer is provided, (C) the transferee continues to be a corporation, trust, registered retirement savings plan or other entity directly or indirectly controlled
by the undersigned or under common control with or controlling the undersigned, at all times prior to the termination of this letter agreement;
and (D) the transferee agrees in writing in favour of the Purchaser and the Parent to be bound by all of the terms and conditions of this
letter agreement as if it were a party hereto; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="padding-right: 27pt">not to exercise any rights of appraisal or rights of dissent provided under any applicable Laws or otherwise
in connection with the Arrangement or the transactions contemplated by the Arrangement Agreement.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">2.</TD><TD STYLE="padding-right: 3pt">Notwithstanding any provision of this letter agreement to the contrary, each of the Purchaser and the Parent
hereby agrees and acknowledges that the undersigned is executing this letter agreement and is bound hereunder solely in his or her capacity
as a securityholder of the Company. Without limiting the provisions of the Arrangement Agreement, nothing contained in this letter agreement
shall limit or affect any actions the undersigned may take in his or her capacity as a director or officer of the Company or limit or
restrict in any way the exercise of his or her fiduciary duties as director or officer of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">3.</TD><TD>The undersigned hereby represents and warrants that (a) this letter agreement has been duly executed and delivered and is a valid
and binding agreement, enforceable against the undersigned in accordance with its terms, and the performance by the undersigned of its
obligations hereunder will not constitute a violation or breach of or default under, or conflict with, any contract, commitment, agreement,
understanding or arrangement of any kind to which the undersigned will be a party and by which the undersigned will be bound at the time
of such performance, (b) he or she has been afforded the opportunity to obtain independent legal advice and confirms by the execution
of this letter agreement that he or she has either done so or waived his or her right to do so in connection with the entering into of
this letter agreement, and that any failure on the undersigned&rsquo;s part to seek independent legal advice shall not affect (and the
undersigned shall not assert that it affects) the validity, enforceability or effect of this letter agreement or the Arrangement Agreement,
(c) as of the date hereof, he or she, or one of his or her Affiliates or associates is, the sole, registered and/or beneficial owner of
the number of Shares, other securities convertible into or exchangeable or exercisable for Shares, or any other rights to acquire Shares,
as set forth on the signature page to this letter agreement (collectively, &ldquo;<B>Subject Securities</B>&rdquo;), with good title thereto
free of any and all encumbrances and demands of any nature or kind whatsoever, and he or she has the sole right to vote (in the case of
the Shares) and sell (in the case of transferable Subject Securities) all of the Subject Securities, (d) except for the Arrangement Agreement
and this letter agreement, no person has any agreement or option, or any right or privilege (whether by law, preemptive or contractual)
capable of becoming an agreement or option for the purchase, acquisition or transfer from the undersigned or the applicable holder of
any of the Subject Securities and (e) the only securities of the Company beneficially owned or controlled, directly or indirectly, by
the undersigned on the date hereof are the Subject Securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">This letter agreement may terminate at any time upon the mutual written agreement of the parties hereto
and shall automatically terminate and be of no further force or effect upon the earlier of: (i) the Effective Time or (ii) termination
of the Arrangement Agreement in accordance with its terms.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">5.</TD><TD STYLE="padding-right: 2pt">This letter agreement will be governed by and interpreted and enforced in accordance with the laws of the
Province of Qu&eacute;bec and the federal laws of Canada applicable therein. Each party hereto irrevocably attorns and submits to the
non-exclusive jurisdiction of the Qu&eacute;bec courts situated in the City of Montr&eacute;al and waives objection to the venue of any
proceeding in such court or that such court provides an inconvenient forum. This letter agreement may be executed in any number of counterparts
(including counterparts by electronic copies) and all such counterparts taken together shall be deemed to constitute one and the same
instrument.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">6.</TD><TD STYLE="padding-right: 4pt">Each of the Purchaser and the Parent may, without the prior written consent of the undersigned, assign,
delegate or otherwise Transfer rights and interests hereunder to an assignee of rights and obligations of the Purchaser or the Parent
under the Arrangement Agreement pursuant to an assignment thereof in accordance with the Arrangement Agreement. Except as contemplated
by and in accordance with Section 1d. above, the undersigned may not assign, delegate or otherwise Transfer any of its rights, interests
or obligations under this letter agreement without the prior written consent of the Purchaser and the Parent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">7.</TD><TD STYLE="padding-right: 8pt">Each of the undersigned, the Purchaser and the Parent hereby consents to the disclosure of the substance
of this letter agreement in any press release, documents filed with the Court in connection with the Arrangement or transactions contemplated
by the Arrangement Agreement or any filing pursuant to applicable Securities Laws, including the Circular.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">8.</TD><TD STYLE="padding-right: 21pt">This letter agreement may be executed in any number of counterparts (including counterparts by facsimile
or electronic copy) and all such counterparts taken together shall be deemed to constitute one and the same instrument.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">9.</TD><TD STYLE="padding-right: 2pt">If the foregoing is in accordance with the Purchaser&rsquo;s and the Parent&rsquo;s understanding and is
agreed to by the Purchaser and the Parent, please signify the Purchaser&rsquo;s and the Parent&rsquo;s respective acceptance by the execution
of the enclosed copies of this letter agreement where indicated below by an authorized signatory of the Purchaser and the Parent and return
the same to the undersigned, upon which this letter agreement as so accepted shall constitute an agreement between the Purchaser, the
Parent and the undersigned.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">10.</TD><TD>The parties expressly acknowledge that they have requested that this letter agreement and all ancillary related documents thereto
be drafted in the English language only. <I>Les parties aux pr&eacute;sentes reconnaissent avoir exig&eacute; que la pr&eacute;sente lettre
entente et tous les documents qui y sont accessoires soient r&eacute;dig&eacute;s en anglais seulement. </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>[Remainder of page left intentionally blank. Signature
page follows.]</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->-</FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yours
    truly,</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Signature)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Print
    Name)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Title)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Place
    of Residency)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    and Title)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Quantity and type of Subject Securities owned (beneficially
or otherwise) as of the date hereof:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 12%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
  Shares:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 6%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 15%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
  Share Units:</FONT></TD>
  <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>Signature Page - D&amp;O Support and Voting Agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
and agreed on this 17<SUP>th</SUP> day of April, 2023.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GSK
    PLC</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 3%">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif; width: 3%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 44%"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David Redfern</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Corporate Development</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14934792
    CANADA INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher W. Cummins</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Secretary</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"> <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mark S. Tillbrook</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><I>Signature Page - D&amp;O Support and Voting Agreement</I></P>



<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
